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Introduction
‘…in the beginning of the malady it is easy to cure but difficult to
detect, but in the course of time, not having been either detected or
treated … it becomes easy to detect but difficult to cure.’
Niccolo Machiavelli, The Prince
This book is aimed at trainees in internal medicine, surgery,
anaesthesia, intensive care, and emergency medicine – people
who deal with acutely ill adults. Final year medical students
and nursing staff in critical care areas will also find this book
extremely useful.
There are many books on the management of patients who
are acutely ill, but all have a traditional “recipe” format. One
looks up a diagnosis and the management is summarised. Few
of us are trained how to deal with the generic altered
physiology that can accompany acute illness. The result is that
many doctors are unable to deal logically with patients in
physiological decline and this often leads to suboptimal care.
In our surveys of doctors of all specialties, few can explain
how different oxygen masks work, the difference between
hypercapnic respiratory failure and “CO2 retention”, what a
fluid challenge is and how to effectively treat organ failure.
This book contains information that you really need to
know and that is not found in a standard textbook.
Throughout the text are “mini-tutorials” that explain the
latest thinking or controversies. Case histories and problem-
solving exercises are included at the end of each chapter.
Further reading is included for more information. It is our aim
that this book should provide a foundation in learning how to
care effectively for those who are acutely ill.
Nicola Cooper and Paul Cramp
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Units used in this book
Standard International (SI) units are used throughout this
book, with metric units in brackets where these differ. Below
are some reference ranges for common blood results.
Reference ranges vary from laboratory to laboratory.
Metric units × conversion factor = SI units
ix
Conversion 
Test Metric units factor SI units
Sodium 135–145 meq/litre 1 135–145 mmol/litre
Potassium 3·5–5·0 meq/litre 1 3·5–5·0 mmol/litre
Urea (blood 8–20 mg/dl 0·36 2·9–7·1 mmol/litre
urea nitrogen)
Creatinine 0·6–1·2 mg/dl 83·3 50–100 µmol/litre
Glucose 60–115 mg/dl 0·06 3·3–6·3 mmol/litre
Partial 83–108 mmHg 0·13 11–14·36 kPa
pressure O2
Partial 32–48 mmHg 0·13 4·26–6·38 kPa
pressure CO2
Bicarbonate 22–28 meq/litre 1 22–28 mmol/litre
Calcium 8·5–10·5 mg/dl 0·25 2·1–2·6 mmol/litre
Chloride 98–107 meq/litre 1 98–107 mmol/litre
Lactate 0·5–2·0 meq/litre 1 0·5–2·0 mmol/litre

Abbreviations
Please find below a list of common abbreviations used
throughout this book.
ACTH adrenocorticotropic hormone
ADH antidiuretic hormone
AF atrial fibrillation
ALI acute lung injury
APC activated protein C
ARDS acute respiratory distress syndrome
ARF acute renal failure
AS aortic stenosis
ATLS Advanced Trauma and Life Support
ATN acute tubular necrosis
BE base excess
BiPAP biphasic or bilevel positive airway pressure
BP blood pressure
BUN blood urea nitrogen
CAVH continuous arteriovenous haemofiltration
CBF cerebral blood flow
CO cardiac output
COPD chronic obstructive pulmonary disease
CPAP continuous positive airway pressure
CPP cerebral perfusion pressure
CPR cardiopulmonary resuscitation
CT computed tomography
CVP central venous pressure
CVVH continuous venovenous haemofiltration
DIC disseminated intravascular coagulation
DO2 oxygen delivery
DVT deep vein thrombosis
ECF extracellular fluid
xi
EFW electrolyte-free water
ERCP endoscopic retrograde cholangiopancreatogram
FiO2 fraction of inspired oxygen
FVC forced vital capacity
GCS Glasgow Coma Scale
Hb haemoglobin
HDUs high dependency units
HES hydroxyethyl starch
HR heart rate
ICF intracellular fluid
ICP intracranial pressure
ICU Intensive Care Unit
IPPV intermittent positive pressure ventilation
LIDCO lithium dilution and arterial waveform analysis
LP lumbar puncture
LVEDP left ventricular end-diastolic pressure
MAP mean arterial pressure
METs medical emergency teams
METS metabolic equivalents
MODS multiple organ dysfunction syndrome
MRI magnetic resonance imaging
MRSA methicillin-resistant Staphylococcus aureus
NIV non-invasive ventilation
NSAIDs non-steroidal anti-inflammatory drugs
OSA obstructive sleep apnoea
PAF platelet-activating factor
PAO2 or PACO2 alveolar partial pressure of oxygen or carbon
dioxide
PaO2 or PaCO2 arterial partial pressure of oxygen or carbon
dioxide
PAOP pulmonary artery occlusion pressure
PE pulmonary embolism
PEEP positive end-expiratory pressure
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xii
PiCCO transpulmonary thermodilution and arterial pulse
contour analysis
PSV pressure support ventilation
RRT renal replacement therapy
SAH subarachnoid haemorrhage
SaO2 arterial oxygen saturation of haemoglobin
SID strong ion difference
SIMV synchronised intermittent mandatory ventilation
SIRS systemic inflammatory response syndrome
SV stroke volume
SVR systemic vascular resistance
SVRI systemic vascular resistance index
TBI traumatic brain injury
TBW total body water
TF tissue factor
TNF tumour necrosis factor
TTP thrombotic thrombocytopenic purpura
ABBREVIATIONS
xiii

11: Patients at risk
By the end of this chapter you will be able to:
• redefine resuscitation
• recognise patients at risk and understand early warning scores
• know about current developments in this area
• understand the importance of the generic altered physiology that
accompanies acute illness (understanding A, B, C, D)
• know how to communicate effectively with colleagues
• understand the benefits and limitations of intensive care
• have a context for the chapters that follow
Redefining resuscitation
Cardiopulmonary resuscitation (CPR) has evolved over the last
40 years into a significant part of healthcare training.
International organisations govern resuscitation protocols. Yet
survival to discharge after in-hospital CPR is poor. Study survival
rates range from 2 to 14%. Public perception of CPR is informed
by television where there are far better outcomes than in reality.
A great deal of attention is focused on saving life after cardiac
arrest, but the vast majority of in-hospital cardiac arrests are
predictable. Hardly any attention is focused on detecting
commonplace reversible physiological deterioration or
preventing cardiac arrest in the first place. Two studies
illustrate this well. In 1990, Schein et al. found that 84% of
patients had documented observations of clinical deterioration
or new complaints within 8 hours of arrest; 70% had either
deterioration of respiratory or mental function observed during
this time. Whilst there did not appear to be any single
reproducible warning signs, the average respiratory rate of the
patients prior to arrest was 30 per minute. The investigators
observed that the predominantly respiratory and metabolic
derangements which preceded cardiac arrest (hypoxaemia,
hypotension, and acidosis) were not rapidly fatal and that
efforts to predict and prevent arrest would therefore be
beneficial. Only 8% patients survived to discharge after CPR in
this study. In 1994, Franklin et al. observed that documented
physiological deterioration occurred within 6 hours in 66% of
patients with cardiac arrest, but no action was taken.
Researchers have commented that there appears to be a failure
of the system to recognise and effectively intervene when
patients in hospital deteriorate. There is little postgraduate
training in the resuscitation of critically ill adults (that is, A, B,
C, D – airway, breathing, circulation and disability), and in the
UK there are too few available senior staff who have the skills to
manage these patients effectively. This impacts on the quality of
admissions to the Intensive Care Unit (ICU). In 1999, McGloin
et al. observed that 36% ICU admissions received suboptimal
care beforehand and that survival was worse in this group. In
1998 McQuillan et al. looked at 100 emergency ICU admissions.
Two external assessors observed that only 20 cases were well
managed beforehand. The majority (54) received suboptimal
care prior to admission to ICU and there was disagreement over
the remaining 26 cases. The patients were of a similar case-mix
and APACHE II (acute physiological and chronic health
evaluation) scores. In the suboptimal group, ICU admission
was considered late in 69% cases and avoidable altogether in
41%. The main causes of suboptimal care were considered to be
failure of organisation, lack of knowledge, failure to appreciate
the clinical urgency, lack of supervision, and failure to seek
advice. Other studies have shown that suboptimal care before
admission to ICU increases mortality by around 50%. ICU
mortality is doubled if the patient is admitted from a general
ward rather than from theatres or the Emergency Department,
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Box 1.1 Recognition of critical illness
1. Physiological
• Signs of massive sympathetic activation, for example, raised
heart rate, blood pressure, pale, shut down
• Signs of systemic inflammation (see chapter 7)
• Signs of organ hypoperfusion, for example, cold peripheries,
increased respiratory rate, oliguria (see chapter 5)
2. Biochemical
• Base deficit/raised lactate
• Raised or low white cell count
• Low platelets
• Raised urea and creatinine
• Raised CRP
in theory because they arrive so sick that they are unlikely to
recover.
Resuscitation is therefore not about CPR. It is about recognising
patients in physiological decline in the first place and then
effectively treating them. This is an area of medicine that has
been neglected in terms of training, organisation, and resources.
Medical emergency teams
Ken Hillman first developed medical emergency teams
(METs) in Sydney, Australia as an alternative to the cardiac
arrest team. The MET was alerted to any critical changes in A,
B, C or D and parameters were provided for guidance. The
MET included an ICU doctor and an ICU nurse. At its disposal
was a critical care facility larger than in most UK hospitals.
In Liverpool, UK, there has been a rise in the number of
MET calls (up to 44% occurring at night) since it was formed
and a decline in the number of cardiac arrests. This is due to
an increase in “Do not attempt CPR” orders as well as
prevention of cardiac arrests: 25% patients seen by the MET
were deemed to be unsuitable for CPR, although that decision
had not yet been made by the referring team. General wards
in the UK are increasingly likely to be filled with patients at
risk of physiological decline. Most patients admitted to ICU
have obvious physiological derangements (Figure 1.1). They
are recognised by general ward staff as being at risk, yet there
is often a lack of effective intervention.
Up to 30% patients admitted to ICUs in the UK have had a
cardiac or respiratory arrest in the preceding 24 hours. Most of
these are already hospital in-patients. Half die immediately
and mortality for the rest on ICU is at least 70%. The purpose
of a medical emergency team instead of a cardiac arrest team
is simple – early action saves lives. As Peter Safar, a pioneer of
resuscitation, has commented, “the most sophisticated
intensive care often becomes unnecessarily expensive
terminal care when the pre-ICU system fails”.
Current developments
In October 1999, the publication in the UK of the Audit
Commission’s Critical to Success – the place of efficient and
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effective critical care services within the acute hospital re-
emphasised the concept of the patient at risk – patients at risk
of their condition deteriorating into a need for critical care.
The report advocated better training of medical and nursing
staff, early warning scoring systems and “outreach” critical
care. The Commission commented that intensive care is
something that tends to happen within four walls, but that
patients should not be defined by what bed they occupy, but
by their severity of illness (Box 1.2).
Following this, Comprehensive Critical Care – a review of adult
critical care services was published by the Department of
Health. The report reiterated the idea that patients should be
classified according to their severity of illness and the
necessary resources mobilised. This includes critical care
outreach teams. In the USA and parts of Europe, there is
considerable provision of high dependency units (HDUs). In
most UK hospitals it is recognised that there are not enough
HDU facilities. A needs assessment survey in Wales, using
ESSENTIAL GUIDE TO ACUTE CARE
4
0
10
20
30
40
50
60
70
80
90
GCS Temp Creat MAP pH WBC Resp Oxygen Pulse
%
Figure 1.1 Abnormal physiological values (%) before admission to ICU.
Reproduced with permission from Theta Press Ltd (Goldhill D. Medical
Emergency Teams. Care of the Critically Ill. 2000;16:209–12. Creat,
creatinine; GCS, Glasgow Coma Score; MAP, mean arterial pressure;
Resp, respiratory rate; Temp, temperature, WBC, white blood cells
objective criteria for HDU and ICU admission, found that 56%
of these patients were being cared for on general wards rather
than in critical care areas. A 1-month needs assessment in
Newcastle, UK found that 26% of the unselected emergency
patients admitted to a medical admissions unit required a
higher level of care: 17% needed level 1 care, 9% needed level
2 care and 0·5% level 2 care. This would indicate the need for
far higher level 1–2 facilities in the UK than at present.
Early warning scores have been developed and advocated as
a means of targeting resources early and therefore more
effectively (Table 1.1). Increasingly abnormal vital signs mean
that the patient is sick and a high score requires early
assessment and intervention by experienced staff. Whilst
these scores could lead to a false sense of security if they are
normal, evidence is emerging that early warning scores can
reduce CPR rates and ICU mortality (Figure 1.2).
A, B, C, D – an overview
History, examination, differential diagnosis and treatment
will not help someone who is critically ill. Diagnosis is
PATIENTS AT RISK
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Box 1.2 New UK severity of illness classification
• Level 0: Patients whose needs can be met through normal ward
care in an acute hospital
• Level 1: Patients at risk of their condition deteriorating, or those
recently relocated from higher levels of care, whose needs can be
met on an acute ward with additional advice and support from the
critical care team
• Level 2: Patients requiring more detailed observation or
intervention including support for a single failing organ system or
post-operative care and those ‘stepping down’ from higher levels
of care
• Level 3: Patients requiring advanced respiratory support alone or
basic respiratory support together with support of at least two
organ systems. This level includes all complex patients requiring
support for multi-organ failure
Level 2 is equivalent to previous HDU care; Level 3 is equivalent to
previous ICU care. Reproduced with permission from DOH
(Comprehensive critical care. London, Department of Health, 2000).
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irrelevant when the things that kill first are literally A (airway
compromise), B (breathing problems), and C (circulation
problems) – in that order. What the patient needs is
resuscitation not deliberation. Patients can be alert and “look”
well from the end of the bed, but the clue is often in the vital
signs. A common theme in studies is the inability of hospital
staff to recognise when a patient is at risk. Even when the vital
signs are documented, there is a failure to appreciate that
serious abnormal physiology is an emergency.
The most common abnormalities before cardiac arrest are
hypoxaemia with an increased respiratory rate and
hypotension leading to hypoperfusion with an accompanying
metabolic acidosis and tissue hypoxia. Hypoperfusion is
common in hospital. If this is left untreated, a downward
physiological spiral ensues. With time the hypoperfusion may
become resistant to treatment with fluids and drugs. Therefore
early action is vital. The following chapters teach the theory
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Figure 1.2 Impact of PART in a London hospital. Abbreviations: CPR,
cardiopulmonary resuscitation; ICU, intensive care unit; PART, patient at
risk team. Reproduced with permission from Theta Press Ltd (Goldhill D.
Medical Emergency Teams. Care of the Critically Ill. 2000;16:209–12
behind A, B, C, D in detail. Practical courses also exist that
use scenario-based teaching on how to manage patients at
risk. These are recommended because the A, B, C approach
described below requires practical skills (for example,
assessment and management of the airway), which cannot be
learned adequately from a book.
A, B, C, D, E is the initial approach to any patient who is
acutely ill:
• A – assess airway and treat if needed
• B – assess breathing and treat if needed
• C – assess circulation (that is, pulse, blood pressure, and
skin perfusion) and treat if needed
• D – assess disability (the simple AVPU scale can be used
(alert, responds to voice, responds to pain, unresponsive)
• E – expose and examine patient fully once A, B, and C are
stable. Arterial blood gases and a bedside glucose
measurement are the first investigations in any critically ill
patient. Further information gathering can be done at this
stage – for example, further history and details from notes
and charts.
If there is one thing in medicine which is evidence-based, it
is that patients with serious abnormal physiology are an
emergency. The management of such patients requires pro-
activity, a sense of urgency, and the continuous presence of
the attending doctor. For example, if a patient is hypotensive
and hypoxaemic from pneumonia, it is not acceptable for
oxygen, fluids, and antibiotics simply to be prescribed. The
oxygen concentration may need to be changed several times
before the PaO2 is acceptable. More than one fluid challenge
may be required to get an acceptable blood pressure – and
even then, vasopressors may be needed if the patient remains
hypotensive because of severe sepsis. Intravenous antibiotics
need to be given immediately. ICU and CPR decisions need to
be made at this time – not later. The emphasis is on both rapid
and effective intervention.
Integral to the management of the acutely ill patient is the
administration of effective analgesia. This is not discussed
further in subsequent chapters but it is extremely important.
Suffice to say that titrated intravenous analgesia is the method
ESSENTIAL GUIDE TO ACUTE CARE
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of choice in critically ill patients who suffer from delayed
gastric emptying and reduced skin and muscle perfusion,
making oral, subcutaneous, or intramuscular drugs less
reliable.
Communication and the critically ill
A new doctor once asked his senior how to treat a patient
who had too much beta blocker. The senior was half listening,
writing in some notes. Another senior was nearby and asked,
“What do you mean – what is the pulse and blood pressure?”
The new doctor replied, “Pulse 30, blood pressure
unrecordable”. Both seniors dashed to the patient’s bedside. It
is important to communicate well if you want other people to
act. When talking to a colleague about a patient who is acutely
ill, use the following guide:
• where you are and your request (for example, “Can you
come to …?”)
• brief history (for example, “New admission with asthma”)
and current physiology: conscious level, pulse, blood
pressure, respiratory rate, oxygen saturations (and urine
output if relevant)
• further details can follow (for example, test results).
It is important to give a summary of the current physiology,
which gives the listener a sense of how urgent the case is. It is
also important to communicate clearly what help is needed,
particularly if you want your colleague to come and see the
patient.
The benefits and limitations of intensive care
Physiological derangement and the need for admission to
ICU is not the same thing. It would not be in the best interests
of all patients to be admitted to an ICU; instead optimising
ward care or even palliative care may be required. Intensive
care supports failing organ systems when there is potentially
reversible disease. Intensive (level 3) care is appropriate for
PATIENTS AT RISK
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patients requiring advanced respiratory support alone or
support of at least two failing organ systems. High dependency
(level 2) care is appropriate for patients requiring detailed
observation or intervention for a single failing organ system.
For the majority of people who have never worked in an
ICU, the benefits and limitations of what is available may be
poorly understood. Patients with acute reversible disease
benefit most from intensive care if they are admitted sooner
rather than later. Waiting for someone to become even more
critically ill before contacting the ICU team is not evidence-
based. On the other hand, some patients may be so ill they are
unlikely to recover at all – even with intensive organ support.
All potential admissions should therefore be assessed by an
experienced doctor. Patients who are not admitted to the ICU
can (and should) still receive good ward care.
The following chapters will describe the theory behind the
assessment and management of acutely ill adults. They are
intended as a foundation upon which experience and
practical training can be built. Understanding and practising
the basics well can prevent in-hospital deaths and admissions
to ICU.
Further reading
Audit Commission. Critical to success – the place of efficient and effective critical
care services within the acute hospital. London: Audit Commission, 1999.
Department of Health. Comprehensive Critical Care – a review of adult critical
care services. London: DoH, 2000.
Franklin C, Matthew J. Developing strategies to prevent in-hospital cardiac
arrest: analysing responses to physicians and nurses in the hourse before
the event. Crit Care Med 1994;22:244–7.
Goldhill D. Medical Emergency Teams. Care of the Critically Ill 2000;16:
209–12.
Hillman K, Parr M, Flabouris A, Bishop G, Stewart A. Redefining in-hospital
resuscitation: the concept of the medical emergency team. Resuscitation
2001;48:105–10.
McGloin H, Adam SK, Singer M. Unexpected deaths and referrals to Intensive
Care of patient on general wards: are some potentially avoidable? J R Coll
Physicians 1999;33:255–9.
McQuillan P, Pilkington S, Allan A et al. Confidential enquiry into quality of
care before admission to intensive care. BMJ 1998;316:1853–8.
Royal College of Physicians of London. Working party report on the interface
between acute general [internal] medicine and critical care. London: RCPL, 2002.
Schein RM, Hazday N, Pena N, Ruben BH. Clinical antecedents to in-hospital
cardiopulmonary arrest. Chest 1990;98:1388–92.
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Practical courses on the management
of acutely ill adults
ALERT (acute life-threatening events recognition and treatment). A generic acute
care course developed by the School of Postgraduate Medicine, University
of Portsmouth, UK.
CCrIMP (care of the critically ill medical patient) is being developed with the
Royal College of Physicians of London.
CCrISP (care of the critically ill surgical patient) is run by the Royal College of
Surgeons of England and Edinburgh.
ALS (advanced life support) is run by the Resuscitation Council UK. This course
centres on the management of cardiac arrest and peri-arrest scenarios.
ATLS (advanced trauma and life support) is run by the Royal College of Surgeons
of England and Edinburgh and focuses on trauma care.
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2: Oxygen
By the end of this chapter you will be able to:
• understand how to prescribe oxygen therapy
• understand what hypoxaemia is
• understand the different devices used to deliver oxygen
• optimise oxygen delivery
• understand the limitations of pulse oximetry
• understand the dif ference between “CO2 retention” from
uncontrolled oxygen therapy and hypercapnic respiratory failure
owing to other reasons
• apply this to your clinical practice
Myths about oxygen
Oxygen was discovered by Joseph Priestley in 1777 and has
become one of the most commonly used drugs in medical
practice. Yet it is poorly prescribed by most medical staff. In 2000
we carried out two surveys of oxygen therapy. The first looked at
oxygen prescriptions in postoperative patients in a large district
general hospital. It found that there were several dozen ways
used to prescribe oxygen and that the prescriptions were rarely
followed. The second surveyed 50 medical and nursing staff
working on a medical admissions, coronary care, and respiratory
unit of another district hospital. They were asked questions
about oxygen masks and the concentration of oxygen delivered
by each mask. They were also asked which mask was most
appropriate for a range of clinical situations and how much
oxygen may be given to patients with chronic obstructive
pulmonary disease (COPD). The answers were very revealing:
• Many people could not name the different types of oxygen
mask.
• The relationship between litres per minute and oxygen
concentration (%) was poorly understood – for example,
most people thought that a patient receives 28% oxygen
from nasal cannulae at 2 litres per minute and 100%
oxygen from a mask with a reservoir bag at 15 litres per
minute.
OXYGEN
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• One-third chose a 28% Venturi mask for an unwell patient
with asthma.
• Just over one-third thought that a diagnosis of COPD
meant that one could never give more than 28% oxygen.
• Not one person understood the different reasons why
PaCO2 rises – the difference between “CO2 retention” from
uncontrolled oxygen therapy and hypercapnic respiratory
failure owing to other causes. Reducing the oxygen
concentration in order to “treat” a high PaCO2 was
common practice.
• It was common practice to use simple face masks at 2 litres
per minute if the patient had COPD.
There are many false beliefs about oxygen and the result is
that many patients are incorrectly treated. Yet oxygen is a drug
with a correct concentration and side effects.
Hypoxaemia
Hypoxaemia is defined as the reduction below normal levels
of oxygen in arterial blood – a PaO2 of < 8·0 kPa (60 mmHg) or
oxygen saturations < 90%. Hypoxia is the reduction below
normal levels of oxygen in the tissues. The normal range for
arterial blood oxygen is 11–14 kPa (85–105 mmHg), which
reduces in old age. It is hypoxia rather than hypoxaemia that
causes cell damage. Hypoxaemia usually results in hypoxia.
The main causes of hypoxaemia are:
• ventilation–perfusion (V
·
/Q
·
) mismatch
• intrapulmonary shunt
• hypoventilation
• increased oxygen consumption.
Severe tissue hypoxia results in cell death and organ damage.
In the ward setting, simple oxygen therapy may reverse the
confusion, agitation, and cardiac ischaemia that is seen in such
circumstances.
Oxygen therapy
There are very few formal criteria for the use of oxygen in
hospital. The American College of Chest Physicians and the
ESSENTIAL GUIDE TO ACUTE CARE
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National Heart, Lung and Blood Institute has published the
following recommendations for instituting oxygen therapy:
• cardiorespiratory arrest
• hypoxaemia (PaO2 < 8·0 kPa/60 mmHg or saturations < 90%)
• hypotension (systolic blood pressure < 100 mmHg)
• low cardiac output with metabolic acidosis
• respiratory distress (respiratory rate > 24 per minute).
Oxygen is also indicated in the perioperative period, in
trauma or other acute illness, carbon monoxide poisoning,
severe anaemia, and when drugs are used that may reduce
ventilation, such as opioids.
In general, the devices available to deliver oxygen can be split
into two categories depending on whether they deliver a
proportion of, or the entire, ventilatory requirement (Figure 2.1;
Table 2.1):
• Low flow devices deliver oxygen at less than the inspiratory
flow rate, for example nasal cannulae and simple face
masks (including masks with a reservoir bag). Although
they are low flow, they can deliver a high concentration of
oxygen. The oxygen concentration is variable.
• High flow devices deliver oxygen at above the inspiratory
flow rate, such as Venturi masks. Although they are high
flow, a low concentration of oxygen may be delivered. The
oxygen concentration is fixed.
Low flow devices – nasal cannulae, simple face
masks and reservoir bag masks
Nasal cannulae are commonly used because they are
convenient and comfortable. They deliver 2–4 litres per
minute of 100% oxygen in addition to the air a person is
breathing. If a person is breathing slowly with 10 breaths per
minute and 500 ml tidal volumes, the minute volume (or
inspiratory flow rate) will be only 5 litres per minute. So the
patient receives 2 litres per minute of 100% oxygen plus
3 litres per minute of air. Two-fifths of what the patient is
breathing is 100% oxygen. However, a person breathing
quickly (40 breaths per minute and 750 ml tidal volumes) will
OXYGEN
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(b)(a)
(d)
Figure 2.1 Different oxygen masks. (a) Nasal cannulae; (b) simple face
mask; (c) reservoir bag mask; (d) Venturi mask. Reproduced with
permission from Intersurgical Complete Respiratory Systems, Wokingham,
Berkshire
Venturi valve colour Flow rate Concentration (%)
(litres per minute)
Blue 2 24
White 4 28
Yellow 6 35
Red 8 40
Green 12 60
(c)
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have a minute volume of 30 litres per minute, so 2 litres per
minute of 100% oxygen should be given plus 28 litres per
minute air. Only two-thirtieths of what the patient is
breathing is 100% oxygen. The person breathing slowly
receives a large proportion of oxygen whilst the person
breathing quickly receives much less. Thus nasal cannulae
deliver a variable concentration of oxygen depending on how
the patient is breathing. It is possible to estimate the
concentration of oxygen by the calculations in Box 2.1.
Table 2.1 Which mask for which patient?
Oxygen device Patients
Nasal cannulae Patients with otherwise normal physiology
(vital signs), for example, postoperative, 
slightly low SaO2, long-term oxygen therapy
Simple face masks Higher concentrations required and controlled
and masks with O2 not necessary, for example, severe
reservoir bag asthma, acute left ventricular failure, 
(> 5 litres/min aiming pneumonia, trauma, severe sepsis
for SaO2 > 94%)
Venturi masks Controlled oxygen therapy required,
for example, patients with COPD
Box 2.1 Calculation of oxygen concentration
• Minute volume: 5 litres per minute (for example, 10 breaths per
minute × 500 ml per breath)
• O2 flow rate: 2 litres per minute
Inspired O2 concentration = 2 litres per minute of 100% O2 + 3 litres
per minute air
• Minute volume: 30 litres per minute (for example, 40 breaths per
minute × 750 ml/breath)
• O2 flow rate: 2 litres per minute
Inspired O2 concentration = 2 litres per minute of 100% O2 + 28 litres
per minute air
1 × 2 + 0·21 × 3
5
1 × 2 + 0·21 × 28
30
= 53%
= 26%
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In some cases the oxygen will not be enough and in some
cases it could be dangerously high, for example in some
patients who retain carbon dioxide. There are several case
reports of these patients becoming unconscious with
hypercapnia once they have been given nasal cannulae,
especially during an acute exacerbation of their illness. There
is no way of accurately knowing how much oxygen is being
delivered.
Simple face masks (also called Hudson or MC masks) deliver
up to 50% oxygen when set to 15 litres per minute. Like
nasal cannulae, the concentration is variable depending on
the fit of the mask and how the patient is breathing.
Sometimes patients are given 2 litres per minute through face
masks because they have COPD. Significant rebreathing of
carbon dioxide can occur if the oxygen is set to < 5 litres per
minute because exhaled air is not adequately flushed from
the mask.
Face masks with a reservoir bag can deliver 70–80% oxygen
at 15 litres per minute but this again depends on the fit of the
mask and how the patient is breathing. A reservoir of oxygen
is held in the bag. A non-rebreathe valve separates the bag and
the mask so that the patient can inhale oxygen from it but not
exhale back into it. Sometimes these masks are called “non
rebreathe bag masks” for this reason. It is impossible for a
patient to receive 100% oxygen via these masks for the simple
reason that there is no air-tight seal between mask and
patient. The reservoir bag should be filled with oxygen before
the mask is placed on the patient. The bag should not deflate
by more than two-thirds with each breath.
Nasal cannulae, simple face masks, and reservoir bag masks
all deliver variable oxygen concentrations – or uncontrolled
oxygen therapy.
High flow devices – Venturi masks
The Venturi valve increases the flow rate of oxygen and air
to above the patient’s inspiratory flow rate which is why these
masks are more noisy (Figure 2.2). By doing this it can provide
a constant oxygen concentration no matter how quickly or
slowly the patient breathes. Venturi masks have colour-coded
valves (labelled 24%, 28%, 35%, 40%, and 60%), which are
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designed to deliver a fixed percentage of oxygen when set to
the appropriate flow rate. To change the oxygen
concentration, both the valve and flow have to be changed. At
oxygen requirements over 40%, the mask may not have
enough total flow to meet high inspiratory demands. Venturi
masks are the mask of choice in acutely ill patients who
require controlled oxygen therapy.
Flow is not the same as concentration. Low flow masks can
deliver high concentrations of oxygen and high flow masks
can deliver low concentrations of oxygen. Therefore the terms
“high concentration” and “low concentration” are preferred
when speaking about the amount of oxygen a patient is
receiving. Humidified oxygen should be given when
prolonged high concentrations are used as the airways may
become dry. This impedes the expectoration of secretions,
which can be extremely important in certain situations.
Entrained 14 litres
per minute air each side
Jet of O2 2 litres
per minute
Total gas flow
30 litres per minute
Entrained air
Figure 2.2 Velocity or flow of gas in a Venturi mask. Bernoulli’s equation
for incompressible flow states that 0·5 pv2 + P = constant (where p is
density), so, if the pressure (P) of a gas falls, it gains velocity (v). When
gas moves through the Venturi valve, there is a sudden pressure drop,
owing to the increase in area. The velocity or flow of the gas increases
according to this equation
Oxygen delivery
Nearly all oxygen is carried to the tissues by haemoglobin
(Hb). Each gram/dl of Hb carries 1·3 ml oxygen when fully
saturated. A negligible amount is dissolved in plasma. The
oxygen content of blood can therefore be calculated:
Hb (g/dl) × oxygen saturation of Hb × 1·3 and
× 10 to convert to litres
The delivery of oxygen to the tissues depends on the cardiac
output. From this we derive the oxygen delivery equation:
Hb × SaO2 × 1·3 × 10 × CO
Understanding that oxygen delivery depends on other
factors as well as oxygen therapy will help to optimise
oxygenation in any patient who is unwell. In a 70 kg man a
normal Hb is 14 g/dl, normal saturation is above 95% and
normal CO is 5 litres per minute. Oxygen delivery is therefore:
14 × 0·95 × 1·3 × 10 × 5 = 864·5 ml O2 per minute.
Patients with pneumonia or severe asthma can be extremely
dehydrated. If a patient has an Hb of 14, an SaO2 of 93%, and
a reduced cardiac output (4 litres per minute) because of
dehydration, his oxygen delivery is 14 × 0·93 × 1·3 × 10 × 4 =
677 ml O2 per minute. By increasing his oxygen so that his
saturations are now 98%, his oxygen delivery can be increased
to 14 × 0·98 × 1·3 × 10 × 4 = 713 ml O2 per minute, but if a
fluid challenge is given to increase his cardiac output to
normal (5 litres per minute) and his oxygen is kept the same,
his oxygen delivery would be 14 × 0·93 × 1·3 × 10 × 5 = 846 ml
O2 per minute. Oxygen delivery has been increased more by
giving fluid than by giving oxygen. The oxygen delivery
equation also illustrates that an SaO2 of 95% with severe
anaemia is worse than an SaO2 of 80% with a haemoglobin of
15 g/dl.
The oxygen-dissociation curve
Oxygen carriage in the blood relies on haemoglobin – the
concentration, its carrying capacity and saturation. The
percentage of Hb saturation with oxygen at different partial
OXYGEN
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pressures of oxygen in blood is described by the oxygen-
dissociation curve (Figure 2.3). It is sigmoid shaped because
oxygen molecules demonstrate “positive cooperativity” when
associating with Hb. Each Hb molecule carries four oxygen
molecules. The first oxygen molecule helps the others to
associate as well. The reason this curve is so important and
clever is that large amounts of oxygen can be released from
the blood for only a small drop in partial pressure in the
capillaries (because of the steep lower part of the curve). Other
local factors affect the curve, or the affinity of Hb to carry
oxygen, like acidosis, which shifts it to the right. This means
more oxygen is released in acidotic tissue, which needs it. The
oxygen-dissociation curve flattens after 94% saturation
(usually equivalent to a PaO2 of 8·3 kPa or 64 mmHg).
Pulse oximetry
Cyanosis can be difficult to detect and one objective
measurement of oxygenation is pulse oximetry. Oximetry
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Figure 2.3 The oxygen-dissociation curve. Sigmoid shape is due to “positive
cooperativity”. Acidosis, raised 2,3DPG and raised temperature all cause the
curve to shift to the right. Alkalosis, myoglobin and fetal Hb cause shift to
the left. The shift caused by pH is called the Bohr effect
measures the percentage saturation of haemoglobin and this
indirectly relates to PaO2 through the oxygen dissociation
curve. This indirect relationship can lead to errors in clinical
practice if one forgets that pulse oximetry measures
saturation, not PaO2. Red and infrared light are transmitted
through the tissues by a light-emitting diode. A photodetector
picks up the transmitted light and the ratio of light emitted to
light absorbed is translated into a percentage saturation value.
Inaccurate pulse oximeter readings arise from:
• light interference
• motion artefact
• low perfusion states
• abnormal haemoglobin.
Why PaCO2 rises
There is much misunderstanding around the causes of a
high PaCO2 in relation to oxygen therapy. For the purposes of
explanation, “CO2 retention” is the name used for the
phenomenon that occurs because of uncontrolled oxygen
therapy in patients with chronic hypoxaemia. “Hypercapnic
respiratory failure” is the term used when the PaCO2 rises for
other reasons.
CO2 retention
At one time it was thought that suppression of hypoxic
drive was the cause of CO2 retention. Changes in CO2 is one
of the main controls of ventilation in normal people. In
patients with a chronically high CO2 the chemoreceptors in
the brain become blunted and the patient depends on
hypoxaemia to stimulate ventilation, something that
normally occurs only at altitude or during illness. If these
patients are given too much oxygen, their “hypoxic drive” is
abolished, breathing will slow, and PaCO2 will rise as a result,
causing CO2 narcosis and eventually apnoea. Although this is
the traditional explanation for CO2 retention, some studies
have shown that minute volume and respiratory rate are
unchanged in such patients and alternative explanations are
as follows:
OXYGEN
21
• There is release of hypoxic vasoconstriction with oxygen
therapy, with a change in ventilation–perfusion in the lung
and an increase in dead space ventilation. Hypoxic
vasoconstriction is an important physiological mechanism
in normal people, designed to improve the match between
perfusion and ventilation by diverting blood away from
poorly ventilated areas. Patients with COPD have a poor
chemical drive for breathing and compensatory
hyperventilation does not occur.
• There is a reduced ventilatory drive in some patients with
COPD, both in response to hypercapnia and hypoxaemia.
The reasons for this are not really known, but genetic
factors play a part (the “normal” family members of
hypercapnic COPD patients often demonstrate blunted
hypercapnic and hypoxaemic responses). Acquired loss of
drive as an adaptation to increased work of breathing is
also implicated. In “CO2 retainers” a different pattern of
ventilation has been observed, with lower tidal volumes
but an increased respiratory rate. This could be a
compensatory mechanism designed to reduce the work of
breathing.
• The Haldane effect may also play a part. When haemoglobin
is saturated with oxygen, the amount of carbon dioxide it
can carry is reduced. Most CO2 is carried in solution and
when the affinity of haemoglobin for H+ ions is reduced,
the number of H+ ions in solution increases as a result.
Patients with COPD do not compensate.
Patients with severe mechanical impairment of lung
function are susceptible to CO2 retention as described above.
This includes some, but by no means all, patients with COPD.
Various studies show that when CO2 retention exists, it occurs
when the FEV1 is < 1·0 litre. It may be that these patients
are particularly prone to CO2 retention during an acute
exacerbation of their illness. Other patients are also vulnerable
to CO2 retention for example those with obstructive sleep
apnoea. Such patients require controlled oxygen therapy
using a Venturi mask to get the PaO2 to around 8·0 kPa
(60 mmHg).
One in five patients with COPD admitted to hospital has a
respiratory acidosis. The more severe the respiratory acidosis,
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the greater the mortality. Some of this acidosis is caused by
uncontrolled oxygen therapy. A recent study looked at oxygen
administration in 101 consecutive admissions via the
Emergency Department in patients with COPD. The British
Thoracic Society recommends that patients with COPD
should receive 28% oxygen via a Venturi mask until the results
of arterial blood gases are known. In this study 56% patients
received more than 28% oxygen and the median time from
ambulance to arterial blood gas analysis was 1 hour. In-
hospital mortality was 14% for patients who received more
than 28% oxygen and 2% for those who received 28% oxygen
or less. Many patients identified their condition as asthma to
the ambulance crew. This study was heavily criticised by
subsequent letters which illustrate the ongoing debate on the
cause of CO2 retention and the correct use of oxygen therapy
in acute exacerbations of COPD.
It is important to note that depriving a critically ill patient
from oxygen can be harmful. Experts in critical care point out
that hypoxaemia can be fatal. In certain circumstances it may
be necessary to administer higher concentrations of oxygen
to patients with COPD if they are acutely and severely
hypoxaemic, pending ventilation.
Acute hypercapnic respiratory failure
Unfortunately, teaching on CO2 retention as described above
has been misunderstood so that many doctors persist in
reducing the oxygen concentration in any patient who has a
high PaCO2. This is illogical and can be harmful. The most
common reason for a high PaCO2 is a problem with ventilation.
This occurs when the load on the respiratory muscles is too
great or there is respiratory muscle weakness (Figure 2.4).
Excessive load results from increased resistance (for
example, upper or lower airway obstruction), reduced
compliance (for example, infection, oedema, rib fractures, or
obesity), and increased respiratory rate. Respiratory muscle
weakness can be caused by a problem in any part of the
neurorespiratory pathway starting in the brain and working
down (for example, drug overdose, motor neurone disease,
Guillain–Barré syndrome, myasthenia gravis, and electrolyte
abnormalities – low potassium, magnesium, phosphate or
calcium).
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Hypercapnia as a result of ventilatory failure is important to
recognise. Reducing the oxygen concentration in order to
“treat” a high CO2 is entirely the wrong thing to do in this
situation. High concentrations of oxygen do not depress
ventilation in patients with a high CO2 caused by an
imbalance between respiratory muscle load and strength.
Correct treatment is of the underlying cause and assistance
with ventilation.
Does my patient have chronic hypoxaemia/
hypercapnia?
There are clues to help you decide whether or not your
patient may be prone to CO2 retention:
• Patients with chronic hypoxaemia develop compensatory
responses – polycythaemia and pulmonary hypertension
(or cor pulmonale). Look for these.
• Background history – what is the patient normally like and
what medication is being taken? Are there any previous
lung function tests?
• History of the acute episode.
• Analysis of admission arterial blood gases.
If your patient is young and normally fit and well you can be
virtually certain that any rise in CO2 is due to a problem with
ventilation and nothing to do with oxygen therapy. If the
acute diagnosis is a drug overdose, head injury, neuromuscular
Respiratory
muscle load
Respiratory
muscle
strength
Figure 2.4 Hypercapnic respiratory failure and the balance between load
and muscle strength
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weakness, or acute left ventricular failure, the high CO2 is due
to a problem with ventilation. Note that patients with a
background of COPD can also present with these problems. In
terms of the history, a newly diagnosed patient with COPD
who still goes hill-walking is less likely than a housebound
patient on long-term oxygen therapy to have chronic
hypoxaemia/hypercapnia. Analysis of the admission arterial
blood gases can also give useful information. Both these
patients have COPD:
• pH 7·36, PaCO2 9·0 kPa (65·3 mmHg), bicarbonate 35 mmol/l,
BE +6, PaO2 6·0 kPa (46 mmHg)
• pH 7·25, PaCO2 8·0 kPa (65·3 mmHg), bicarbonate 26 mmol/l,
BE −2, PaO2 8·0 kPa (62 mmHg)
The first is from a patient who has a chronically high PaCO2
(because the pH is normal and the base excess is high). The
hypoxaemia is also likely to be chronic. The second is from an
acutely decompensated patient who is hypoxaemic and
hypoperfused (because the base excess is low). This patient
needs oxygen, assistance with ventilation and intravenous
fluids. Non-invasive ventilation in COPD should be instituted
early – as soon as the pH falls below 7·35 according to trials –
because the further the degree of respiratory acidosis, the less
the chances of recovery (see Chapter 4). Worsening respiratory
acidosis may require intubation.
In summary:
• The most common cause of hypercapnia is a problem with
ventilation – this has nothing to do with oxygen therapy.
• In patients with COPD, use Venturi masks titrated to
arterial blood gases and institute non-invasive ventilation
early where indicated.
Self-assessment – case histories
1. A 60-year-old lady arrives in the Emergency Department with
breathlessness. She was given 12 litres per minute oxygen via a
simple face mask by the paramedics. She is on inhalers for
COPD, is a smoker, and a diabetic. She is clammy and has
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widespread crackles and wheeze in the lungs. The chest x ray
film has an appearance consistent with severe left ventricular
failure. Her blood gases show: pH 7·15, PaCO2 8·0 kPa (61·5 mmHg),
PaO2 9·0 kPa (69·2 mmHg), bicarbonate 20 mmol/l, BE − 6. The
attending doctor has taken the oxygen mask off because of “CO2
retention” by the time you arrive. The oxygen saturations were
95% and are now 85%. Blood pressure is 140/70 mmHg.
Comment on her oxygen therapy.
2. A 50-year-old man arrives in the Medical Admissions Unit with
breathlessness. He is an ex-miner, has COPD, and is on inhalers
at home. His blood gases on 28% oxygen show: pH 7·4, PaCO2
8·5 kPa (65·3 mmHg), PaO2 8·5 kPa (65·3 mmHg), bicarbonate
38·4 mmol litre−1, BE + 7. A colleague asks you if he needs non-
invasive ventilation because of his hypercapnia. What is your
reply?
3. A 30-year-old patient on the chemotherapy ward becomes unwell
with breathlessness. The nurses report oxygen saturations of
75%. When you go to the patient, you find the other observations
are as follows: pulse 130 per minute, blood pressure 70/40
mmHg, respiratory rate 40 per minute, patient confused. Blood
gases on air show: pH 7·1, PaCO2 3·0 kPa (23 mmHg), PaO2 11
kPa (115 mmHg), bicarbonate 6·8 mmol/l, BE − 20. The chest is
clear. A chest x ray film is taken and is normal. Can you explain
the oxygen saturations and the breathlessness?
4. A 50-year-old man is undergoing a urological procedure. As part
of this, intravenous methylene blue is given. Shortly afterwards,
the junior anaesthetist notices the patient’s oxygen saturations
drop suddenly to 70%. All the equipment seems to be working
normally. Worried that the patient has had some kind of
embolism, he calls his senior. What is the explanation?
5. A 45-year-old man arrives unconscious in the Emergency
Department. There is no history available apart from the fact that
he was found collapsed in his car by passers-by. On examination
he is unresponsive, pulse 90 per minute, blood pressure 130/60
mmHg, oxygen saturations 98% on 15 litres per minute oxygen
via a reservoir bag mask. His ECG shows widespread ST
depression and his arterial blood gases show: pH 7·25, PaCO2
6·0 kPa (46 mmHg), PaO2 7·5 kPa (57·6 mmHg), bicarbonate
19·4 mmol/l, BE − 10. His full blood count is normal. What is the
explanation for the discrepancy in the SaO2 and PaO2?
6. A 25-year-old man with no past medical history was found on the
floor at home having taken a mixed overdose of benzodiazepines and
tricyclic antidepressant tablets. He is drowsy (Glasgow Coma Score
is 8) and he has probably aspirated, because there is right upper
lobe consolidation on the chest x ray film. He arrives hypothermic
(34°C) and arterial blood gases on 15 litres per minute via a
reservoir bag mask show: pH 7·2, PaCO2 9.·5 kPa (73 mmHg), PaO2
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12·0 kPa (92·3 mmHg), bicarbonate 27·3 mmol/l, BE +2. His blood
pressure is 80/50 mmHg and his pulse is 120 per minute. The
attending doctor changes his oxygen to a 28% Venturi mask because
of his high CO2 and repeat blood gases show: pH 7·2, PaCO2 9·0 kPa
(69·2 mmHg), PaO2 6·0 kPa (46·1 mmHg), bicarbonate 26 mmol/l,
BE +1. What would your management be?
Self-assessment – discussion
1. This patient has COPD, but:
• the problem is severe acute left ventricular failure (LVF);
• acute hypoxaemia will aggravate cardiac ischaemia;
• other aspects of the history and examination may give clues
as to whether or not she is likely to have severe COPD.
The arterial blood gases show a mixed respiratory and metabolic
acidosis with relative hypoxaemia. Ventilatory failure owing to LVF
is the main reason for the high PaCO2 and needs treatment as
soon as possible. Initial treatment should concentrate on A, B, C.
Medical treatment for left ventricular failure is required. Intubation
is indicated if there is no improvement. Non-invasive continuous
positive airway pressure (CPAP) may be tried first in an ICU setting.
The patient should not be hypoxaemic.
2. No. His pH is normal. His PaCO2 is normally high (he has a high
standard bicarbonate and BE to have fully compensated for his
chronic respiratory acidosis). He should stay on a Venturi mask
whilst unwell.
3. The main reason why this patient’s oxygen saturations are so low
is hypoperfusion. The PaO2 is normal on air – this makes
pulmonary embolism (PE) unlikely in someone so unwell (cancer
and chemotherapy are two independent risk factors for PE). This
patient has circulatory shock as illustrated by the low blood
pressure and severe metabolic acidosis seen on the arterial blood
gases. Shocked patients breathe faster because of circulatory
hypoxia and metabolic acidosis. The history and examination will
tell you whether or not this shock is due to bleeding (Are the
platelets very low?) or severe sepsis (Is the white cell count very
low?). Patients with septic shock do not always have the classical
warm peripheries and bounding pulses – they can be peripherally
vasoconstricted. Treatment priorities are A, B (including high
concentration oxygen therapy), and C – the patient needs fluid.
Oxygen delivery can be optimised by correcting any fluid deficit
and improving cardiac output. Severe anaemia may require blood
transfusion.
4. Methylene blue in the circulation affects oxygen saturation
measurement. The apparently low saturations return to normal
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within a few minutes. The junior anaesthetist did the right thing:
he checked the airway (tube position), breathing (listened to the
chest and checked the ventilator settings), and circulation
(measured blood pressure and pulse) before asking for advice.
5. The arterial blood gases show a metabolic acidosis with
hypoxaemia. The PaCO2 is at the upper limit of normal. It should
be low in a metabolic acidosis, indicating a relative respiratory
acidosis as well. Treatment priorities in this patient are as
follows: securing the airway and administering the highest
concentration of oxygen possible, assessing and treating
breathing problems, and correcting any circulation problems.
There is a discrepancy between the SaO2 of 98% and the arterial
blood gas result, which shows a PaO2 of 7·5 kPa (57·6 mmHg).
Tied in with the history and ischaemic-looking ECG, the
explanation for this is carbon monoxide (CO) poisoning. CO
poisoning produces carboxyhaemoglobin seen by the pulse
oximeter as oxyhaemoglobin causing an overestimation of
saturations. CO poisoning is the commonest cause of death by
poisoning in the UK. Mortality is especially high in those with pre-
existing atherosclerosis. Toxicity is not just due to COHb
formation. Free radicals, platelet activating factors and
cytochrome AA3 formation also play a part. Loss of CO from the
body is a slow process at normal atmospheric pressure and
oxygen concentration (21%). It takes 4·5 hours for the
concentration of CO to fall to half its original value (Table 2.2). CO
removal is increased by increasing the oxygen concentration or by
placing the victim in a hyperbaric chamber. This increases the
amount of oxygen in the blood, forcing off CO.
There is debate as to whether treatment with hyperbaric oxygen
is superior to ventilation with 100% oxygen on intensive care. Five
randomised trials to date disagree. Therefore a pragmatic
approach is recommended:
• any history of unconsciousness
• COHb levels of > 40% at any time
Table 2.2 Half life of CO depending on conditions
Oxygen concentration Half life of CO (minutes)
Room air (21%) 240–300
15 litres/min reservoir bag mask (80%) 80–100
Intubated and ventilated 50–70
(with 100% oxygen)
Hyperbaric chamber 20–25 
(100% oxygen at 3 atmospheres)
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• neurological or psychiatric features at the time of examination
• pregnancy (because the fetal COHb curve is shifted to the left
of the mother’s)
• ECG changes
are all features that lead to hyperbaric oxygen being considered –
but the risks of transporting critically ill patients to a hyperbaric
unit also needs to be taken into account. Ventilation with 100%
oxygen is an acceptable alternative, and treatment with high
concentrations of oxygen should continue for a minimum of
12 hours.
6. This is a 25-year-old man with no previous medical problems.
He does not have chronic hypoxaemia. He will not “retain CO2”
– he has a problem with ventilation. The arterial blood gases
show an acute respiratory acidosis with a lower PaO2 than
expected. He has a reduced conscious level so his airway
needs to be secured. He needs a high concentration of oxygen
(that is, 15 litres per minute via a reservoir bag mask) until he
is intubated. He has several reasons to have a problem with
ventilation – reduced conscious level, aspiration pneumonia,
and respiratory depressant drugs. With regards to circulation,
he needs volume expansion with warmed fluids. The
combination of cardiac toxins he has taken with superimposed
hypoxaemia and hypoperfusion could lead to cardiac arrest.
Sodium bicarbonate infusion is indicated in severe tricyclic
poisoning (see Chapter 9). Flumazenil (a benzodiazepine
antidote) is not advised when significant amounts of tricyclic
antidepressants have also been taken as it reduces the fit
threshold. It is worth measuring creatinine kinase levels in this
case as rhabdomyolysis (from lying on the floor for a long time)
will affect fluid management.
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3: Acid-base balance
By the end of this chapter you will be able to:
• understand how the body maintains a narrow pH
• know the common causes of acid-base abnormalities
• understand why the arterial blood gas is one of the first
investigations in any critically ill patient
• interpret arterial blood gas reports and calculate the anion gap
• apply this to your clinical practice
Acid as a by-product of metabolism
The human body continually produces acid as a by-product of
metabolism. However, it must also maintain a stable pH,
which is necessary for normal enzyme activity and the
millions of chemical reactions that take place in the body each
day. Normal blood pH is 7·35–7·45. This is maintained by:
• intracellular buffers, for example proteins and phosphate
• then by extracellular buffers, for example plasma proteins,
haemoglobin and carbonic acid/bicarbonate
• finally the kidneys and lungs.
A buffer is a substance that resists pH change by absorbing
or releasing hydrogen ions (H+) when acid or base is added to
it. The carbonic acid/bicarbonate system is the most
important buffer – more effective at buffering acid than base.
The relationship between CO2, carbonic acid and bicarbonate
is quite clever:
H2O + CO2 ↔ H2CO3 ↔ HCO3
− + H+
Carbonic anhydrase
Unlike other buffer systems, the components of the
carbonic acid/bicarbonate system can be varied independently
of one another. Adjusting the rate of alveolar ventilation
changes CO2 levels and the kidneys regulate H
+ excretion in
the urine. The excretory functions of the lungs and kidneys
are connected by H2CO3 (carbonic acid). This ensures that if
one organ becomes overwhelmed, the other can help or
“compensate”.
The lungs have a simple way of regulating CO2 excretion,
but the kidneys have three main ways of excreting H+:
• by regulating the amount of HCO3
– absorbed (80–90% is
reabsorbed in the proximal tubule);
• by the reaction: HPO4
2 − + H+ → H2PO4
−. The H+ comes from
carbonic acid, leaving HCO3
–, which passes into the blood;
• by combining ammonia with H+ from carbonic acid. The
resulting ammonium ions cannot pass back into the cells
and are excreted.
The kidney produces HCO3
– which reacts with free
hydrogen ions. This results in a fall in serum HCO3
–
concentration, which is why in a metabolic acidosis, the
serum HCO3
– is low.
pH and the Henderson–Hasselbach equation
H+ ions are difficult to measure as there are literally billions
of them. We use pH instead, which simply put is the negative
logarithm of the H+ concentration in moles.
pH = −log [H+ ]
Buffers are weak acids. When a weak acid dissociates:
AH ↔ A− + H+
where A is the acid and AH is the conjugate base, the product
of [A] and [H+] divided by [AH] remains constant. Put in
equation form:
Ka is called the dissociation constant. pKa is like pH – it is
the negative logarithm of Ka. The Henderson–Hasselbach
equation puts the pH and the dissociation equations together
and describes the relationship between pH and the molal
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[AH]
Ka =
[A−] · [H+ ]
concentrations of the dissociated and undissociated form of a
dissolved substance.
The Henderson–Hasselbach equation is:
A simplified version is:
H + concentration is sometimes used instead of pH. A simple
conversion between pH 7·2 and 7·5 is that [H+] = 80 − the two
digits after the decimal point. So if the pH is 7·35, [H+] is 80 −
35 = 45 nmol/l.
From the law of mass action:
[H+] = Ka ×
PaCO2
HCO3
or
[H+] =
181 × PaCO2 in kPa (24 × PaCO2 in mmHg)
HCO3
[H+] is related to the PaCO2/HCO3 ratio. This is clinically
relevant when checking the consistency of arterial blood gas
data.
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[acid]
pH =
pK + log [conjugate base]
pH ∝
[HCO3
–] dissociated
PaCO2 undissociated 
Table 3.1 pH and equivalent [H+]
pH [H+] nmol/l
7·6 26
7·5 32
7·4 40
7·3 50
7·2 63
7·1 80
7·0 100
6·9 125
6·8 160
Compensation versus correction
Normal acid-base balance is a normal pH (euphaemia) plus
a normal PaCO2 and HCO3. Compensation is normal pH even
though the HCO3
− and PaCo2 are disturbed. Correction is the
restoration of normal pH, HCO3
− and PaCO2 through
correction of the underlying cause. Acidaemia is a low pH
whereas acidosis is a high PaCO2 or a low bicarbonate. In the
same way, alkalaemia is a high pH whereas alkalosis is a low
PaCO2 or high bicarbonate. Acidosis and alkalosis refer to
processes that tend to lower or raise pH. Compensatory
mechanisms rarely restore the pH to normal. Thus a normal
pH in the presence of an abnormal HCO3
− and PaCO2
immediately suggests a mixed disorder.
The base excess and standard bicarbonate
The base excess and base deficit measure how much extra
acid or base is in the system as a result of a metabolic problem.
The base excess is calculated by measuring the amount of
strong acid that has to be added to the sample to produce a
normal pH of 7·4 – it is therefore taking into account all the
buffer systems. Minus is a base deficit (that is, the sample is
already acidotic so no acid has to be added). Plus is a base
excess (that is, the sample is alkalotic so acid has to be added).
The normal range is − 2 to + 2 mmol/l. Base deficit can be an
important predictor of severity of illness (see Chapter 5).
Standard bicarbonate is the concentration of bicarbonate in
a sample kept under standard conditions – 37°C with a PaCO2
of 5·3 kPa (40 mmHg). This is calculated from the actual
bicarbonate. Standard bicarbonate therefore purely reflects the
metabolic component of acid-base balance as opposed to any
subsequent changes in bicarbonate occurring as a result of
respiratory problems.
Common causes of acid-base disturbances
Changes in pH occur because of:
• abnormal respiratory function
• abnormal renal function
• an overwhelming acid or base load.
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Since [H+] is regulated by two systems – the respiratory
system and the kidneys – there are four possible primary acid-
base disorders:
• respiratory acidosis (acute or chronic)
• metabolic acidosis (further divided into increased or
normal anion gap)
• respiratory alkalosis (acute or chronic)
• metabolic alkalosis (further divided into saline responsive
and saline unresponsive).
A summary of the changes in pH, PaCO2 and bicarbonate in
the different acid-base disturbances is shown in Table 3.2.
Respiratory acidosis
Respiratory acidosis is caused by alveolar hypoventilation.
Alveolar hypoventilation is not the same as a reduced
respiratory rate – a person may be breathing at a normal or
high rate but have a reduced minute volume (= frequency ×
tidal volume). Acute alveolar hypoventilation results from an
imbalance between respiratory muscle strength and load (see
previous chapter). Chronic alveolar hypoventilation as seen in
chronic obstructive pulmonary disease (COPD) involves
multiple mechanisms.
In acute respiratory acidosis, compensation occurs firstly by
cellular buffering over minutes to hours. Renal compensation
then occurs over 3–5 days. 
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Table 3.2 Changes in pH, PaCO2 and bicarbonate in different
acid-base disturbances
base standard
pH PaCO2 excess bicarbonate
Respiratory low high normal normal
acidosis
Metabolic low normal low low
acidosis
Respiratory high low normal normal
alkalosis
Metabolic high normal high high
alkalosis
Metabolic acidosis
Metabolic acidosis usually arises from an increased acid
load but can also be due to loss of bicarbonate. Respiratory
compensation occurs within minutes. Maximal compensation
occurs within 12–24 hours, but respiratory compensation is
limited by the work involved in breathing and the systemic
effects of a low carbon dioxide. It is unusual for the body to be
able to fully compensate for a metabolic acidosis.
The anion gap
Blood tests measure most cations (positively charged
molecules) but only a few anions (negatively charged
molecules). Anions and cations are equal in the human body,
but if we add all the measured cations and anions together there
will be a gap – this reflects the concentration of those anions
not measured, for example plasma proteins, phosphates, and
organic acids. This is called the anion gap and is calculated by:
(Na + K) − (chloride + HCO3)
The normal range is 10–16 mmol litre–1. In an increased
anion gap metabolic acidosis, the body has gained an acid
load. In a normal anion gap metabolic acidosis, the body has
usually lost bicarbonate. Causes of an increased anion gap
metabolic acidosis include (Box 3.1):
• excess acid through ingestion
• excess acid through the body’s own production
• excess acid through an inability to excrete.
In a normal anion gap metabolic acidosis, bicarbonate is lost
via the gastrointestinal tract (diarrhoea or ileostomy) or the
kidneys (tubular damage or acetazolamide therapy).
Occasionally there is reduced renal H+ excretion.
Change in anion gap versus change in HCO3
If there is an increased anion gap, it may be helpful to relate
this to the fall in plasma HCO3. Fifty per cent of excess H+ is
buffered by cells and not by HCO3, but most of the excess
anions remain in the extracelluar fluid as they cannot cross
the cell membrane. Therefore, the increase in anion gap
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usually exceeds the fall in plasma HCO3. In lactic acidosis
the ratio is around 1·6 to 1·0. In ketoacidosis the ratio is nearer
1·0 to 1·0 because of the loss of ketoacids in the urine which
does not occur in lactic acidosis. Thus, calculating the change
in anion gap versus change in HCO3 can help differentiate
ketoacidosis from other acidosis.
Mini-tutorial: the use of intravenous sodium bicarbonate in
metabolic acidosis
HCO3
– as sodium bicarbonate may be administered intravenously to raise
blood pH in severe metabolic acidosis but this has several problems. It
increases the formation of CO2, which passes readily into cells (unlike
HCO3
–). This worsens intracellular acidosis. Some compromised patients
may need ventilation to counter the increased CO2 production caused by
an infusion of sodium bicarbonate. The oxygen-dissociation curve is
shifted to the left by alkalosis leading to impaired oxygen delivery to the
tissues. Sodium bicarbonate contains a significant sodium load and
because 8·4% solution is hypertonic, the increase in plasma osmolality
can lead to vasodilatation and hypotension. Tissue necrosis can result
from extravasation from the cannula. Many of the causes of metabolic
acidosis respond to restoration of intravascular volume, tissue
perfusion, and treatment of the underlying cause. For these reasons,
intravenous sodium bicarbonate is not often used in metabolic acidosis;
8·4% sodium bicarbonate = 1 mmol ml–1 of sodium or bicarbonate.
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Box 3.1 Causes of an increased anion gap metabolic acidosis
• Exogenous acids
• salicylate poisoning
• methanol/ethylene glycol poisoning
• tricyclic poisoning
• Lactic acidosis – type A
• anaerobic tissue metabolism in states of hypoperfusion – this
is the most common cause of any metabolic acidosis
• Lactic acidosis – type B
• reduced hepatic lactate metabolism in liver failure
• metformin (rare)
• Ketoacidosis
• insulin deficiency (DKA)
• starvation
• Renal failure
Respiratory alkalosis
Respiratory alkalosis is caused by alveolar hyperventilation –
the opposite of respiratory acidosis. The kidneys take 2–5 days
to compensate fully by excreting bicarbonate in the urine
and retaining hydrogen ions. Many people tend to think
that “hyperventilation” means hysteria. This is incorrect.
Hyperventilation is a sign, not a diagnosis, and it has many causes:
• shock
• lung causes (hypoxaemia, pulmonary embolism, pneumonia,
pneumothorax, pulmonary oedema)
• CNS causes (meningitis/encephalitis, raised intracranial
pressure, stroke, cerebral haemorrhage)
• metabolic causes (fever, acute liver failure, hyperthyroidism)
• drugs (salicylate poisoning)
• Gram-negative septicaemia
• psychogenic causes (pain, anxiety).
Metabolic alkalosis
Metabolic alkalosis is the least well known of the acid-base
disturbances. It can be divided into two groups: saline
responsive and saline unresponsive. Saline responsive
metabolic alkalosis is the most common and occurs with
volume contraction, for example diuretic use or volume
depletion. Urinary chloride is low in the saline responsive
type. Vomiting or nasogastric suction leads to loss of
hydrochloric acid, but the decline in glomerular filtration rate
that accompanies this perpetuates the metabolic alkalosis. The
kidneys try to reabsorb chloride (hence the urine levels are
low), but there is less of it from loss of hydrochloric acid, so
the only available anion to be reabsorbed is bicarbonate.
Metabolic alkalosis is often associated with hypokalaemia,
owing to secondary hyperaldosteronism from volume
depletion.
Another cause of saline responsive metabolic alkalosis is
when hypercapnia is quickly corrected. Post-hypercapnia
alkalosis occurs because hypercapnia directly affects the
proximal tubules and decreases sodium chloride reabsorption
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leading to volume depletion. If chronic hypercapnia is
corrected rapidly with mechanical ventilation, metabolic
alkalosis ensues because there is already a high bicarbonate
and the kidney needs time to excrete it. The pH change causes
hypokalaemia, which can lead to cardiac arrhythmias. 
Saline unresponsive metabolic alkalosis occurs due to renal
problems:
• with high blood pressure – excess mineralocorticoid
(exogenous or endogenous)
• with normal blood pressure – severe low potassium, high
calcium
• exogenous alkali with low glomerular filtration rate
A summary of the changes in pH, PaCO2, and base excess in
different acid-base disturbances is shown in Table 3.3.
Interpreting an arterial blood gas report
Arterial blood gas analysis can be performed quickly and
gives useful information about A (oxygenation), B
(ventilation) and C (perfusion) – which is why it is one of the
first tests (with bedside glucose measurement) performed in
critical illness. However, many clinicians fail to carry out a full
analysis and benefit from information that could influence
therapy.
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Table 3.3 Changes in pH, PaCO2, base excess and standard
bicarbonate in different acid-base disturbances.
Acid-base Standard 
disturbance pH PaCO2 Base excess bicarbonate
Respiratory acidosis Low High Normal Normal
Metabolic acidosis Low Normal Low Low
Respiratory alkalosis High Low Normal Normal
Metabolic alkalosis High Normal High High
The box below describes the 6 steps in arterial blood gas
analysis:
1. Is the data consistent?
2. What is the primary acid-base abnormality? An abnormal pH
always indicates the primary acid-base disturbance – the body
never overcompensates
3. Check the appropriateness of compensation – there may be more
than one acid-base disturbance
4. Measure the anion gap in any metabolic acidosis
5. Look at PaO2 – the A-a gradient may reveal disorders of
oxygenation (see chapter 4)
6. Finally, consider the clinical situation – does the analysis fit with
the clinical picture?
For example, in the following arterial blood gas: pH 7·25,
PaCO2 4·5 kPa (35 mmHg) bicarbonate 14·8 mmol/l, PaO2 8·0
kPa (61 mmHg), there is a metabolic acidosis. pH 7·25 = [H+]
55 nmol/l. From the law of mass action we can see that the
data is consistent – that is, there is no lab error.
[H+] =
181 × 4·5 in kPa 
= 55
14·8
Metabolic acidosis is the primary diagnosis. But although the
PaCO2 is “normal” in this example, it is possible to estimate
what the PaCO2 should be from compensatory responses
empirically derived from human studies (see Table 3.4).
In this example there should be a 0·15 kPa (1·2 mmHg) fall in
PaCO2 for every 1 mmol/l fall in HCO3. Assuming the lower limit
of normal for HCO3 is 22 mmol/l, there has been a 7 mmol/l fall
in HCO3 which should cause a 1·1 kPa (8·4 mmHg) fall in PaCO2.
The PaCO2 in this example should be 3·4 kPa. It is “normal”
because there is also a respiratory acidosis. This alerts you to the
fact that the patient may be sicker than at first thought. Mixed
acid-base disorders are common in clinical practice.
Normal arterial blood values are: pH 7·35−7·45, PaCO2
4·5–6·0 (35−46 mmHg), PaO2 11−14·5 kPa (83–108 mmHg), BE
–2 to +2, bicarbonate 22−28 mmol/l. Useful information on
acid-base balance can easily be gained from venous blood;
oxygenation, however, cannot be interpreted.
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Self-assessment – case histories
1. A 65-year-old man with COPD comes to the Emergency
Department with shortness of breath. His arterial blood gases on
air show: pH 7·29, PaCO2 8·5 (65·3 mmHg), standard
bicarbonate 30·5 mmol/l, BE +4, PaO2 8·0 kPa (62 mmHg). What
is the acid-base disturbance and what is your management?
2. A 60-year-old ex-miner with COPD is admitted with shortness of
breath. His arterial blood gases on air show: pH 7·36, PaCO2 9·0
(65·3 mmHg), standard bicarbonate 35 mmol/l, BE +6, PaO2 6·0
(46·1 mmHg). What is the acid-base disturbance and what is your
management?
3. A 24-year-old man with epilepsy comes to hospital in status
epilepticus. He is given intravenous diazepam. Arterial blood
gases on 10 l/min oxygen via reservoir bag mask show: pH 7·05,
PaCO2 8·0 (61·5 mmHg), standard bicarbonate 16 mmol/l,
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Table 3.4 Compensatory responses
Disorder Primary change Compensatory
response
Metabolic Reduction in 0·15 kPa (1·2 mmHg)
acidosis HCO3 fall in PaCO2 for
every 1 mmol/l fall
in HCO3
Metabolic Increase in 0·01 kPa (0·7 mmHg)
alkalosis HCO3 increase in PaCO2
for every 1 mmol/l
rise in HCO3
Acute respiratory Increase in 1 mmol/l increase in 
acidosis PaCO2 HCO3 for every 1·3
kPa (10 mmHg)
rise in PaCO2
Chronic respiratory Increase in 3·5 mmol/l increase
acidosis PaCO2 in HCO3 for every
1·3 kPa (10 mmHg)
rise in PaCO2
Acute respiratory Reduction in 2·0 mmol/l reduction
alkalosis PaCO2 in HCO3 for every 
1·3 kPa (10 mmHg)
fall in PaCO2
Chronic respiratory Reduction in 5·0 mmol/l reduction
alkalosis PaCO2 in HCO3 for every
1·3 kPa (10 mmHg)
fall in PaCO2
BE −8, PaO2 15 kPa (115 mmHg). His other results are sodium
140 mmol/l, potassium 4·0 mmol/l and chloride 98 mmol/l.
What is his acid-base status and why? 
4. A patient is admitted in a coma from a drug overdose and
responds only to painful stimuli. Arterial blood gases on air
show: pH 7·24, PaCO2 8·32 (64 mmHg), standard bicarbonate
29 mmol/l, BE +2, PaO2 7·8 kPa (60 mmHg). The Emergency
Department doctor diagnoses drug intoxication with aspiration
pneumonia because of the hypoxaemia. What is your
assessment?
5. Twenty-four hours later you are asked to assess the same
patient for discharge. She has woken up and the arterial blood
gases have improved: pH 7·60, PaCO2 3·1 (24 mmHg), standard
bicarbonate 22 mmol/l, BE −2, PaO2 9·1 kPa (70 mmHg). The
hospital is in need of beds. Should you discharge this patient?
6. An 80-year-old lady is admitted with abdominal pain. Her vital
signs are normal, apar t from cold peripheries and a
tachycardia. Her arterial blood gases on air show: pH 7·1,
PaCO2 3·5 (30 mmHg), PaO2 9·5 kPa (73 mmHg), standard
bicarbonate 8 mmol/l, BE −15. You review the clinical situation
again – she has generalised tenderness in the abdomen but it
is soft. Her blood glucose is 6·0 mmol/l (100 mg/dl), sodium
140 mmol/l, potassium 3·7 mmol/l, chloride 89 mmol/l, urea
6·5 mmol/l (BUN 18 mg/dl). There are reduced bowel sounds.
The chest x ray is normal. The ECG shows atrial fibrillation.
What is the reason for the acid-base disturbance?
7. A 44-year-old man comes to the Emergency Department with
pleuritic chest pain and shortness of breath which he has had
for five days. A moderately sized pneumothorax is seen on the
chest x ray. His arterial blood gases on 10 l/min oxygen via
simple face mask show: pH 7·44, PaCO2 3·0 (23 mmHg),
standard bicarbonate 16·0 mmol/l, BE −4, PaO2 30·5 (234·6
mmHg). Is there a problem with acid-base balance?
8. A patient is admitted to hospital with breathlessness and
arterial blood gases on air show: pH 7·2, PaCO2 4·1 (31·5
mmHg), standard bicarbonate 36 mmol/l, BE +10, PaO2 7·8
(60 mmHg). Can you explain this?
9. A 45-year-old woman with a history of peptic ulcer disease
reports six days of persistent vomiting. On examination she has
a blood pressure of 100/60 mmHg and looks dehydrated. Her
blood results are as follows: sodium 140 mmol/l, potassium
2.2 mmol/l, chloride 86 mmol/l, bicarbonate 40 mmol/l, urea
29 mmol/l (BUN 80 mg/dl), pH 7·5, PaCO2 6·2 kPa (53 mmHg),
PaO2 14 (107 mmHg), urine pH 5·0, urine sodium 2 mmol/l,
urine potassium 21 mmol/l and urine chloride 3 mmol/l. What
is the acid-base disturbance? How would you treat this patient?
Twenty-four hours after appropriate therapy the HCO3 level is
30 mmol/l. The following urine values are obtained: pH 7·8,
sodium 100 mmol/l, potassium 20 mmol/l and chloride
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3 mmol/l. How do you account for the high urine sodium but low
chloride concentration?
10. A 50-year-old alcoholic is brought in to the Emergency
Department unconscious. He had appeared drunk beforehand
with ataxia and slurred speech and has slowly lapsed into a
coma. On examination he is unresponsive and has nystagmus.
His vital signs are: respiratory rate 30/min, blood pressure
190/100 mmHg, pulse 110/min, temperature 360C. His
bedside glucose measurement is 5 mmol/l (83 mg/dl). His
arterial blood gases on 10 litres oxygen via reservoir bag mask
show: pH 7·15, PaCO2 3·0 (23 mmHg), standard bicarbonate
7·6 mmol/l, BE –20, PaO2 40 (308 mmHg). His full blood count,
liver enzymes and clotting are normal. Other results are: sodium
145 mmol/l, potassium 5 mmol/l, urea 3 mmol/l, creatinine
100 µmol/l, chloride 80 mmol/l. What do these arterial blood
gases show? What is the cause of his unconsciousness?
11. Match the clinical history with the appropriate arterial blood gas
values:
pH PaCO2 HCO3 (mmol/l)
a 7·39 8·45 kPa (65 mmHg) 37
b 7·27 7·8 kPa (60 mmHg) 26
c 7·35 7·8 kPa (60 mmHg) 32
• A severely obese 24-year-old man
• A 56-year-old woman with COPD who is started on diuretic
therapy for peripheral oedema resulting in 3 kg weight loss
• A 14-year-old girl with a severe asthma attack
12. A 50-year-old man is recovering on the surgical ward ten days after
a total colectomy for bowel obstruction. He has type 1 diabetes
and is on an intravenous insulin sliding scale and his ileostomy is
working normally. His vital signs are: BP 150/70, respiratory rate
16/min, SaO2 98% on air, urine output 1500 ml/day, temperature
normal and he is alert. Abdominal examination is normal and he
is well perfused. The surgical team are concerned about his
persistently high potassium level (which was noted before surgery)
and metabolic acidosis. His blood results are: sodium 130
mmol/l, potassium 6·5 mmol/l, urea 14 mmol/l (BUN 39 mg/dl),
creatinine 180 µmol/l (2·16 mg/dl), chloride 109 mmol/l, 8am
cortisol 500 nmol/l (18 µg/dl). He is known to have diabetic
nephropathy and is on Ramipril. His arterial blood gases on air
show: pH 7·29, PaCO2 3·5 kPa (27 mmHg), PaO2 14 kPa (108
mmHg), bicarbonate 12 mmol/l. What is his acid-base
disturbance and why? Should the surgeons request a CT scan of
the abdomen to look for a cause for his acidosis?
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Self-assessment – discussion
1. Is the data consistent? Yes – [H+] = 181 × 8·5/30·5 = 50 nmol/l
which is pH 7·3. There is an acidaemia (low pH) with a high
PaCO2 – a primary respiratory acidosis. The fact that the pH is
abnormal indicates an acute change (or “decompensation”).
There should be a 1 mmol/l increase in HCO3 for every 1·3 kPa
(10 mmHg) rise in PaCO2 in an acute respiratory acidosis. The
PaCO2 has risen by 2·5 kPa above the upper limit of normal so
HCO3 should rise by around 2 mmol/l – as in this case.
Management starts with assessment/treatment of the airway,
breathing and circulation, followed by a quick assessment of
disability (neurology), bedside glucose measurement, arterial
blood gases, fur ther information gathering and definitive
treatment. Non-invasive ventilation is appropriate in this case if
simple measures fail to improve the respiratory acidosis quickly.
2. Is the data consistent? Yes – [H+] = 181 × 9·0/35 = 46·5 nmol/l
which is pH 7·36. There is a normal pH (euphaemia) despite a
high PaCO2 (respiratory acidosis). This is due to compensation.
There should be a 3·5 mmol/l increase in HCO3 for every 1·3 kPa
(10 mmHg) rise in PaCO2. The PaCO2 has risen by 3·0 kPa above
the upper limit of normal, so HCO3 should rise by around
8 mmol/l. The measured HCO3 is consistent at 35 mmol/l.
Management includes assessment/treatment of airway,
breathing,  circulation and disability (neurology). A 28% Venturi
mask is appropriate oxygen therapy, titrated to arterial PaO2 and
PaCO2 plus treatment for his exacerbation of COPD. 
3. Is the data consistent? Yes – [H+] = 181 × 8·0/16 = 90·5 nmol/l
which is pH 7·05. There is both a raised PaCO2 and a reduced
HCO3 suggesting mixed respiratory and metabolic acidosis. The
anion gap is 26 mmol/l which is raised. The change in anion gap
is 10 (upper limit of normal is 16) versus a change in HCO3 of 6
(lower limit of normal is 22). This ratio is raised and is suggestive
of lactic acidosis. This interpretation is consistent with the
clinical scenario – the patient has a lactic acidosis from fitting
and a respiratory acidosis due to intravenous diazepam. This
acid-base disturbance should spontaneously return to normal
with supportive measures.
4. Is the data consistent? Yes – [H+] = 181 × 8·32/27 = 56 nmol/l
which is pH 7·24. There is an acidaemia with a raised PaCO2 –
the primary disturbance is a respiratory acidosis. In acute
respiratory acidosis there should be a 1 mmol/l increase in HCO3
for every 1·3 kPa (10 mmHg) rise in PaCO2. The PaCO2 has risen
by 2·3 kPa above the upper limit of normal so HCO3 should be
around 29 mmol/l, which it is. The anion gap cannot be
measured in this case without further information. The A-a
gradient (see chapter 4) is normal in this case – suggesting that
the hypoxaemia is due to alveolar hypoventilation rather than
pneumonia.
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5. Is the data consistent? Yes – [H+] = 181 × 3·1/22 = 26 nmol/l
which is pH 7·6. There is alkalaemia with a low PaCO2 – a primary
respiratory alkalosis. The fall in PaCO2 from 4·5 kPa (lower limit
of normal) to 3·1 kPa should result in a reduction in HCO3 by
nearly 4 mmol/l. The measured bicarbonate of 22 mmol/l is
consistent. The A-a gradient (see chapter 4) is now raised which
indicates that the respiratory alkalosis is due to intrinsic lung
disease, for example, aspiration pneumonia. This analysis fits
with the clinical picture. The patient should not be discharged.
6. Is the data consistent? Yes – [H+] = 181 × 3·5/8 = 80 nmol/l
which is pH 7·1. There is acidaemia with a low HCO3 and low
PaCO2 – a primary metabolic acidosis. There should be a 0·15
kPa (1·2 mmHg) fall in PaCO2 for every 1 mmol/l fall in HCO3.
HCO3 has fallen from 22 (the lower limit of normal) to 8 mmol/l
so PaCO2 should fall by 14 × 0·15 which is 2·1 kPa. The PaCO2
should be 2·4 kPa. The measured PaCO2 of 3·5 kPa indicates an
accompanying respiratory acidosis. The anion gap is (140 + 3·7) −
(89 + 8) = 46·7 mmol/l which is high. The change in anion gap
versus the change in bicarbonate is 30·7/14 and this suggests
lactic acidosis. The A-a gradient is slightly elevated which could
indicate developing SIRS (see chapter 7). Is this analysis in
keeping with the clinical picture? Yes – the combination of
abdominal pain and a lactic acidosis should alert you to the
possibility of intra-abdominal ischaemia. The elderly show few
signs of an inflammatory response because of their less active
immune system. The presence of atrial fibrillation is a clue to this
diagnosis. Priorities in the management of this case are:
assessment and treatment of the airway, breathing, circulation
and disability followed by analgesia, further information gathering
and definitive treatment. 
7. Is the data consistent? Yes – [H+] = 181 × 3·0/15·1 = 36 nmol/l
which is pH 7·44. Although the pH is normal, acid-base status is
not. How can we tell which acid-base disturbance occurred first –
the low PaCO2 or the low bicarbonate? By considering the clinical
picture. Given the history of breathlessness for a few days, we
can say the low PaCO2 due to hyperventilation occurred first. This
is a compensated respiratory alkalosis. In a chronic respiratory
alkalosis, there should be a 5·0 mmol/l reduction in HCO3 for
every 1·3 kPa (10 mmHg) fall in PaCO2. The PaCO2 has fallen by
1·5 kPa below the lower limit of normal so the HCO3 should have
fallen by just over 5·0 mmol/l – which it has in this case.
Increased minute ventilation in normal pregnancy also causes a
compensated respiratory alkalosis. This can cause confusion if
the patient is being investigated for possible pulmonary
embolism. The A-a gradient is not affected. 
8. Is the data consistent? No – [H+] = 181 × 4·1/36 = 20 nmol/l
which is pH 7·7. As you may have guessed, this is an impossible
blood gas – the answer is lab error!
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9. Is the data consistent? Yes – [H+] = 181 × 6·9/40 = 31 nmol/l
which is pH 7·5. The results show an alkalaemia with a raised
HCO3 and PaCO2 is a primary metabolic alkalosis. There should
be a 0·01 kPa (0·7 mmHg) increase in PaCO2 for every 1 mmol/l
rise in HCO3. The HCO3 has risen by 12 mmol/l above the upper
limit of normal so PaCO2 should rise by 12 × 0·01 = 0·12 kPa.
The expected PaCO2 is 6·12 kPa which is roughly the measured
level. The physical findings and low urinary sodium levels point
to volume depletion. The patient should be treated with both
intravenous sodium chloride and potassium chloride. During
therapy, volume expansion reduces sodium reabsorption in
order to correct the metabolic alkalosis by excreting excess
HCO3. The discrepancy between urinary sodium and chloride is
primarily due to urinary HCO3 excretion. Urinary PaCO2 is similar
to renal venous PaCO2 so from the law of mass action:
Urinary [H+] 16 nmol/l = 181 × 6·2/urinary bicarbonate 
Urinary bicarbonate may be calculated as 70 mmol/l
Further chloride replacement is necessary for as long as
chloride depletion exists. Low urinary chloride may be seen as
a marker of continuing volume depletion.
10. Is the data consistent? Yes – [H+] = 181 × 3·0/7·6 = 72 nmol/l
which is pH 7·15. These results show a primary metabolic
acidosis. There should be a 0·15 kPa (1·2 mmHg) fall in PaCO2
for every 1 mmol/l fall in HCO3. The HCO3 has fallen by 14·4 so
PaCO2 should fall by 14·4 × 0·15 or 2·16 kPa. The expected
PaCO2 level is 2·3 kPa. There is an accompanying respiratory
acidosis, probably due to fatigue. The anion gap is (145 + 5) −
(80 + 5) = 65 mmol/l which is very large. Poisoning, lactic/keto
acidosis or renal failure are candidates. In this case poisoning
is the most likely cause, given the normal liver tests, glucose
and creatinine levels. Certain poisons characteristically cause
a huge anion gap and are more commonly ingested by
alcoholics – ethylene glycol (antifreeze) and methanol. These
can be measured in the serum to confirm the diagnosis.
Alternatively, the osmolal gap can be calculated. This is the
difference between the calculated and actual osmolality of the
serum. The calculated osmolality is as follows:
1·86 × sodium + urea + glucose
0·93
In normal individuals the osmolal gap is less than 10
mosmol/kg H20. In ethylene glycol poisoning it is raised,
reflecting the unmeasured presence of ethylene glycol in the
serum. Specific treatment consists of alcohol dehydrogenase
inhibitors – either alcohol or 4-methylpyrazole (4-MP).
Intravenous ethanol (alcohol) therapy requires frequent
monitoring of blood alcohol levels, aiming for 100–150 mg/dl.
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4-MP is more expensive but easier to administer, does not
cause central nervous system depression and has more
predictable pharmacokinetics. Management in this case is to
secure the airway and give oxygen, assist ventilation and
assess/treat circulatory abnormalities before moving on to a
full examination, information gathering and definitive treatment.
11. From the history:
• Severe obesity suggests chronic hypercapnia (c)
• COPD and diuretic therapy suggests chronic hypercapnia with
superimposed metabolic alkalosis (a)
• A severe asthma attack suggests acute respiratory acidosis (b)
12. Is the data consistent? Yes – [H+] = 181 × 3·5/14 = 53 nmol/l
which is pH 7·29. The results show a primary metabolic
acidosis. The expected PaCO2 is 3·1 kPa. The anion gap is (130
+ 6·5) – (14 + 109) = 13·5 mmol/l which is normal. The PaO2
is normal on air. In a normal anion gap metabolic acidosis,
bicarbonate is lost via the gastrointestinal tract (diarrhoea,
fistula or uterosigmoidostomy) or the kidneys (tubular damage
or acetazolamide therapy). Sometimes there is reduced renal
H+ excretion. In this case there are no excess gastrointestinal
losses, leaving the possibility of a renal problem, which fits with
the clinical setting of diabetic nephropathy. Renal tubular
acidosis is a collection of disorders where the kidneys either
cannot excrete H+ or generate HCO3
−. Serum potassium can
help differentiate the types (see Table 3.5).
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Table 3.5 Renal tubular acidosis
Problem GFR Serum
potassium
Type 1 Distal H+ Normal Low
(distal) secretion
Type 2 Proximal H+ Normal Low
(proximal) secretion
Type 3 NH3 production Reduced Normal
(glomerular (hence HCO3
insufficiency) generation)
Type 4 Distal sodium Reduced High
(hyporeninaemic reabsorption,
hypoaldosteronism potassium
secretion and 
H+ secretion
GFR = glomerular filtration rate
Hyporeninaemic hypoaldosteronism is commonly found in diabetic
nephropathy and hypertensive renal disease. ACE inhibitors,
spironolactone and NSAIDs (which further reduce aldosterone
levels) worsen the hyperkalaemia. Treatment consists of
restricting dietary potassium and using fludrocortisone or
bicarbonate supplements. Based on these findings and the
clinical examination the surgeons do not need to request a CT
scan of the abdomen.
Further reading
Burton David Rose, Theodore Post. Clinical physiology of acid-base disorders (5th
edition). New York: McGraw-Hill, 2000.
Driscoll P, Brown T, Gwinnutt C, Wardle T. A simple guide to blood gas analysis.
London: BMJ Publishing Group, 1997.
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4: Respiratory failure
By the end of this chapter you will be able to:
• classify respiratory failure according to arterial blood gases
• know about the alveolar gas equation
• understand about different types of ventilatory support
• apply this to your clinical practice
Definitions
The major function of the respiratory system is to supply the
blood with adequate oxygen and to remove carbon dioxide.
This process is achieved by three distinct mechanisms:
• ventilation – the delivery and removal of air to and from
the alveoli
• diffusion – oxygen and carbon dioxide cross the alveolar-
capillary wall
• circulation – transported from the site of gas exchange to
the cells and back again.
To accomplish this, the lungs function as an area of gas
exchange and as a pump for effective ventilation. Failure of
these two functions results in hypoxaemia or hypercapnia
respectively. Hence respiratory failure is traditionally defined
as hypoxaemic respiratory failure (PaO2 < 8·0 kPA or 60 mmHg)
or hypercapnic respiratory failure (hypoxaemia with PaCO2
above 6·0 kPA or 50 mmHg).
Respiratory failure may be classified as three main types:
• hypoxaemia – mainly an imbalance between ventilation
and perfusion in the lung
• hypercapnia – an imbalance between ventilatory capacity
and demand
• a mixture of hypoxaemia and hypercapnia, commonly
seen in clinical practice.
Hypoxaemia
Cardiac output is important in the delivery of oxygen to the
tissues. The proportion of oxygen delivery increased by
increasing the PaO2 or SaO2 when it is already above the
shoulder of the haemoglobin–oxygen dissociation curve is
small compared with improving a reduced cardiac output.
Therefore in the management of the critically ill patient as
much attention should be paid to fluid resuscitation as to the
normalisation of hypoxaemia (see Chapter 2).
Oxygen tension in the air is around 20 kPA (154 mmHg) at
sea level, falling to 0·5 kPA (3·8 mmHg) in the mitochondria.
This gradient is known as the oxygen “cascade” (Figure 4.1). An
interruption at any point can cause hypoxia – high altitude,
upper or lower airway obstruction, alveolar flooding, abnormal
haemoglobins, circulatory failure and mitochondrial poisoning
are examples.
Hypoxaemic respiratory failure is characterised by a low
PaO2, leading to an elevated alveolar–arterial oxygen gradient
and a low PaCO2, reflecting adequate ventilation but
inadequate gas exchange. Hypoxaemia is most commonly
due to the mismatch of ventilation (V
·
) and perfusion (Q
·
) or
intrapulmonary right-to-left shunts (Figure 4.2).
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Figure 4.1 Oxygen partial pressure (vertical lines) in parts of the body
(horizontal lines). A, inspired dry gas; B, humidified at 37°C; C, mixed
with expired gas; D, alveolar ventilation and O2 consumption; E, venous
mixing and V·/Q· mismatch; F, capillary blood concentration depends on
blood flow and haemoglobin concentration; G, mitochondria
V·/Q· mismatch
If an airway supplying a region of the lung is impaired by the
presence of secretions or narrowed by bronchoconstriction,
that segment will be perfused but only partially ventilated. The
resulting V
·
/Q
·
mismatch will result in hypoxaemia, but giving
supplemental oxygen will cause the PaO2 to increase.
Intrapulmonary right-to-left shunts
If an alveolus is totally filled with fluid or collapsed, the
segment will be perfused but not ventilated at all. Mixed
venous blood is shunted across that segment. Increasing
the inspired oxygen in the presence of a moderate to severe
shunt will not improve PaO2. Intrapulmonary shunting as
a cause of hypoxaemia is observed in pneumonia and
atelectasis.
V
·
/Q
·
mismatch and intrapulmonary shunting can often be
distinguished by the response of the patient to supplemental
oxygen.
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· ·
Figure 4.2 Ventilation/perfusion mismatch and shunts
The A–a gradient
The A–a gradient is a measure of the drop in partial pressure
of oxygen between the alveolus and arterial blood. It can be
estimated from the arterial blood gases. A PaO2 of 14 kPA (107
mmHg) could be considered normal – until one realises that
the patient is breathing 60% oxygen. The predicted PaO2
should be approximately 8 kPA (75 mmHg) below the FiO2.
There is a significant problem with gas exchange in this
example. This problem can be measured by the A–a gradient.
In some situations, the A–a gradient can be a more sensitive
measure than PaO2 alone in indicating a problem with gas
exchange.
Alveolar oxygen can be estimated using the alveolar gas
equation. Oxygen leaves the alveolus in exchange for carbon
dioxide. The amount of CO2 entering the alveolus is known as
this is almost the same as arterial CO2. Slightly less CO2 is
excreted than O2 absorbed so a correction factor (0·8) is added.
The alveolar gas equation is:
PAO2 = PiO2 (PB − PAH2O) − PACO2/0·8
where PB equals the ambient barometric pressure which
equals 101 kPA at sea level and PAH2O equals the alveolar
partial pressure of water which equals 6 kPA. This is often
simplified to:
PAO2 = PiO2 − PACO2/0·8
Once PAO2 has been estimated, the A–a gradient (PAO2 −
PaO2) can be calculated. Any significant difference is due to
abnormal gas exchange. Normal people have a small
difference because the bronchial veins of the lung and
thebesian veins of the heart carry unsaturated blood to the left
ventricle, bypassing the alveoli. A normal A–a gradient is up to
2 kPA (15 mmHg) or 4 kPA (30 mmHg) in smokers and the
elderly.
A person breathing air with a PaO2 of 12·0 kPA and a PaCO2
of 5·0 kPA has an A–a gradient as follows:
0·21 × 95 − 5/0·8
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When calculating the A–a gradient on air, 0·21 × 95 is often
shortened to 20:
20 − 5/0·8 = 13·75
The A–a gradient is:
13·75 − 12 = 1·75 kPA
The calculation of the A–a gradient illustrates the
importance of always documenting the inspired oxygen
concentration. Relative hypoxaemia cannot be detected
without this.
Hypercapnia
The reasons why PaCO2 rises are often misunderstood. This
is explained in detail in Chapter 2. To summarise:
• “CO2 retention” is the phenomenon that occurs with
uncontrolled oxygen therapy in patients with chronic
hypoxaemia (for example, some patients with COPD).
• Hypercapnic respiratory failure – or ventilatory failure – has
nothing to do with oxygen therapy. Ventilatory capacity is
the amount of spontaneous ventilation that can be
maintained without the development of respiratory muscle
fatigue. Normally ventilatory capacity matches demand.
Hypercapnic respiratory failure results from either a
reduction in ventilatory capacity or an increase in
ventilatory demand – or both.
Metabolism rapidly generates acid. The metabolism of fats
and carbohydrates leads to the formation of a large amount of
CO2. This combines with water to form carbonic acid. The
lungs excrete the volatile fraction through ventilation.
Ventilation is influenced and regulated by chemoreceptors for
PaCO2, PaO2, and pH located in the brainstem as well as by
neural impulses from lung stretch receptors and impulses
from the cerebral cortex. PaCO2 is determined by the balance
between CO2 production and its removal via alveolar
ventilation. This can be expressed by the equation:
PaCO2 ∝ V
·
co2/V
·
A
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where V
·
co2 is the rate of delivery of CO2 to the alveoli by
capillary blood and V
·
a is the rate of removal of CO2 by
alveolar ventilation.
CO2 production is increased in hypermetabolic states and by
infusions of sodium bicarbonate. At a constant rate of carbon
dioxide production, PaCO2 is determined by the level of
alveolar ventilation. A decrease in alveolar ventilation can
result either from reduced minute ventilation or increased
dead space.
Mixed hypoxaemic and hypercapnic respiratory failure
The functions of the lung as a pump and as an area of gas
exchange are not independent. Disease commonly causes
problems with both. A good example of this is seen
postoperatively. Surgery causes atelectasis because of a
combination of supine position, general anaesthesia, and
pain. A reduction in functional residual capacity below closing
volume also contributes to hypoxaemia. Good analgesia, chest
physiotherapy, and early mobilisation help to prevent this.
Excessive load from reduced compliance and increased minute
volume in combination with opiates which depress
respiration lead to hypercapnia. At risk patients are those with
pre-existing lung disease, who are obese, or who have upper
abdominal or thoracic surgery.
Treatments for respiratory failure
Any patient with acute respiratory failure should be
admitted to a respiratory care unit or other level 2–3 facility.
Hypoxaemia is the most life-threatening facet of respiratory
failure. The goal is to ensure adequate oxygen delivery to
tissues which is generally achieved with a PaO2 above 8·0 kPA
(60 mmHg) or SaO2 of at least 94%. However, patients who
normally have hypoxaemia, hypercapnia, and breathlessness
require different therapeutic targets than patients without
lung disease. One would not necessarily aim for “normal”
values in such patients.
Apart from oxygen therapy (see Chapter 2), various types of
respiratory support are used to treat respiratory failure. These
can be extremely confusing for the uninitiated. A simplified
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version is as follows. As well as treatment of the underlying
cause (for example, antibiotics for pneumonia), the lungs can
be supported in the following ways:
• through an invasive airway, for example the patient is
intubated
• non-invasive respiratory support via a tight-fitting mask.
Whether the patient is intubated or has a tight-fitting mask,
various modes of respiratory support exist (Figure 4.3), which
are described below.
The most important decision when faced with a person
with acute respiratory failure is to decide which should be the
first line method of respiratory support. Some situations
require intubation whereas others can be managed non-
invasively.
Non-invasive ventilation (NIV) is contraindicated in:
• patients with recent facial or upper airway surgery, facial
burns or trauma
• vomiting
• recent upper gastrointestinal surgery, bowel obstruction
• inability to protect own airway
• copious respiratory secretions
• other organ system failure, for example haemodynamic
instability
• severe confusion/agitation.
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Invasive airway
IPPV
(several modes)
IPPV
(usually BiPAP)
CPAPCPAP
(used in weaning)
Non-invasive (mask)
Figure 4.3 Different types of respiratory support. Modes of IPPV
(intermittent positive pressure ventilation): volume control; pressure
control; pressure support; synchronised intermittent mandatory
ventilation; biphasic positive airway pressure (BiPAP)
However, NIV is sometimes used in drowsy or confused
patients if it is decided that the patient is not suitable for
intubation because of severe chronic lung disease.
The effects of ventilation
Spontaneous ventilation can be assisted or replaced by
delivering an intermittent positive pressure to the lungs. This
is what happens when an unconscious patient is ventilated by
hand with a bag and mask. In the past “iron lungs” were used
to apply an intermittent negative pressure to the thorax, but
manual intermittent positive pressure ventilation (IPPV) was
introduced during a large polio epidemic in Copenhagen in
1952. Mortality rates were much more favourable than those
following previously used techniques. This heralded the
introduction of intensive care units.
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Table 4.1 First-line methods of respiratory support in different
conditions
Non-invasive ventilation Non-invasive 
Intubation (NIV or BiPAP) CPAP
Asthma COPD pH 7·25-–7·35 Acute cardiogenic
pulmonary
oedema
ARDS Decompensated sleep Hypoxaemia in
apnoea chest trauma
Severe respiratory Acute on chronic hypercapnic 
acidosis respiratory failure due to 
chest wall deformity/
neuromuscular disease
Any cause with
impaired 
conscious level
Pneumonia*
*If NIV or CPAP is used as a trial of treatment in pneumonia or
postoperative respiratory failure, this should be done on an ICU with
close monitoring and rapid access to intubation. ARDS, acute
respiratory distress syndrome; BiPAP, bilevel positive airway pressure;
COPD, chronic obstructive pulmonary disease; CPAP, continuous positive
airway pressure; NIV, non-invasive ventilation.
During IPPV there is reversal of the thoracic pump – the
normal negative intrathoracic pressure during spontaneous
inspiration, which draws blood into the chest from the vena
cavae, a significant aspect of venous return. With IPPV, venous
return decreases during inspiration and, if a positive pressure
is added during expiration as well (positive end-expiratory
pressure or PEEP), venous return will be impeded throughout
the respiratory cycle. This can cause hypotension. The degree
of impairment of venous return is directly proportional to the
mean intrathoracic pressure. So changes in ventilatory
pattern, not just pressures, can cause cardiovascular changes.
At high lung volumes the heart may be directly compressed
by lung expansion. This prevents adequate filling of the
cardiac chambers. Ventricular contractility is also affected.
Elevated intrathoracic pressures directly reduce the left and
right ventricular ejection pressure which is the difference
between the pressure inside and outside the ventricular wall
during systole. As a result, stroke volume is reduced for a given
end-diastolic volume. This is usually detrimental, but in
failing hearts IPPV can improve cardiac output by reducing
filling pressures and returning the heart to a more favourable
portion on the Frank–Starling curve.
IPPV indirectly produces an overall decline in renal function
with a reduced urine volume and sodium excretion. Hepatic
function can also be adversely affected by the decrease in
cardiac output, with increased vascular resistance and elevated
bile duct pressure. The gastric mucosa does not have an
autoregulatory capability. Therefore mucosal ischaemia and
surgical bleeding may result from a decreased cardiac output
and an increased gastric venous pressure.
These physiological changes during IPPV can be
precipitously revealed when intubating critically ill patients.
Marked hypotension and cardiovascular collapse can occur as
a result of uncorrected volume depletion prior to intubation.
This is compounded by the administration of anaesthetic
drugs, which vasodilate and reduce circulating catecholamine
levels as patients lose consciousness.
The effects on cardiac output are seen in both invasive and
non-invasive IPPV, but the effects are not as dramatic in non-
invasive ventilation as the patient is awake and breathing
spontaneously, with the ventilator acting only as an assistant.
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Specific modes of IPPV
Ventilators that deliver IPPV are set to deliver either a
certain volume or a certain pressure. This is termed
“volume-control” or “pressure-control” ventilation and the
different characteristics have advantages and disadvantages
(Figure 4.2).
In volume-controlled ventilation, inhalation proceeds until
a preset tidal volume is delivered and this is followed by
passive exhalation. A feature of this mode is that gas is
delivered at a constant inspiratory flow, resulting in peak
pressures applied to the airways higher than that required for
lung distension. Since the volume delivered is constant,
airway pressures vary with changing pulmonary compliance
and airway resistance. A major disadvantage is that excessive
airway pressure may be generated, resulting in barotrauma.
In pressure-control ventilation a peak inspiratory pressure is
applied and the pressure difference between the ventilator and
lung results in inflation until that pressure is attained. Passive
exhalation follows. The delivered volume is dependent on
pulmonary and thoracic compliance. A major advantage of
pressure control is the decelerating inspiratory flow pattern, in
which inspiratory flow tapers off as the lung inflates. This
usually results in a more homogeneous gas distribution
throughout the lungs. A major disadvantage is that dynamic
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Parameters
Delivery
Leaks
PEEP
Volume control
Delivers a set tidal volume
no matter what pressure
this requires. This can
cause barotrauma
Poor compensation
Many volume control
ventilators cannot apply
PEEP
Pressure control
If airway pressures are
high, only small tidal
volumes will be delivered.
Not good if lung
compliance keeps
changing
Compensates for leaks
well (e.g. poor fitting mask
or circuit fault)
PEEP easily added
Table 4.2 Advantages and disadvantages of volume versus
pressure control
PEEP, positive end-expiratory pressure.
changes in pulmonary mechanics may result in varying tidal
volumes.
More sophisticated ventilators have been manufactured,
mainly for intensive care units, which incorporate the
characteristics of both modes (for example, pressure-limited
volume control). Alarms have been added for excessive leaks
and abnormally high or low pressures and volumes. Some
examples are illustrated below:
• Pressure support ventilation (PSV) – PSV is patient-
initiated, pressure-control ventilation. The ventilator
assists in response to the patient’s spontaneous inspiratory
effort. With each inspiratory effort the ventilator delivers a
preset pressure.
• Synchronised intermittent mandatory ventilation (SIMV) –
the ventilator delivers preset breaths (for example, 12 per
minute) in coordination with the respiratory effort of the
patient. Spontaneous breathing is allowed between breaths.
Synchronisation attempts to limit barotrauma, which can
occur if a preset breath is delivered to a patient who is
already in maximal inhalation or is forcefully exhaling.
• Biphasic or bilevel positive airway pressure (BiPAP) – this
delivers a continuous positive airway pressure (CPAP) that
cycles between a higher and a lower positive pressure.
The pressure waveforms of different ventilation modes are
shown in Figure 4.4.
Additional ventilator settings typically include breaths per
minute, inspired oxygen concentration, the ratio of
inspiration to expiration, inspiratory and expiratory pressures,
pressure limits, and tidal volume measurements. In this way
the dual lung functions of oxygenation and ventilation can be
manipulated.
Weaning from invasive ventilation
Weaning is the progressive reduction in respiratory support
as respiratory failure improves. The respiratory muscles
become deconditioned during prolonged ventilation so an
abrupt withdrawal of ventilatory support is often
unsuccessful. Weaning is appropriate when the underlying
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cause of respiratory failure has been treated, other organ
systems are stable, an appropriately low level of FiO2 is
required and PEEP is 5 cm H2O or less. Some ventilatory
modes are better than others during the weaning process,
although limited evidence exists. There is usually a reduction
in pressure support and a trial of breathing unsupported
before extubation occurs. The rapid shallow breathing index
has been studied extensively and is the best measurement to
predict successful weaning. It measures the respiratory
rate:tidal volume ratio during a 1-minute trial of breathing
unsupported through a T-piece. Patients who develop more
rapid and shallow breathing are unlikely to manage without
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allowed for expiration in wheeze)
Patient’s spontaneous
breath
BiPAP
CPAP
SIMV
(spontaneous breaths in
between)20
10
0
20
10
0
20
10
0
Figure 4.4 Pressure waveforms of different ventilation modes (cm H2O)
ventilatory support. The cut-off figure is 105 – so a patient
with 20 breaths per minute and tidal volumes of 0·5 litres has
a rapid shallow breathing index of 40 and is likely to wean
successfully, whereas a patient with 40 breaths per minute and
tidal volumes of 0·25 litres has an index of 160 and is unlikely
to manage unsupported.
Mini-tutorial: intubation in acute severe asthma
Intubation can be a life-saving intervention. Therefore it is important
that it is performed early if indicated, particularly in acute severe
asthma. A few minutes preparation beforehand is time well spent,
particularly in those who are most unstable, as cardiovascular
collapse can occur from uncorrected volume depletion, the abolition
of catecholamine responses, and vasodilatation when general
anaesthesia is given. Patients are volume loaded prior to intubation
and a vasopressor (for example, ephedrine) is kept ready to treat
hypotension. Anaesthetic drugs are given cautiously to minimise any
vasodilatory effect and drugs that cause histamine release are
avoided if possible. In life-threatening asthma, maximum medical
therapy includes less commonly used bronchodilators, such as
nebulised or subcutaneous adrenaline, intravenous salbutamol,
magnesium sulphate, ketamine, and volatile anaesthetic agents.
Once intubated, the patient is ventilated to allow a long expiratory
time and this may mean only 6–8 breaths per minute is possible.
“Permissive hypercapnia” is the term used when the PaCO2 is
allowed to rise in such situations, in order to prevent “stacking”. In
asthma, if the next positive pressure is delivered before there has
been enough time for expiration to occur, the lung volume slowly
expands, reducing venous return and leading to a progressive fall in
cardiac output. The resulting hypotension which occurs is corrected
by disconnecting the ventilator and allowing passive expiration to
occur (which can take several seconds).
Non-invasive ventilation
Non-invasive ventilators are usually much simpler than
those found on the ICU, with less settings to choose from. This
is because most are designed for home use. The disadvantage of
this is that they also tend to be poorly equipped in terms of
monitoring and alarms when used in hospital. Home NIV will
not be discussed here. The recent trials of NIV in exacerbations
of COPD have used pressure-controlled ventilators. BiPAP
(Respironics Inc.) is a commonly used pressure control
ventilator in acute respiratory units in the UK.
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Acute NIV should be considered in patients with mild to
moderate acute respiratory failure (hypercapnia causing a pH
of 7·2–7·35). The patient should have an intact airway,
protective airway reflexes and be alert enough to follow
commands. A common method is to begin with the expiratory
level (EPAP) at 5 cm H2O and the inspiratory level (IPAP) at 15
cm H2O. The levels are adjusted based on patient comfort,
tidal volume achieved (if measured), and arterial blood gases.
The main indications for acute NIV are:
• exacerbation of COPD with a mild to moderate respiratory
acidosis
• weaning from invasive ventilation.
The only condition for which there is conclusive evidence
for acute NIV is acute exacerbations of COPD (see mini-
tutorial below). NIV can also be used as a step-down treatment
in patients who have been intubated and ventilated on ICU.
Failure to wean exceeds 60% in COPD patients and this is a
major cause of prolonged ICU stay and ICU costs. A recent
randomised multicentre trial has shown that NIV is more
successful in weaning than a conventional approach in
patients with COPD. Patients who failed a T-piece trial
(breathing spontaneously with no support) 48 hours after
intubation were randomly assigned to receive either NIV
immediately after extubation or conventional weaning (a
gradual reduction in pressure support). The NIV group took a
shorter time to wean, had shorter ICU stays, a lower incidence
of hospital-acquired pneumonia, and increased 60-day
survival. Other studies have reported similar findings.
Reports conflict regarding the efficacy of NIV in acute
respiratory failure from other conditions such as ARDS and
pneumonia. Earlier trials of NIV in pneumonia were
discouraging, but a recent prospective randomised trial of NIV
in community acquired pneumonia (56 patients) showed a
significant fall in respiratory rate and the need for intubation.
Just under one half of the patients in this study had COPD and
it was carried out in an ICU with ready access to intubation.
Generally, NIV failure rates are higher in non-COPD patients.
NIV should never be used in acute severe asthma.
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Mini-tutorial: NIV for exacerbations of COPD
An exacerbation of COPD requiring admission to hospital carries a
6–26% mortality. One study found a 5-year survival of 45% after
discharge and this reduced to 28% with further admissions. Invasive
ventilation in COPD carries a 50% or less survival to discharge.
Ventilator-associated pneumonia is common and increases mortality
still further. NIV is associated with less complications than intubation
(Table 4.3).
Most studies of NIV in acute exacerbations of COPD have been
performed in critical care areas. The majority used ICU ventilators
with a face mask as opposed to custom-built NIV ventilators. The
studies performed in general ward areas involved patients with a pH
of > 7·29. There have been at least half a dozen prospective
randomised controlled trials of NIV in acute exacerbations of COPD.
The studies performed in ICUs showed a reduction in intubation
rates and some also showed reduced mortality when compared with
conventional medical therapy. None has directly compared NIV with
intubation. A recent multicentre randomised controlled trial of NIV in
general respiratory wards showed both a reduced need for intubation
and reduced hospital mortality. Patients with a pH of < 7·3 after
initial treatment did less well and it has been recommended that this
group is managed in an ICU.
NIV should be commenced as soon as the pH falls below 7·35
because the further the degree of acidosis, the less the chances are
of improvement. It should be used as an adjunct to full medical
therapy, which treats the underlying cause of acute respiratory failure.
However, in a 1-year prevalence study of 954 patients admitted with
an exacerbation of COPD to one hospital, 25% were acidotic on arrival
in the Emergency Department, but their pH was normal by the time
they were admitted to a ward. This included patients with an initial pH
of < 7·25, which suggests that NIV should be commenced after
controlled oxygen and medical therapy has been administered.
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Table 4.3 Complications of NIV versus intubation
NIV Intubation
Necrosis of skin over bridge of nose Pneumonia
Aspiration Barotrauma and volutrauma
Changes in cardiac output (less) changes in cardiac output
complications of sedation 
and paralysis tracheal
stenosis/tracheomalacia
Patients on NIV require close supervision because sudden
deterioration can occur at any time. Simple measures such as
adjusting the mask to reduce excessive air leaks can make a
difference to the success or otherwise of treatment. Basic vital signs
measured frequently give a indication of whether or not NIV is
effective or failing. If NIV does not improve pH and respiratory rate in
the first 2 hours, intubation should be considered. Predictors of
failure of NIV in acute COPD are as follows:
• no improvement within 2 hours
• high APACHE II score (acute physiological and chronic health
evaluation)
• pneumonia
• very underweight patient
• neurological compromise
• pH < 7·2 prior to starting NIV.
Non-invasive CPAP
Non-invasive CPAP was first introduced in the 1980s as a
therapy for obstructive sleep apnoea (OSA). This is when a
tight-fitting face or nasal mask delivers a single pressure
throughout the patient’s respiratory cycle. It is therefore not
ventilation. In OSA, CPAP prevents pharyngeal collapse. CPAP
can also be delivered through an endotracheal tube or
tracheostomy tube in spontaneously breathing patients and
is usually used this way during weaning. The application of a
continuous pressure keeps the alveoli open for longer and
improves oxygenation. This is therefore the main indication
for CPAP.
The main indications for acute non-invasive CPAP are:
• to deliver increased oxygen in pneumonia or postoperative
respiratory failure associated with atelectasis – this should
be performed in an ICU;
• acute cardiogenic pulmonary oedema (see below).
CPAP is employed in patients with acute respiratory
failure to correct hypoxaemia. In the spontaneously
breathing patient, the application of CPAP provides positive
end-expiratory pressure (PEEP) that can reverse or prevent
atelectasis, improve functional residual capacity, and
oxygenation. These improvements may prevent the need for
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endotracheal intubation. The inspiratory flow in a CPAP
circuit needs to high enough to match the patient’s peak
inspiratory flow rate. If this is not achieved the patient will
breathe against a closed valve with the risk that the generation
of significant negative intrapleural pressure will lead to the
development of pulmonary oedema. Always look at the
expiratory valve in patients on CPAP. The valve should always
remain slightly open during inspiration (Figure 4.5).
CPAP in patients with acute cardiogenic
pulmonary oedema
One can think of acute cardiac failure in terms of “forward
failure” (the inability to drive the circulation) or “backward
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Tight-fitting
mask (nasal,
facial or hood)
CPAP valve:
5, 7·5 or 10 cm H2O
(gas flow adjusted
to get correct valve
movement)
Humidifier
Tubing
O2 %
sensor 
Three control
buttons:
On
Gas flow
O2 concentration
Safety valve
(limits
barotrauma)
Figure 4.5 A CPAP circuit
failure” (the congestion caused by an inefficient pump).
Backward failure causes pulmonary oedema and is often
associated with a normal or high blood pressure. Treatment
aims toward off-loading the heart. Medical therapy does this by
• sitting the patient up which reduces venous return, and 
• giving frusemide, diamorphine and nitrates for their
vasodilator properties.
When medical therapy fails, intubation may be the next
step, but there are several studies that show that non-invasive
CPAP reduces the need for intubation by reducing afterload
and improving left ventricular function as well as its effects on
the lungs.
Meta-analysis shows that non-invasive CPAP reduces the
need for intubation in patients with acute cardiogenic
pulmonary oedema (numbers needed to treat = 4) with a
trend towards a reduction but no significant difference in
mortality.
The respiratory effects of non-invasive CPAP are:
• Fluid is “squeezed” out of the alveoli into the circulation –
there is a decline in the level of shunt because of
redistribution of lung water from the alveolar space to the
perivascular cuffs. PEEP reduces extravascular lung water
and increases lymphatic flow through the thoracic duct in
animal studies.
• PEEP prevents the collapse of alveoli at end-expiration,
improving oxygenation.
The cardiac effects of non-invasive CPAP are:
• Left ventricular function is improved because afterload is
reduced (leading to an increase in stroke volume). This
occurs because the increased intrathoracic pressure has a
squeezing effect on the left ventricle. There is a subsequent
reduction in the pressure gradient between the ventricle
and the aorta which has the effect of reducing the work
required during contraction, that is, afterload.
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• Relief of respiratory distress leads to haemodynamic
improvement and reversal of hypertension and tachycardia –
probably through reduced sympathoadrenergic stimulation.
• Sedation and a large reduction in venous return, which
would be caused by high intrathoracic pressures, is
avoided. These occur in intubated patients.
Non-invasive CPAP in acute cardiogenic pulmonary oedema
is indicated when the patient has failed to respond to
maximum medical therapy and there is an acute respiratory
acidosis, unacceptable fatigue or hypoxaemia despite
supplemental oxygen. Patients who do not respond quickly to
CPAP should be considered for intubation.
Assessing the patient with respiratory failure
A, B, C, D, E is still the way to approach any patient,
including one with respiratory failure (Box 4.1)
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Box 4.1 Approach to a patient with respiratory failure
A
• relieve any upper airway obstruction
• administer oxygen 
B
• count respiratory rate
• treat wheezing, fluid, consolidation or pneumothorax
• assess oxygen saturations and arterial blood gases
• consider if ventilatory support is required early and if so, what
method
C
• fluid therapy
• treat any associated severe sepsis (see Chapter 7)
D
• assess conscious level as this affects treatment options
E
• full history and examination once A, B and C are stable
Self-assessment – case histories
1. A 30-year-old lady is admitted with acute severe asthma. Her vital
signs are as follows: BP 100/60 mmHg, pulse 130, RR 40 per
minute with poor respiratory effort, temperature 37°C and she is
drowsy. Her arterial blood gases on 10 litres per minute reservoir bag
mask show: pH 7·15, PaCO2 9·0 kPA (70 mmHg), PaO2 7 kPA (54
mmHg), bicarbonate 22 mmol/l, BE − 5. What is your management?
2. Later on ICU the same patient develops hypotension (60/30
mmHg). The patient is paralysed and the ventilator is set to 12
breaths per minute. The inspiratory to expiratory ratio is 1:4, tidal
volumes are 600 ml, and peak airway pressures are 45 cm H20.
She is on volume-controlled ventilation. What are the possible
causes of the hypotension and what is your management?
3. A 50-year-old man is admitted with an exacerbation of his COPD.
His arterial blood gases on 28% oxygen (Venturi mask) show: pH
7·3, PaCO2 8·0 kPA (62 mmHg), PaO2 7 kPA (54 mmHg)
bicarbonate 29 mmol/l, BE + 3. What is your management?
4. A 40-year-old man with no past medical history is admitted with
a severe pneumonia. His vital signs are: BP 120/70 mmHg,
pulse 110, RR 40 per minute, temperature 38°C and he is alert.
His arterial blood gases on 15 litres per minute via a reservoir
bag mask show: pH 7·31, PaCO2 4·0 kPA (31·mmHg), PaO2 6 kPA
(46 mmHg), bicarbonate 14 mmol/l, BE − 8. What do you do?
5. You are called to see a 70-year-old man who is 2 days post-
laparotomy. He has developed a cough with green phlegm and
fever. His respiratory rate is increased (30 per minute) and his
arterial blood gases on 10 litres per minute simple face mask
show: pH 7·3, PaCO2 8·0 kPA (62 mmHg), PaO2 7·6 kPA (58
mmHg), bicarbonate 29 mmol/l, BE + 4. What is your management?
6. A 60 kg 25-year-old lady with Guillain–Barré syndrome has been
undergoing twice-daily forced vital capacity (FVC) measurements
and treatment with intravenous immunoglobulin. Her FVC has
fallen below 1 litre and her arterial blood gases on air now show:
pH 7·3, PaCO2 7·5 kPA (58 mmHg), PaO2 10 kPA (77 mmHg),
bicarbonate 27 mmol/l, BE + 3. Her respiratory rate is 28 per
minute. What do you do?
7. A 60-year-old man is admitted with acute severe left ventricular
failure. He has been given 100 mg intravenous frusemide,
salbutamol nebulisers, and a small dose of intravenous
diamorphine. His arterial blood gases on 10 litres per minute
oxygen via a reservoir bag mask show: pH 7·15, PaCO2 7 kPA (54
mmHg), PaO2 9 kPA (70 mmHg), bicarbonate 18 mmol/l, BE − 8.
His blood pressure is 180/90 mmHg and his respiratory rate is
38 per minute. What is your next step?
8. A 50-year-old lady is admitted with breathlessness. On
examination she has an unrecordable blood pressure (which is
80 systolic by palpation). Her pulse is 110 per minute, RR 36 per
minute, and she is alert. The chest sounds clear. The ECG shows
sinus tachycardia with right heart strain and her chest x ray film
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is normal. The arterial blood gases on 15 litres per minute via
a reservoir bag mask show: pH 7·25, PaCO2 3·0 kPA (23
mmHg), PaO2 12 kPA (92 mmHg), bicarbonate 10 mmol/l,
BE − 12. What is the diagnosis and what is your management?
9. A 70-year-old man with COPD is admitted in extremis. He has
been more breathless for a few days. He responds to painful
stimuli only, his blood pressure is 130/60 mmHg, pulse 120
per minute and arterial blood gases on air show: pH 7·1, PaCO2
14·0 kPA (108 mmHg), PaO2 6 kPA (46 mmHg), bicarbonate 20
mmol/l, BE − 4. What is your management?
10. A 30-year-old man arrives with pleurisy. There seems to be no
obvious explanation for this and he has had a previous DVT.
Calculate the A–a gradient using the arterial blood gas sample
taken whilst the patient is breathing air. pH 7·5, PaCO2 4·0 kPa
(30·7 mmHg) bicarbonate 24 mmol/l, BE 0, PaO2 10·0 kPa
(77 mmHg).
11. Your team is treating a patient with acute respiratory distress
syndrome (ARDS) associated with pneumonia. He may need
ventilation if his condition worsens. His physiology is stable apart
from a respiratory rate of 30 per minute. Your boss has asked
you to calculate the A–a gradient daily so that his progress can
be charted. Yesterday’s A–a gradient was 47 kPA. Today he is
breathing 60% oxygen and his arterial blood gases show: pH 7·35,
PaCO2 5·6 kPA (43 mmHg), bicarbonate 22.5 mmol/l, BE − 1, PaO2
10·0 kPA (77 mmHg). What is the A–a gradient today?
Self-assessment – discussion
1. The arterial blood gases show a respiratory acidosis with
hypoxaemia. Nine per cent of people with an attack of acute severe
asthma have respiratory failure; 1% patients with asthma have a
fatal or near fatal attack each year. Previous life-threatening
attacks increase the risk of death from asthma. Initial
management here is to ensure there is no upper airway
obstruction, administer the highest concentration of oxygen
possible (15 litres per minute via a reservoir bag mask) and treat
her breathing with medication to relieve lower airway obstruction.
The initial assessment of breathing should include looking for
clinical signs of a pneumothorax, which can occur in asthma. The
ICU team should be contacted immediately. A large bore
intravenous cannula should be inserted and fluid given quickly (for
example, 1–2 litres 0·9% saline stat) because the patient is likely
to be dehydrated and needs imminent intubation. We can assume
she is drowsy because of hypercapnia and hypoxaemia, but a
bedside blood glucose estimation followed by a formal neurological
examination should be performed once A, B and C are stable.
2. Patients with severe asthma who have just been intubated
require long expiratory times because of severe airway
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obstruction. This limits the respiratory rate, otherwise stacking
or “gas trapping” occurs. The expiratory time can be lengthened
by reducing the respiratory rate or decreasing the inspiratory
time (by increasing the inspiratory flow rate) or a combination of
the two. Suitable settings would be 6–8 breaths per minute with
an inspiratory to expiratory ratio of 1:4 or longer. The ventilator
should be set to a pressure limit to prevent barotrauma and with
peak airway pressures not exceeding 35–40 cm H20. This is
slightly complicated by the fact that peak pressures in acute
severe asthma do not necessarily reflect alveolar pressures but
the pressures needed to overcome bronchial obstruction. An
appropriate tidal volume should be < 10 ml kg−1. After excluding
pneumothorax and volume depletion in this case, consider
stacking as a cause of hypotension. The ventilator should be
disconnected and the patient allowed to passively exhale – this
can take several seconds and a prolonged wheeze can be heard
by placing an ear near the end of the endotracheal tube. If this is
the cause, the blood pressure will return to normal within
seconds. PEEP is not usually of benefit in acute severe asthma
as patients already have significant intrinsic or auto-PEEP.
3. The arterial blood gases show a respiratory acidosis with
hypoxaemia. Initial management includes an assessment of his
airway, medical treatment of his lower airway obstruction, and
any other lung pathology that may have triggered his
breathlessness (for example, pneumonia or pneumothorax). His
oxygen should be increased using a 35% Venturi mask to get the
PaO2 to around 8·0 kPA (60 mmHg). Intravenous fluid should be
started for dehydration. If there is no prompt improvement of his
respiratory acidosis with medical therapy, non-invasive ventilation
should be started. Oxygen therapy is given through the ventilator
mask, titrated to arterial blood gases.
4. This man is at risk of further physiological deterioration. He has
hypoxaemic respiratory failure despite a high concentration of
oxygen. His respiratory rate is 40 per minute. There is also a
metabolic acidosis which could indicate hypoperfusion. In this
situation, non-invasive CPAP in a critical care area could be tried.
This will improve oxygenation and can reduce the work of
breathing. However, intubation is indicated within hours if there
is no improvement. Intravenous fluids should be administered to
treat hypoperfusion, improve oxygen delivery, and aid the
expectoration of secretions.
5. The arterial blood gases show a respiratory acidosis with
hypoxaemia. Postoperative chest infections and respiratory
failure often involve atelectasis (owing to the effects of supine
position, general anaesthesia, and difficulty in taking a deep
breath from poor pain relief). Retained secretions may be the
result of an inability to cough properly. Therefore, close attention
should be paid to improving analgesia to allow deep breaths and
proper coughing. The acute pain team can be consulted, who may
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suggest epidural analgesia. Physiotherapy also has an important
role to play and in some cases acute physiotherapy can
significantly improve respiratory function. Humidified oxygen
therapy is indicated in this circumstance as this aids the
expectoration of secretions. The oxygen concentration should be
increased. Antibiotics should be commenced and blood and
sputum cultures sent. If these measures do not help, the ICU
should be contacted for advice on further respiratory support.
6. There is a respiratory acidosis. This patient needs intubation
both to support ventilation and to protect the airway from
aspiration because of the profound muscle weakness seen in
patients with Guillain–Barré syndrome. Up to 30% patients with
this syndrome admitted to hospital require mechanical
ventilation. There is evidence of ventilatory failure (high PaCO2
and increased respiratory rate) as a result of increasing
respiratory muscle weakness as indicated by the falling FVC.
Closer examination may reveal a patient who is using accessory
respiratory muscles and has a cough, which is bovine in nature.
Neurological examination may reveal poor bulbar function.
Monitoring oxygen saturations and arterial blood gases in this
condition are of little help when deciding when to institute
respiratory support. Arterial blood gases follow the condition
rather than precede it. Autonomic neuropathy can accompany
Guillain–Barré syndrome, leading to tachycardia and
hypotension, which also require close observation, especially
during anaesthesia and intubation, which can precipitate an
asystolic cardiac arrest from profound vagal stimulation.
Plasmapheresis is useful in severe or rapidly progressing cases.
7. The arterial blood gases show a mixed respiratory and metabolic
acidosis with a lower than expected PaO2. After his airway has
been assessed and oxygen increased to 15 litres per minute, the
breathing and circulation are treated in the following way: preload
is reduced by sitting the patient up and giving small doses of
intravenous diamorphine. Frusemide is a pulmonary vasodilator
as well as a diuretic and has a quick onset of action in acute
severe left ventricular failure. Around 1 mg kg−1 frusemide is
given in the first instance and an intravenous nitrate infusion (a
vasodilator) can be commenced, titrated to effect and blood
pressure. If the patient does not improve, a further dose of
frusemide (1–2 mg kg−1) is administered. After this, non-invasive
CPAP is indicated to improve both left ventricular and respiratory
function. This is appropriate in alert patients with a moderate
respiratory acidosis. If the patient deteriorates or fails to
improve, intubation is indicated.
8. The airway is fine, as the patient is alert and talking. Breathing
and circulation are abnormal. She is extremely breathless but the
chest x ray film is normal and the chest sounds clear. Is this
because of shock alone? Her arterial blood gases show a lower
than expected PaO2 (the A–a gradient is 41·2 assuming an FiO2
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of 0·6) and a metabolic acidosis from hypoperfusion. The
diagnosis is massive pulmonary embolism. Treatment is to give
a high concentration of oxygen (for example, 15 litres per minute
via a reservoir bag mask), fluid challenges, and thrombolysis.
Intravenous thrombolysis should be considered in pulmonary
embolism causing shock and is as effective as surgical
embolectomy. Newer literature suggests thrombolysis is safe
and effective in “sub-massive” pulmonary embolism as well.
9. The arterial blood gases show a severe respiratory acidosis
with a metabolic acidosis and hypoxaemia. Management is to
secure the airway by intubation, administer enough oxygen to
get the PaO2 to around 8·0 kPA (62 mmHg), treat his
exacerbation of COPD and any precipitating infection, and give
intravenous fluid. Breathless patients who have been unwell for
a few days are often dehydrated and general anaesthesia can
cause vasodilatation which also leads to hypovolaemia. This
patient has a base deficit of − 4 suggesting hypoperfusion. An
unresponsive patient is not appropriate for non-invasive
ventilation. However, before the patient is intubated, further
information should be sought as to the severity of the patient’s
chronic lung disease. Has a discussion already taken place
about intubation and ventilation between the patient and his
specialist? Do the next of kin have information about what the
patient would want in these circumstances? What was his
quality of life beforehand and what is his anticipated quality of
life after potential discharge from ICU?
10. A–a gradient in kPA = 20 − (3·5/0·8) − 10 = 5.0. This is above
normal for this patient – this could indicate a pulmonary
embolism given the history.
11. A–a gradient in kPA = 0·6 × 95 − (5·6/0·8) − 10·0 = 40. His
physiology is stable, the PaCO2 is satisfactory and the A–a
gradient is improving rather than worsening.
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5: Fluid balance and volume
resuscitation
By the end of this chapter you will be able to:
• calculate a patient’s normal fluid requirements
• understand how fluid balance is affected by illness
• understand the concept of the “third space” and capillary leak
• understand the principles of volume resuscitation
• know about the different types of fluid available including blood
• apply this to your clinical practice
The main aim of fluid therapy in critical illness is to restore
tissue perfusion and optimise organ function by correcting
hypovolaemia.
Normal fluid requirements
Normal people balance their daily intake and output. Adults
exchange approximately 5% of their body water each day.
Normal maintenance fluid requirements are calculated as
follows:
• 4 ml kg−1 per hour for the first 10 kg
• 2 ml kg−1 per hour for the second 10 kg
• 1 mg kg−1 per hour after that.
So a 70 kg man requires 2640 ml per day – which is where
the commonly used 3 litres a day comes from (Table 5.1).
Maintenance fluid covers insensible losses plus the required
intake to maintain normal fluid balance (like replacing urine
output). Insensible losses include things like sweating and
breathing and are around 1200 ml per day. The maximum
concentrating power of the kidney is 1200 mosmol kg−1 so a
minimum of 500 ml urine is needed to excrete the daily solute
load of 600 mosmol. Oliguria is defined as a urine output of
< 0·5 ml kg−1 per hour for two consecutive hours or < 400 ml
in 24 hours. The elderly have a reduced ability to concentrate
urine because of age-related nephron loss.
Electrolytes are needed as well as water: 50–150 mmol
sodium and 20–40 mmol potassium is the average daily
requirement. An average water and sodium requirement can
be found in 1 litre 0·9% saline and 2 litres 5% dextrose per 24
hours; however, note that this is maintenance fluid in a
normal person.
Accurate replacement of fluid depends on understanding
the distribution of water, sodium, and colloid in the body
(Figure 5.1). Humans are 60% water. Females have less because
of more fat (which contains less water). Total body water is up
to 80% in neonates falling to 45% in the elderly. Two-thirds of
total body water is in cells (ICF) and the remaining one-third is
in the extracellular compartment (ECF). Sodium is the major
extracellular cation and, with chloride, provides the effective
osmolality (or tonicity) of this compartment. Potassium and
phosphate are the major intracellular ions (Table 5.2). The ICF
and ECF are separated by a semi-permeable membrane, which
allows free movement of water. Movement of sodium and
glucose results in movement of water between the ICF and ECF.
Serum osmolality is regulated by osmoreceptors in the
hypothalamus. Osmolality is a measure of the total number
of particles in a given weight of plasma. Any minor increase
(> 2%) is sensed by these receptors and this causes the release
of antidiuretic hormone (ADH), which acts on receptors in the
collecting duct, opening aquaporin channels and causing
water reabsorption with the excretion of a concentrated urine.
A reduction in serum osmolality normally inhibits the release
of ADH leading to more dilute urine. A normal 70 kg man
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Table 5.1 Maintenance fluid according to weight
Weight (kg) ml per hour ml per 24 hours
50 90 2169
60 100 2400
70 110 2640
80 120 2880
90 130 3120
100 140 3360
filters 140 litres of water at the glomerulus per day and the
majority (70%) is reabsorbed in the proximal convoluted
tubule. ADH is controlled to a lesser extent by baroreceptors
located in the heart and great vessels. In the presence of
volume contraction, ADH is released.
Fluid requirements in illness
Trauma and illness alter the volume and composition of the
intracellular and extracellular spaces as well as the kinetics of
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(water passes freely).
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Figure 5.1 Water distribution in the body (of a 70 kg man). Sodium
changes in the extracellular compartments cause water shifts to and
from cells, contracting or expanding the ICF. The third space is a
non-exchangeable compartment in the ISF
Table 5.2 Electrolyte contents of different body compartments
(in mmol litre−1)
Compartment Sodium Potassium Chloride Bicarbonate
Plasma 142 4 103 27
Interstitial 144 4 114 30
Intracellular 10 150 0 10
fluid distribution and excretion. Patients may have increased
fluid losses from fever, dehydration, polyuria, bleeding, or
breathlessness. An extra 500 ml/day is required for every
degree Celsius above 37. Gastrointestinal losses also need to be
considered – a patient with diarrhoea or gastric outflow
obstruction could be litres behind in terms of fluid balance.
Certain patients are at increased risk of pulmonary oedema.
Patients with heart failure, renal failure and the elderly are the
most common examples. Patients with capillary leak, for
example, in severe sepsis, are also at risk of interstitial oedema,
yet can require large amounts of intravenous fluid as they are
volume depleted. Monitoring and management in these cases
is more complex (see Chapter 7).
To preserve plasma volume after trauma, surgery, haemorrhagic
shock, or severe sepsis, the kidney reabsorbs filtered water and
sodium avidly via ADH. Intravascular volume loss stimulates the
renin–angiotensin–aldosterone axis and inhibits natriuretic
peptide. This leads to sodium retention (Figure 5.2). Sodium
loading occurs with sodium containing crystalloids or colloids.
This results in a hyperosmolar state which in turn stimulates
further ADH release and fluid retention. This tends to reduce
urine output. In addition, high chloride levels from sodium
chloride infusions cause renal vasoconstriction and a
hyperchloraemic metabolic acidosis. The critically ill have a
reduced renal concentrating ability and need to excrete more
water to get rid of their solute load. However, these patients often
become fluid overloaded and are subsequently fluid restricted,
making the problem of sodium retention worse.
To get round these problems of sodium overload in critical
illness one should always aim to give specific fluids for specific
reasons:
• for electrolyte losses or maintenance – Hartmann’s
• for water losses – 5% dextrose or water via nasogastric
feeding
• for volume expansion – blood or another appropriate colloid.
Sodium abnormalities in illness
Regulation of salt and water homeostasis is frequently
abnormal in hospitalised patients. Hyponatraemia (< 130
mmol litre−1) is the most common electrolyte abnormality
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with an incidence of 2·5% in the general hospital population.
Except in rare circumstances (for example, hyperglycaemia) a
reduced serum sodium usually indicates a low serum
osmolality and an expanded ICF.
Acute hyponatraemia, defined as a fall in serum Na below
130 mmol litre−1 in 48 hours, can result in cerebral oedema.
This phenomenon has been described in both adults and
children and has been frequently associated with the
administration of hypotonic intravenous fluids in the
perioperative period. In an adult series of patients having
minor surgery, otherwise fit and healthy women were given
an average of 8·8 litres in 48 hours – with a net positive
balance of 7·5 litres. These patients failed to mount a normal
physiological response to expansion of the ECF, which is to
produce dilute urine. This is because ADH secretion is
increased by a variety of stimuli in hospitalised patients
including pain, anxiety, opiate and anaesthetic agents,
surgery, and positive pressure ventilation.
The use of hypotonic solutions has been standard in
paediatrics for many years and is based on assumptions
extrapolated from studies of water requirement and energy
expenditure done on normal children almost 50 years ago.
The formulae are used for calculating what are commonly
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Figure 5.2 Sodium/water retention following surgery or hypovolaemia
referred to as maintenance fluid requirements and this can
result in the administration of large amounts of electrolyte-
free water (EFW), which then requires the patient to inhibit
ADH secretion and produce a dilute urine. Failure to do so
would result in a fall in serum sodium with occasionally
catastrophic results. The flaw in the application of these
formulae is that hospitalised patients do not necessarily follow
the rules that govern normal physiology. Different rules apply
to sick patients. The assumption should be that when serum
sodium is < 140 mmol litre−1 in the absence of sodium loss,
ADH is acting. These patients, whatever their age, should not
be given hypotonic fluids; 4% dextrose/0·18% saline is
isotonic before administration but is effectively hypotonic in
the patient once the glucose has been metabolised.
A study of over 100 children admitted to hospital with the
usual spectrum of medical illnesses showed elevated ADH
levels and low serum sodium levels at the time of admission,
compared with a cohort of elective surgical admissions who
had normal ADH and sodium levels. Other groups particularly
at risk for the development of acute hyponatraemia are elderly
females treated with thiazide diuretics for hypertension who
undergo hip replacement surgery and patients undergoing
colonoscopy.
At present the standard of care in many institutions is to use
only isotonic fluids during surgery and in the postoperative
period. This reduces the risk of a fall in serum sodium. In a
study where only Ringer’s lactate was used during elective
surgery and in the first postoperative day, sodium fell from
140 to 136 mmol litre−1. This was associated with a total
intravenous intake of 5 litres and a positive balance of 3 litres.
The explanation for this fall despite isotonic fluids was
demonstrated when urine sodium was measured. Most of the
patients were producing a hypertonic urine (sodium > 150
mmol litre−1). The hypothesis proposed to explain this was that
large volumes of fluid were infused during surgery to maintain
blood pressure, which falls due to the vasodilatory effect of
anaesthetic drugs. When vasomotor tone was restored to
normal at the end of surgery, the ECF was overfilled and the
kidneys responded by eliminating sodium. In summary,
hypotonic fluids may be used when the plasma sodium is > 145
mmol litre−1 and there is a need for EFW. Patients with sodium
levels < 140 mmol litre−1 should receive isotonic fluids.
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Capillary leak and the concept of the “third space”
Oedema is excessive fluid accumulation in the interstitial
space and can be localised or generalised. Third space losses
occur when fluid accumulates in a potential space such as the
peritoneum, pleura, or bowel. The concept of the third space
was developed to explain the phenomenon that some
postoperative patients required more replacement fluid than
their measurable losses. Studies showed that the patients’
weight did not reduce but that they were intravascularly
volume depleted. This was due to movement rather than loss
of fluid.
“Capillary leak syndrome” has been defined as a syndrome
characterised by a prolonged and severe increase in capillary
permeability, the clinical features of which include
hypoalbuminaemia, microalbuminuria, severe positive fluid
balance, clinical oedema, and decreased oxygen delivery and
uptake.
Capillary leak or microvascular failure is part of the
inflammatory response to a range of insults (Figure 5.3).
Studies have shown rapid and profound transcapillary loss of
radiolabelled albumin occurring within 6 hours of surgery and
similar changes occur in patients with severe inflammatory
conditions (for example, sepsis, trauma, and ischaemia). The
kidneys are uniquely placed to mirror changes in capillary
permeability because they receive 25% of the cardiac output,
which is filtered over a wide surface area. The unique nature
of the renal-concentrating mechanism allows low level
albumin loss (microalbuminuria) to be used as a sensitive
monitor of changes in systemic capillary permeability. In
uncomplicated cases capillary permeability returns to normal
within 24 hours of major surgery. In extreme cases the result
is SIRS – systemic inflammatory response syndrome – an
unregulated inflammatory response that results in significant
end-organ dysfunction and later multiple organ dysfunction
syndrome (MODS) (Figure 5.4).
Haemorrhagic shock
Blood volume is normally 7% body weight (5 litres in a 70 kg
man). Acute loss of circulating blood leads to compensatory
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responses. Tachycardia is the first measurable sign. At the
cellular level, inadequately perfused cells compensate initially
by anaerobic metabolism producing a lactic acidosis. Mild
metabolic acidosis is common following major surgery for this
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Figure 5.3 Capillary leak after major surgery or in critical illness.
Electron microscopy in rats with severe sepsis shows holes that appear
in the endothelium
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Figure 5.4 Microalbuminuria as a measure of capillary leak during
surgery and in systemic inflammatory response syndrome (SIRS)
ESSENTIAL GUIDE TO ACUTE CARE
82
reason and a persistent metabolic acidosis in some patients
may indicate inadequate fluid resuscitation. Eventually cell
membrane damage and cell swelling occurs which leads to
fluid shifts. The best way to think of haemorrhage is by using
tennis scores (Table 5.3).
By the time blood pressure has dropped in a healthy patient
because of bleeding, at least 30% of circulating blood volume has
been lost. Certain groups do not manifest the usual signs of
hypovolaemia: athletes can compensate for blood loss very well,
patients on beta blockers or calcium antagonists may not
generate a tachycardia, and patients with permanent pacemakers
and the elderly also have altered responses. Therefore a 30% loss
of blood volume (nearly 2 litres in an average adult) is the
smallest amount of blood loss that consistently causes a drop in
systolic blood pressure – classical haemorrhagic shock.
Fluid resuscitation
Successful fluid resuscitation is integral to the management
of the critically ill patient. However, volume status can
sometimes be difficult to assess. This makes it vitally
Table 5.3 Estimated fluid and blood losses based on patient’s initial
presentation (for a 70 kg man)
Losses Class 1 Class 2 Class 3 Class 4
Blood loss (ml) Up to 750 750–1500 1500−2000 Over 2000
Blood loss or Up to 15% 15–30% 30–40% Over 40%
tennis score loss loss loss loss
(% blood vol)
Pulse rate < 100 > 100 > 120 > 140
Blood pressure Normal Normal Reduced Reduced
Pulse pressure* Normal Reduced Reduced Reduced
Respiratory rate 14–20 20–30 30–40 > 35
Urine output 
(ml h−1) > 30 20–30 5–15 Negligible
CNS Alert Mild Anxious and Confused and
anxiety confused lethargic
*Pulse pressure is the difference between systolic and diastolic blood
pressure. (Adapted with permission from the American College of
Surgeons: Committee on Trauma. Advanced Trauma Life Support for
Doctors. Student course manual. 6th edn. Chicago: American College of
Surgeons, 1997.)
important to have an effective strategy to define both trigger
points to institute therapy and endpoints when the goal of
therapy has been reached. Trigger points are based on a
thorough assessment of the patient including history and
examination. History alone can point to likely hypovolaemia,
for example bowel obstruction, sepsis, burns, pancreatitis, and
trauma. Markers of inadequate circulating volume include:
Skin temperature
Cold extremities can be a sign of poor organ perfusion. A
capillary refill time of more than 2 seconds is significant. The
central–peripheral temperature gradient has long been used in
surgical specialties as an early warning sign for hypovolaemia.
When the difference between core (nasopharynx or tympanic)
and peripheral (great toe) temperature increases, it is due to
vasoconstriction. This can be a sign of hypovolaemia although
pain, vasoactive drugs and central hypothermia are
confounding variables.
One study looked at whether physical examination alone in
combination with biochemical markers could accurately
diagnose hypoperfusion: 264 consecutive surgical intensive
care patients were divided into two groups – those with cool
extremities and those with warm extremities. Vital signs,
arterial blood gases and lactate, haemoglobin, and PA catheter
data were collected from these patients. There was no
difference between the two groups with regard to heart rate,
systolic blood pressure, pulmonary arterial occlusion pressure,
haemoglobin, PaO2, or PaCO2. However cardiac output and
pH were significantly lower in the cool extremity patients
compared with the warm extremity patients. The investigators
concluded that combining physical examination with serum
bicarbonate and lactate readily identified patients with
hypoperfusion.
Respiratory rate
Respiratory rate increases in hypoperfusion as the body tries
to compensate by increasing oxygen delivery and increasing
the removal of acid waste products. Respiratory rate increases
in early haemorrhage and a rate of above 20 breaths per
minute is significant.
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Metabolic (lactic) acidosis
Of patients requiring ICU admission, 57% present with a
metabolic acidosis and, in three-quarters of these, it is due to a
raised lactate because of hypoperfusion. A raised lactate is
associated with increased mortality. A base deficit of more than
− 4 mmol litre−1 on admission to the ICU is associated with an
in-hospital mortality of 57%, which rises to 70% if it is not
corrected within 24 hours. The base deficit has been shown to
correlate with intravascular fluid requirements in patients
with trauma.
Reduced conscious level
Cerebral blood flow is autoregulated between mean blood
pressure values of 60–150 mmHg. A reduction in cerebral
perfusion pressure leads to drowsiness, confusion, irritability,
and finally coma.
Orthostatic blood pressure measurements
Blood pressure can be “normal” in elderly or normally
hypertensive patients with hypovolaemia. Whilst supine
hypotension implies significant blood volume loss, young
people can compensate well and 30% of the elderly have
postural hypotension as an incidental finding.
Urine output
When any patient becomes oliguric, perfusion should be
assessed. Oliguria can be a sign that the patient is deteriorating.
As vital signs such as blood pressure and pulse can be
unhelpful, multiple clinical variables must be assessed in order
to gain an overall picture when deciding on volume status. No
one variable should be taken in isolation. If there is any
uncertainty about volume status, a fluid challenge is the safest
way to assess this further. The fluid challenge is a fundamental
manoeuvre – the aim is to produce a small but rapid increase
in plasma volume and then to assess the response.
The physiological relationship between cardiac filling and
cardiac output is described in Starling’s curve (see Figure 6.1,
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p 106). This curve describes the functional consequences of
alterations in preload on cardiac output and is the rationale
behind improving cardiac output with volume administration.
Up to a certain point, volume expansion leads to an increased
cardiac output owing to increased end-diastolic ventricular
filling. Beyond this, increased end-diastolic volume will lead to
a reduced cardiac output. Measurement of cardiac responses in
response to a fluid challenge can therefore be used to define
optimal filling pressures (Figure 5.5).
A suitable fluid challenge is 250 ml colloid over 10 minutes.
This may need to be repeated.
Colloids are effective volume expanders for resuscitation,
especially in situations where changes in capillary
permeability have occurred. Different colloids have different
properties. Crystalloids are isotonic and rapidly distribute
throughout the extracellular space causing oedema.
Crystalloids also have to be given in large volumes to achieve
significant volume expansion: 1000 ml of 0·9% sodium
chloride would increase the plasma volume by 200 ml and be
short-lived.
It is also important to understand that simply speeding up
maintenance fluid is not an effective way to treat volume
depletion, as shown in Figure 5.6. The increased maintenance
fluid could take hours to make a patient euvolaemic. During
this time hypoperfusion could cause irreversible renal damage
and metabolic acidosis – problems that become more difficult
to correct with time.
A fluid challenge should be given through a large bore
cannula (14–16G) and wide diameter giving set to give an
adequate flow rate (Table 5.4).
A triple lumen central venous catheter has different sized
ports – the largest is designed for fluid and the others for
measurement and infusions. The relatively small diameter and
long length of a central line compared with a 14G cannula
makes it less suitable for resuscitation when fluid needs to be
given quickly.
Assessment of the fluid challenge can be either pressure-
based (for example, blood pressure and CVP) or flow-based (for
example, cardiac output measurements). When pressure based,
a common approach is to continue giving boluses of fluid until
a sustained rise in central venous pressure (CVP) occurs, rather
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Figure 5.5 The response of CVP/PAOP and stroke volume to small
volume fluid challenges. In a hypovolaemic patient, an increase in
stroke volume with no significant rise in CVP/PAOP would be expected.
In the optimally filled patient, a rise in CVP/PAOP with no significant rise
in stroke volume would be expected. CVP, central venous pressure;
PAOP, pulmonary artery occlusion pressure
than be limited by a predetermined value. A normal heart rate,
blood pressure, and CVP do not exclude volume depletion and
a single CVP reading is unreliable in assessing volume status.
The “rule of threes” is a more useful tool. If the CVP increases
by 3 mmHg and then falls back to the original value after
5 minutes, a further fluid challenge should be administered. If
the CVP increases by 3 mmHg and remains elevated, no further
fluid is indicated. If the CVP increases by more than 3 mmHg
and is above 10 mmHg, the patient could be overfilled.
However there is no “normal” CVP and initial measurements
greater than 10 mmHg are common and can be due to reasons
other than volume status (see Chapter 6).
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Figure 5.6 The effect of fluid challenge(s) versus maintenance fluids
Table 5.4 Flow rates and diameters of cannulae
Size of cannula Colour code Flow rate (ml min–1)
24G Yellow 18
22G Blue 36
20G Pink 61
18G Green 90
16G Grey 200
14G Brown 300
Some patients continue to show signs of inadequate
perfusion (cold extremities, increased respiratory rate,
metabolic acidosis, and oliguria) despite an apparently
optimal intravascular volume. Early referral to the ICU is
required as more advanced monitoring and treatment with
vasoactive drugs may be necessary. Pulmonary artery
catheters, oesophageal Doppler, and other flow-based
monitors permit measurement of cardiac output and other
derived measurements, such as systemic vascular resistance, so
that predefined oxygen delivery goals may be achieved.
Different types of fluid
Crystalloids
Crystalloids are substances that form a true solution and
pass freely through semipermeable membranes. They contain
water, dextrose, and electrolytes, and stay in the intravascular
compartment for about 45 minutes.
Crystalloids pass easily through capillary and glomerular
membranes but, although they do not diffuse through cell
membranes, membrane pumps and metabolism soon alter their
distribution. Their composition varies depending on the type of
solution. Sodium is the particle responsible for plasma volume
expansion and this determines the initial distribution of the
crystalloid (isotonic solutions will distribute throughout the
ECF where sodium is found, but hypotonic solutions, which
contain more water, will distribute in cells as well). Dextrose in
water is basically free water as it does not contain sodium, and
distributes to both the intracellular fluid and extracellular fluid.
Dextrose is not an effective plasma expander as inadequate
amounts reach the intravascular compartment, and it should
never be used in volume resuscitation.
Infusion of 0·9% saline or colloids suspended in 0·9% saline
can produce a dose-dependent hyperchloraemic metabolic
acidosis. The serum sodium is often normal. Calculation of the
anion gap is useful as it is normal in a hyperchloraemic
metabolic acidosis but raised in lactic acidosis. The urinary
chloride will be high in the former and low in the latter. The
clinical significance of saline-induced hyperchloraemic
metabolic acidosis is unknown.
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Crystalloids are used to restore extracellular electrolyte and
volume deficits, are well tolerated, and are usually
administered peripherally. Other advantages of crystalloids
include low cost, safety, easy storage, and availability. The
primary limitation of crystalloids as replacement solutions is
the amount of fluid needed to replace plasma volume. It is
estimated that 5 litres of crystalloid would replace 1 litre of
blood because only one-fourth of the volume reaches the
circulation. Using crystalloids as volume expanders has
theoretical disadvantages. The subsequent increase in
interstitial volume could impair wound healing and gas
exchange. The most commonly used crystalloids are:
• sodium chloride 0·9%
• dextrose 5%
• dextrose 4% saline 0·18%
• Hartmann’s solution – resembles the extracellular fluid.
(Alexis Hartmann was a US paediatrician. Hartmann’s
solution was used in sick children with a metabolic acidosis
because the lactate is metabolised to bicarbonate within a
few hours. It is avoided in certain patients: renal failure
because of the risk of hyperkalaemia, liver failure because of
the risk of lactic acidosis, and diabetes because of lactate
metabolism to glucose. The calcium content of Hartmann’s
means that it may form clots if mixed with stored blood
(which contains citrate) in the same intravenous line.)
The electrolyte content of common crystalloids in mmol
litre−1 (mg dL−1) is shown in Table 5.5.
Colloids
Definition: colloids are substances that do not form true
solutions and do not pass through semipermeable
membranes. Colloid infusions increase osmotic pressure,
draining water out of the interstitial space into the
intravascular compartment. They stay in the intravascular
compartment for varying lengths of time depending on their
molecular weight.
Different colloids have very different properties. The most
commonly used colloids are:
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• Gelatines (for example, Gelofusine and Haemaccel) – gelatine
is a degradation product of animal collagen and is
inexpensive and readily available. Different brands vary in
electrolyte content. The calcium content of Haemaccel
means that it may form clots if mixed with stored blood
(which contains citrate) in the same intravenous line.
• Dextrans – these are glucose polymers available in different
molecular weights (for example, Dextran 70 = 70 000
Daltons). These are rarely used because of side effects.
• Hydroxyethyl starch (HES) – this is derived from
amylopectin, a plant polymer and contains no electrolytes.
Unmodified starch is unsuitable as a plasma substitute
since it is broken down rapidly by amylase. The
hydroxyethylation of starch protects the polymer against
breakdown. Different products with different mean
molecular weights exist. Larger particles have a higher
degree of protection from metabolism and give a more
prolonged effect (days). HES is therefore useful in patients
with capillary leak. Some research suggests that HES reduces
capillary leak by an unknown mechanism. It cannot be used
alone if greater than 30% plasma volume replacement is
needed – water should be given as well, otherwise an
osmotic nephrosis and acute renal failure can occur.
• Human albumin solution (HAS) – albumin is the fraction of
plasma that provides the main part of the circulation’s
osmotic pressure and has therefore been used as a plasma
substitute. It is derived from human plasma and is heat
sterilised so it is virtually disease-free; 4.5% HAS reflects
normal plasma; 20% HAS has water and salt removed –
hence it is sometimes called “salt-poor albumin”. HAS was
mainly used to replace fluid losses in burns where high
albumin loss is also a problem. The major limitations to the
use of HAS are high production costs and limited supplies.
Albumin has a number of other functions which include:
• transport of molecules
• free radical scavenging
• binding of toxins
• inhibition of platelet aggregation.
Colloids are either monodispersed like albumin if the
molecular size and weight are uniform throughout the
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product, or polydispersed if there are a variety of different
molecular sizes and shapes like starches. The molecular weight
determines the retention time and duration of colloidal effect
in the circulation. Lower molecular weight particles have a
higher osmotic effect but are rapidly excreted by the kidneys
in contrast to larger particles.
Most colloid solutions are subject to maximum limits
suggested by the manufacturers on the basis of available
research data. Most UK colloids are suspended in sodium
chloride but colloids in 5% dextrose are available in the USA.
The retention of both crystalloids and colloids in the
circulation is variable. In dehydration, retention time may be
increased but, in critical illness with its associated capillary
leak, retention times are shorter. Generally, crystalloids stay in
the circulation for less than an hour. Gelatines stay in the
circulation for a few hours. Albumin has two half lives, the
first being only 4 hours. Starch solutions have a half life of
several days.
Allergic phenomena and coagulation
abnormalities with colloids
Allergic reactions range from urticaria, the most common
effect of gelatines, to severe anaphylaxis with cardiovascular
collapse, more commonly seen with dextrans. The incidence
of allergic reactions is low with any of the colloids
(0·01%–0·05%).
Colloids affect coagulation through various mechanisms
but these effects are rarely associated with clinical bleeding:
• A dilution coagulopathy is associated with any plasma
substitute.
• Dextrans reduce the activities of factor V and VIII. These
effects are more severe with higher molecular weights.
• Gelatines interfere with fibrin polymerisation and inhibit
platelet aggregation.
• HES solutions interfere with Von Willebrand and factor VIII
release and accelerates the conversion of fibrinogen to
fibrin, which results in weaker clot formation.
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Blood
Giving blood carries a small risk and uses a valuable
resource. The trend is more towards giving blood only when
absolutely necessary. The following are indications for blood
transfusion:
• to expand intravascular volume in serious haemorrhage
• to restore oxygen carrying capacity.
The decision to transfuse blood for anaemia depends very
much on volume status, ongoing blood loss, and any pre-
existing myocardial or cerebrovascular ischaemia rather than
on an absolute haemoglobin. Blood may be required in life-
threatening haemorrhage even if the haemoglobin is normal.
On the other hand, stable patients can tolerate anaemia well
via compensatory mechanisms and consideration of blood
transfusion in these patients is usually only appropriate when
the Hb falls below 8 g dl−1.
Stored whole blood has a haematocrit of 40% but plasma,
platelets, and other components are removed, leaving
concentrated red cells with a haematocrit of 60%. It can be
stored at 1–6C for 28 days. Acid citrate dextrose is one of the
most common additives to prevent clotting. The acid acts as a
buffer, the citrate binds calcium, which inhibits clotting, and
the dextrose acts as a substrate for red cells. Platelets reduce to
virtually zero after 24 hours of storage and clotting factors V
and Vlll are reduced to 50% after 21 days.
• O negative blood is immediately available.
• Type-specific blood (group and rhesus state only) is ready
in 5 minutes.
• Fully cross-matched blood is ready in 20 minutes.
The risks of transfusion decrease with more specific
matching. Transfusion reactions are rare but can occur with
only small amounts of blood. Death occurs in 1 in 100 000
transfusions. Reactions range from fever to haemolytic
syndromes, acute renal failure, and anaphylaxis.
Complications of blood transfusion are immunological,
infective, metabolic, or general (for example, hypothermia
and fluid overload) and there are further complications with
large blood transfusions (Box 5.1).
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Many blood transfusions are given to treat a haemoglobin
level rather than the patient. One randomised Canadian study
(TRICC) looked at two groups of stable patients in ICU. In the
first group, blood transfusion was triggered at a haemoglobin of
7 g dl−1 and maintained at 7–9. The second group was transfused
if the haemoglobin fell below 10 g dl−1 and was maintained at
10–12. There was no advantage for the patients with higher
haemoglobins and blood transfusions were reduced by 54%
overall. At the time of writing one unit of blood costs £72 in the
UK. The TRICC study found a survival advantage in the lower
haemoglobin group among certain subgroups of patients. A
lower haemoglobin conferred an advantage if the APACHE II
score was < 20 and the age was < 55.
A recent study published in the journal JAMA looked at
blood transfusions in ICUs across Europe. Transfused patients
had a significantly higher mortality despite similar disease
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Box 5.1 Complications of blood transfusion.
Immunological
• Haemolysis, immediate or delayed
• Anaphylaxis
• Increased risk of infection and recurrence or cancer
postoperatively
Infective
• Rarely, red cells may become contaminated with bacteria during
storage. There is rapid development of sepsis and cardiovascular
collapse.
• UK blood is screened for hepatitis B and C, HIV-2 and syphilis.
Donors undergo rigorous health screening with several exclusion
criteria. Since 1998, 95% of white cells are removed because of
a theoretical risk of nvCJD transmission.
Metabolic
• Potassium, calcium and acid-base balance may be affected.
Massive blood transfusion (for example, 10 units within 6 hours) has
particular problems in addition to those of transfusion generally:
• Coagulopathy
• Hypothermia
• Hypocalcaemia
• Hyperkalaemia
• Metabolic acidosis followed by metabolic alkalosis from citrate
• ARDS (acute respiratory distress syndrome)
severity scores. The authors suggested that red cell transfusions
may contribute to immunosuppression.
Studies have shown that perioperative blood transfusion
increases the risk of infectious complications after major
surgery and of cancer recurrence after curative surgery. This is
thought to be related to the immunosuppressant effects of
allogeneic blood transfusion and the fact that stored blood
contains angiogenic factors.
Mini-tutorial: the crystalloid versus colloid debate
Despite much debate concerning the choice of fluid in volume
resuscitation, the crystalloid versus colloid debate has largely
reached a stalemate. During the World War II, surgeons realised that
salt and water are retained after surgery and it became common
practice to restrict them. There were subsequent problems with
volume depletion because third space losses were not appreciated.
In the 1960s studies showed that patients who received crystalloid
and blood did better than patients who only received blood. Shire
showed in animal experiments, using radioactive tracers, that the
interstitial compartment contracts during trauma and major surgery.
Crystalloids not only resuscitate the intravascular compartment, they
resuscitate this compartment as well, but large volumes of
crystalloid are needed to resuscitate the intravascular compartment
because they are quickly distributed throughout the ECF – this can
lead to problems with interstitial oedema when large amounts of
crystalloid are given. With the advent of synthetic colloids, many
people believed these were better, because they were more effective
at expanding the intravascular compartment. They are faster to give,
with less sodium load and risk of hypothermia, and a more rapid
expansion in plasma volume restores tissue perfusion quickly, which
can prevent tissue damage and the subsequent release of
inflammatory mediators. However, allergic reactions can occur and
colloids are more expensive. Studies have shown no difference in
mortality but the cost per life saved using colloids is much more.
All the studies that have been done comparing crystalloids and colloids
have yielded conflicting results. Extensive research has failed to show the
superiority of colloids or crystalloids. Most colloid advocates do not
recommend colloids as the only fluid to be used in resuscitation. It may
be that certain subgroups of patients benefit from one type of fluid over
another – but there is no definitive answer and the debate goes on.
Mini-tutorial: controversies over albumin
A recent Cochrane review looked at human albumin administration in
the critically ill and its effects on mortality. The results were widely
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publicised; 30 trials met the inclusion criteria (1419 patients). The
investigators found that the risk of death for patients receiving
albumin was 14% compared with 8% in controls – or that for every 17
critically ill patients treated with albumin there was one additional
death. The validity of the studies included in the systematic review
was extensively debated. A later publication pointed out that more
than half the trials included were pre-1990 and did not reflect current
practice. The trials also included a mixture of patients with different
characteristics and many were not blinded. Nevertheless, the debate
did spark a controversy and probably contributed to a reduction in
albumin use.
Albumin is sometimes given to treat hypoalbuminaemia, which
occurs in critical illness. This has not been shown to improve
outcome when compared with that for synthetic colloids. Albumin
leaks from the circulation in critical illness, but serum albumin levels
do not correlate with the osmotic pressure of the intravascular
compartment. Studies have shown similar osmotic pressures in
critically ill patients with low versus normal albumins. However,
albumin administration reduces mortality when given in spontaneous
bacterial peritonitis and is also used in the hepatorenal syndrome.
None of the controversy around albumin applies to its evidence-
based use in liver disease.
Self-assessment – case histories
1. A 60-year-old man returns to the ward, having had a laparotomy
for bowel obstruction which lasted 2 hours. You are informed that
his urine output for the last 2 hours has been < 30 ml h−1. In
theatre he received 1 litre of Hartmann’s and 1 litre of
Gelofusine. His vital signs are: pulse 80 per minute, blood
pressure 140/70 mmHg, respiratory rate 20 per minute, and
core temperature 37·5°C. The nurse is concerned about his urine
output. How do you assess his volume status?
2. A 55-year-old man is on the coronary care unit when he develops
a low urine output (< 0·5 mg kg−1 per hour for the last 2 hours).
His vital signs are: pulse 90 per minute, blood pressure 110/50
mmHg, respiratory rate 22 per minute, and core temperature
37°C. He has cool hands and feet. He had an inferolateral
myocardial infarction 24 hours ago. The nurse is concerned
about his urine output. How do you assess his volume status?
3. A young woman arrives in the medical admissions unit with
diarrhoea, which she has had for several days. She also has a
macular rash and a high fever. She has a systolic blood pressure
of 70 mmHg and a pulse of 130 per minute. Her blood tests
show an elevated urea and creatinine with low platelets. What is
your immediate management?
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4. A middle-aged man comes to the Emergency Department
having fallen on the path and hurt his left lower ribs. His
observations are: pulse 110 per minute and blood pressure
140/90 mmHg. You notice how clammy he feels to touch.
Could this man have a life-threatening haemorrhage?
5. An 80-year-old lady is admitted with abdominal pain and
malaena. She has a permanent pacemaker and is treated for
congestive cardiac failure, which is under control. Her pulse and
blood pressure are normal. How can you assess her volume
status?
6. A 50-year-old man weighing 70 kg with no past medical history
is admitted with gastric outflow obstruction and is scheduled
for surgery later in the week. His fluid balance chart for the last
24 hours is as follows. Input: nil orally, 3 litres intravenous
0·9% sodium chloride. Output: urine 500 ml total, bowels nil,
nasogastric tube 4000 ml total. There are no intravenous
antibiotics or other drugs, and no fever is recorded. This
morning’s blood results show: Na 150 mmol litre−1, K 3·0 µmol
litre−1, urea 12 mmol litre−1 (33·3 mg dl−1), creatinine 140 µmol
litre−1 (1·68 mg dl−1). What fluids should you prescribe for the
next 24 hours?
7. A patient comes back from theatre to your high dependency area.
His vital signs are: pulse 80 per minute, blood pressure 150/80
mmHg, respiratory rate 25 per minute, and core temperature
36°C. His arterial blood gases show: pH 7·3, PaO2 15·0 kPa
(115 mmHg), PaCO2 4·0 (29 mmHg) and bicarbonate 14·5 mmol/l,
BE − 6. His CVP reading is 12 mmHg. He received Hartmann’s and
blood in theatre. How do you manage his acidosis?
8. A patient on ICU with a tracheostomy has been on maintenance
crystalloid (0·9% saline) for several days and this morning’s
blood results show: Na 145 mmol litre−1, K 4·0 mmol litre−1,
urea 4·5 mmol litre−1 (12·5 mg dl−1), creatinine 80 µmol l−1 (0·96
mg dl−1). The patient is stable and the vital signs are: pulse 60
per minute, blood pressure 130/65 mmHg, respiratory rate 12
per minute and core temperature 36·5°C. The arterial blood
gases show: pH 7·3, PaO2 13·0 (100 mmHg), PaCO2 4·5 (34·6
mmHg) and bicarbonate 16·3 mmol/l, BE − 5. The patient is
doing well in every way and is expected to leave ICU in the next
24 hours. The examination is normal. Can you explain the
arterial blood gas results?
9. You have just put a CVP line into a patient who is unwell with a
severe biliary infection. The CVP measures 15 mmHg. What is
your next course of action?
10. A postoperative patient’s blood results are as follows: Na 120
mmol litre−1, K 4·0 mmol litre−1, urea 6·0 mmol litre−1 (16·6 mg
dl−1), creatinine 95 µmol l−1 (1·14 mg dl−1). How do you assess
the low sodium in order to treat it correctly?
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Self-assessment – discussion
1. The history alone in this case tells you that the patient is likely to
be hypovolaemic – he has a history of bowel obstruction and has
just had a laparotomy, so is likely to have a combination of
hypovolaemia with capillary leak and interstitial oedema. Check
skin temperature and capillary refill at the peripheries as it may
be reduced if there is hypovolaemia. His respiratory rate is raised.
Arterial blood gases may reveal a base deficit suggesting tissue
hypoperfusion. A fluid challenge should be given if there are signs
of hypovolaemia or if there is any uncertainty about his volume
status. This kind of patient should never be given a diuretic as
first-line treatment for a poor urine output. It would be appropriate
to give 250 ml colloid over 10 minutes and assess the response.
2. Patients admitted to hospital following a myocardial infarction
can be dehydrated due to vomiting, sweating, and reduced oral
intake. His respiratory rate is raised and his peripheral skin
temperature may be reduced. In this case, you would want to
know if there are any crackles audible in the lungs. Arterial blood
gases may reveal a base deficit. A fluid challenge can be given
safely if there are signs of hypovolaemia or if there is any
uncertainty about this patient’s volume status. The definition of
cardiogenic shock includes a low cardiac output state, which is
unresponsive to fluid (see Chapter 6) and this implies that fluid
is used in the assessment of this condition.
3. The picture is of a young person with severe sepsis. A search for
the focus of infection should take place but this should not take
priority over A, B, C, and “blind” antibiotic therapy. After you have
initiated high concentration oxygen therapy, two large bore
cannulae should be inserted and fluid challenges given. There is
a history of diarrhoea for several days, which implies severe
volume depletion – but in the context of severe sepsis, an
abnormally low systemic vascular resistance means that the
hypotension may not respond to fluid alone, and invasive
monitoring and vasopressors may be required.
4. Yes. It is highly possible that this man has ruptured his spleen.
Airway is okay. Check breathing (for pneumothorax) and insert
two large bore cannulae for fluid. Assess capillary refill. He could
have lost 20–30% of his circulating blood volume already and
needs urgent imaging and surgery.
5. This is exactly the type of patient in whom volume status can be
incredibly difficult to assess. The elderly do not respond
physiologically to bleeding in the same way as younger patients.
The history of a gastrointestinal bleed points to volume
depletion, as does chronic diuretic use. Although she has a
“normal” blood pressure – is it her normal? Special attention
must be paid to other markers of hypoperfusion in this lady, as 
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pulse and blood pressure (including orthostatic measurements)
will be of little value. Look at peripheral skin temperature and
respiratory rate, and perform an arterial blood gas analysis. A
urinary catheter should be inserted to monitor hourly urine output.
6. The blood tests and the fluid balance chart suggest volume
depletion. Large nasogastric losses have resulted in
hypokalaemia. In a dehydrated patient with hypernatraemia, total
body water deficit may be calculated as follows:
0·5 is the approximate total body water (TBW). In this patient
the TBW deficit is 3·57 litres (Table 5.7). This is required over
the next 24 hours in addition to his maintenance requirements
and anticipated ongoing nasogastric losses. Hartmann’s at
110 ml h−1 is appropriate as maintenance fluid; 5% dextrose with
additional potassium can replace water losses – 4 litres can be
given in addition to the Hartmann’s over the next 24 hours.
7. The history tells you that the metabolic acidosis is most likely due to
lactate because of hypoperfusion. Other markers of hypoperfusion
should be checked – peripheral skin temperature, respiratory rate,
and urine output. “Normal” blood pressure, pulse, and CVP readings
do not exclude hypovolaemia. Fluid challenges should be given and
the response assessed. Patients returning from theatre often have
a reduced core temperature and as they rewarm, vasodilatation
causes relative hypovolaemia, which requires fluid. A metabolic
acidosis that worsens rather than improves with fluid therapy and
rewarming suggests a problem in the abdomen (bleeding or
ischaemia) which needs urgent investigation.
8. Prolonged infusions of 0·9% sodium chloride can lead to a
hyperchloraemic metabolic acidosis. Controversy has surrounded
the aetiology and clinical relevance of the acidifying potential of 
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Volume in litres needed = 0·5 ×
[Na2
+] − 140
140
Table 5.7 Daily volumes and electrolyte contents (mmol litre−1) 
of body secretions
Body secretions ml 24 h–1 Na2
+ K+ Cl– HCO3
–
Saliva + 1500 10 25 10 30
Stomach + 1500 50 10 130 0
Duodenum + 1000 140 5 80 0
Ileum + 3000 140 5 104 30
Colon – 6000 60 30 40 0
Pancreas + 500 140 5 75 100
Biliary + 500 140 5 100 30
Sweat + 1000 50 0 0 0
large volumes of sodium chloride solutions. The term “dilutional
acidosis” implies that plasma expansion and a consecutive
dilutional reduction of plasma bicarbonate are the underlying
mechanisms. In contrast others have suggested the importance
of hyperchloraemia resulting in a reduction of the strong ion
difference (SID), calculated as [Na] + [K] − [chloride] − [lactate].
9. The next course of action is to treat the patient on the basis of
your assessment of volume status, not a single CVP reading. A
fluid challenge should be given and the response of the CVP to
this assessed. The “rule of threes” can be used.
10. Hyponatraemia results from salt losses alone or salt and water
loss with water replacement. There are several causes of
hyponatraemia and one should aim to treat the cause rather
than simply fluid restricting the patient (Figure 5.7):
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Hypotonic hyponatraemia
Assess volume status
Hypovolaemia Euvolaemia Oedema
Diarrhoea and
vomiting
Dehydration
In volume depletion
urinary Na2
+ is 
< 20 mmol litre−1
Renal salt loss owing 
to drugs, renal disease
or mineralocorticoid
deficiency (urinary Na2
+
is > 20 mmol litre−1)
Syndrome of
inappropriate ADH
secretion
Postoperative
Psychogenic
polydipsia
Oedematous 
states, e.g. nephrotic 
syndrome, cirrhosis, 
and congestive 
cardiac failure
In oedematous 
states urinary
Na2
+ is < 20 mmol
litre−1
Chronic renal
failure (urinary Na2
+
is > 20 mmol litre−1)
•
•   Serum osmolality high (> 295 mosm kg−1) − “hypertonic
    hyponatraemia from hypoglycaemia, mannitol, or glycine
    irrigation;
•   Serum osmolality normal − pseudohyponatraemia;
•   Serum osmolality low (<280 mosm kg−1) − “hypotonic 
    hyponatraemia”
• •
•
•
•
•
•
Figure 5.7 Assessment of hyponatraemia
After clinical examination, plasma and urine osmolality and
sodium levels should be measured.
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6: Circulatory failure and the
use of inotropes
By the end of this chapter you will be able to:
• understand what happens in shock
• understand the basic physiology of the circulation
• know that pressure is not the same as flow
• use inotropes logically
• understand how to use and interpret central venous pressure
measurements
• understand the principles and controversies surrounding the PA
catheter
• be aware of other ways of measuring cardiac output
• understand the principles of the medical treatment of cardiogenic
shock
• apply this to your clinical practice
Shock
Shock is when the circulation is unable to perfuse and
oxygenate the tissues adequately. Hypoperfusion can occur at
“normal” blood pressures especially in patients who are
usually hypertensive. The markers of inadequate perfusion are
discussed in Chapter 5. Traditionally, shock is divided into five
types:
• haemorrhagic (see Chapter 5)
• cardiogenic
• septic (see Chapter 7)
• anaphylactic
• neurogenic (after high spinal cord injury due to loss of
sympathetic tone).
The characteristic haemodynamic variables in the different
types of shock are shown in Table 6.1.
Compensatory mechanisms in shock first aim to restore
blood pressure and then intravascular volume. Falling blood
pressure reduces the activity of pressure receptors in the
arterial system, which leads to stimulation of the sympathetic
nervous system, both centrally and via the adrenal glands. In
cardiogenic or hypovolaemic shock, arterial vasoconstriction
occurs and blood is diverted to vital organs (for example, the
coronary arteries and brain). Tachycardia and vasoconstriction
raise the cardiac output. Slower mechanisms aim to restore
volume – the lower filtration pressure in the glomerulus
activates the renin–angiotensin–aldosterone axis, thirst
results, ADH is released because of reduced atrial pressure, and
erythropoietin is manufactured.
Physiology of circulation
Blood pressure 
Blood pressure does not only depend on intravascular
volume. Ohm’s law (voltage = current × resistance) has been
adapted to demonstrate that blood pressure is the product of
cardiac output (CO) and systemic vascular resistance (SVR):
BP = CO × SVR
Blood pressure and flow are not the same thing. A low blood
pressure does not necessarily mean a low cardiac output – it
could be due to a low systemic vascular resistance, or both.
SVR may be thought of as the resistance against which the
heart pumps. Vasoconstriction increases SVR whereas
vasodilatation reduces it.
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Table 6.1 Characteristic haemodynamic variables in different types
of shock
Shock type CO SVR PAOP/CVP
Cardiogenic   Any
Hypovolaemic   
Septic   
Anaphylactic   
Neurogenic   
CO, cardiac output; CVP, central venous pressure; PAOP, pulmonary
artery occlusion pressure; SVR, systemic vascular resistance
Mean arterial pressure (MAP) is the average arterial blood
pressure throughout the cardiac cycle. This is produced by
integrating a pressure signal for the duration of one cycle. A
rough calculation is:
Many critical care clinicians prefer using MAP because it is
less liable to error owing to measuring techniques; it
represents the mean pressure available for perfusing vital
organs and is often used in studies.
Cardiac output
Cardiac output depends on the interrelated factors of heart
rate (HR) and stroke volume (SV):
Cardiac output = HR × SV
Stroke volume is the volume of blood ejected by the
ventricle with a single contraction. It can be defined as the
difference between end-diastolic and end-systolic volume. SV
expressed as a percentage is the ejection fraction. Stroke
volume has three major determinants:
• contractility
• preload
• afterload
This basic physiology is clinically important because, in
low cardiac output states leading to hypoperfusion, the heart
rate, preload, afterload, and then contractility should be
addressed – in that order. There is little point in trying to
pharmacologically improve the contractility of a heart when it
is either too empty or too distended to eject.
Contractility
Contractility is the amount of mechanical work that is done
for a given preload and afterload. Factors affecting
contractility include are given in Box 6.1.
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3
(2 × diastolic) + systolic pressure
Preload and afterload
Preload can be defined as the initial length of the muscle
fibre before contraction (described by the Frank–Starling curve
in Figure 6.1). In a normal heart, we take this to be equivalent
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Box 6.1 Factors affecting contractility
Increased contractility
• Sympathetic stimulation
• Positive inotropic drugs, for example, dobutamine, adrenaline
Reduced contractility
• Parasympathetic stimulation
• Negatively inotropic drugs, for example, β-blockers
• Ischaemia/infarction
• Hypoxaemia
• Acidosis
• Low serum calcium
S
tr
o
ke
 v
o
lu
m
e
LVEDP
Diuretics
Inotropes or
endogenous
catecholamines
Failing heart
Normal
Hypoxaemia,
acidosis
Figure 6.1 The Frank–Starling curve. In isolated myocytes, the tension
developed during contraction is dependent on the initial length of the
muscle fibre. Laplace’s law relates wall tension (T ) to internal pressure
(P) in an elastic sphere where R is the radius: P = 2T/R. Thus, the
Frank–Starling relationship for an isolated muscle fibre translates into a
relationship between stroke volume and left ventricular end-diastolic
pressure (LVEDP)
to the end-diastolic volume. This is not easily measured. It may
be thought of as the filling pressure of the ventricles. In clinical
practice the central venous pressure (right ventricle) and
pulmonary arterial occlusion pressure (left ventricle) are used
to estimate filling pressures – but these have several limitations.
Afterload is defined as the tension developed in the
ventricular wall during systole. It is affected by preload,
systemic vascular resistance, and external pressure on the
ventricles (for example, from positive pressure ventilation). It
may be thought of as a measure of how forcefully the
ventricles have to contract to eject blood.
Receptors in the circulation
Receptors are important to know about in order to
understand how inotropes work. There are four main types of
receptor in the circulation (Table 6.2).
All adrenoreceptors act via G proteins and cyclic AMP at the
cellular level. Down-regulation of coronary β1 adrenoreceptors
occurs in patients who are on long-term β blockers or who have
chronic cardiac failure because of prolonged excess endogenous
catecholamine release. Down-regulation also occurs with
prolonged exogenous catecholamine administration.
Common inotropes
The ideal inotrope would be an agent that increases
myocardial contractility in a predictable and easily titratable
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Table 6.2 Receptors in the circulation
Receptor Action Where
α receptors Vasoconstrict Peripheral, renal,
coronary circulation
β1 receptors Increase contractility, Heart
HR, and CO
β2 receptors Vasodilate Peripheral and renal
circulation
Dopamine (DA) Range of actions Renal, mesenteric,
receptors (see later) coronary circulation
CO, cardiac output; HR, heart rate.
way without side effects. None exists. Strictly speaking, an
inotrope is an agent that increases myocardial contractility
whereas a vasopressor is an agent that causes vasoconstriction.
A vasoactive drug means either an inotrope or a vasopressor.
All should be administered via a central vein.
Dobutamine
Dose range is 1–25 micrograms kg−1 per minute. Dobutamine
was the first designer inotrope. It has predominant β1 effects,
which increase heart rate and contractility and hence cardiac
output. It has mild β2 effects, which reduce systemic and
pulmonary vascular resistance. Mild α effects may be
unmasked in a patient on β blockers. The increase in cardiac
work from administration of dobutamine can induce
ischaemia in patients with cardiac disease – this is the basis of
the dobutamine stress test. However, because of its
vasodilatory properties, myocardial oxygen consumption is
less than expected because of the reduction in afterload that
occurs. These properties make dobutamine a logical first
choice inotrope in ischaemic cardiac failure. Dobutamine has
no effect on visceral vascular beds; the increased renal and
splanchnic flow occur as a resultof increased cardiac output.
The increase in cardiac output may increase blood pressure
but, since systemic vascular resistance may be reduced or
remain unchanged, the effect of dobutamine on systemic
blood pressure is variable and depends to some extent on
circulatory volume. The indications for and disadvantages of
dobutamine are given in Box 6.2.
ESSENTIAL GUIDE TO ACUTE CARE
108
Box 6.2 Dobutamine indications and disadvantages
Indications
• Low cardiac output states especially if due to ischaemic heart
disease
Disadvantages
• May not increase blood pressure
• Tachycardia and arrythmias
• Myocardial ischaemia
Epinephrine (adrenaline)
Dose range is 0·01–0·3 micrograms kg−1 per minute.
Epinephrine is a potent β1, β2 and α agonist. The
cardiovascular effects of epinephrine depend on dose. At lower
doses (0·005–0·02 micrograms kg−1 per minute which is the
equivalent of 1 ml h−1 of 5mg epinephrine in 50 ml saline), β1
stimulation predominates, that is, increased contractility, heart
rate, and hence cardiac output. There is some stimulation of
β2 receptors causing bronchodilation and vasodilatation in
certain vascular beds (skeletal muscle). Systemic vascular
resistance may fall, which explains the reduction in diastolic
blood pressure that is sometimes seen. However, blood
pressure tends to rise because β1 effects predominate.
Epinephrine also enhances the rate of myocardial relaxation,
to allow increased diastolic filling time.
Alpha stimulation becomes more predominant with
increasing doses leading to vasoconstriction, which increases
systolic blood pressure. There is also visceral bed vasoconstriction
at these higher doses. There is a more marked increase in
myocardial oxygen consumption than is seen with
dobutamine. Other effects include a fall in plasma potassium
and a rise in serum glucose. Although its vasoconstrictor
effects tend to limit its use, epinephrine is useful in low
cardiac output failure unresponsive to dobutamine. This is
because increasing cardiac output, but not blood pressure, in
severe hypotension may not succeed in improving flow to
vital organs that depend on a critical perfusion pressure (the
kidneys, coronary arteries, and brain). The indications for and
disadvantages of epinephrine are given in Box 6.3.
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Box 6.3 Epinephrine (adrenaline) indications and
disadvantages
Indications
• Low cardiac output states especially if severe hypotension
Disadvantages
• Tachycardia and arrythmias
• Myocardial ischaemia
• Splanchnic vasoconstriction
• Hypokalaemia and hyperglycaemia
Dopamine
Dose range is 0·5–25 micrograms kg−1 per minute. Dopamine
stimulates adrenoreceptors and dopaminergic receptors. The
effects of dopamine change with increasing dose.
At low doses (up to 3 micrograms kg−1 per minute) the
predominant effects are those of dopaminergic stimulation
causing an increase in renal and mesenteric blood flow.
Between doses of 2·5 and 10 micrograms kg−1 per minute, β1
receptor effects predominate causing increased myocardial
contractility, heart rate, and cardiac output. At doses >10
micrograms kg−1 per minute, α stimulation predominates,
causing a rise in systemic vascular resistance and reduction in
renal blood flow. High doses of dopamine are associated with
arrhythmias and increased myocardial oxygen demand.
It has been shown that there is marked individual variation
in plasma level compared with dose in the critically ill,
making it difficult to know which effects are predominating.
Dopamine may accumulate in patients with hepatic
dysfunction. There is no evidence to justify using low dose
dopamine in acute renal failure either as prevention or
treatment (see Chapter 8). The indications for and
disadvantages of dopamine are given in Box 6.4.
Dopexamine
Dose range is 0·25–6 micrograms kg−1 per minute. Dopexamine
is a synthetic analogue of dopamine without α effects. It is a
β2 agonist with one-third of the potency of dopamine on DA1
receptors. Dopexamine causes an increase in heart rate and
cardiac output as well as causing peripheral vasodilatation and
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Box 6.4 Dopamine indications and disadvantages
Indications
• NB No indications for low dose dopamine
• Low cardiac output states
Disadvantages
• Excessive peripheral vasoconstriction
• Tachycardia and arrythmias
• Myocardial ischaemia
• Nausea and vomiting
• Dose does not correspond with blood levels
an increase in renal and splanchnic blood flow. Cardiac
output is increased as a result of afterload reduction and mild
inotropy. In comparison to other inotropes, dopexamine
causes less increase in myocardial oxygen consumption.
Dopexamine may have some anti-inflammatory activity, but
its main focus of interest has been on its ability, at doses of
0·35–0·5 micrograms kg−1 per minute, to improve renal,
mesenteric, splanchnic, and hepatic blood flow, which is
thought to be beneficial in preserving gastrointestinal
mucosal integrity in certain patients. Dopexamine has been
shown to improve outcome in certain high risk surgical
patients (see Chapter 10). Like dopamine, there is no evidence
to justify using dopexamine as a specific treatment for renal
failure. The indications for and disadvantages of dopexamine
are given in Box 6.5.
Norepinephrine (noradrenaline)
Dose range is 0·01–0·4 micrograms kg−1 per minute.
Norepinephrine is a potent α agonist (vasoconstrictor), raising
blood pressure by increasing systemic vascular resistance. It
has some β1 receptor activity causing increased contractility,
heart rate, and cardiac output but it has no effect on β2
receptors. It increases myocardial oxygen demands without
increasing coronary blood flow. It acts mainly as a vasopressor,
with little inotropic effect. Norepinephrine reduces renal,
hepatic, and muscle blood flow but, in patients with severe
sepsis, it can increase renal blood flow and urine output by
increasing perfusion pressure. The indications for and
disadvantages of norepinephrine are given in Box 6.6.
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Box 6.5 Dopexamine indications and disadvantages
Indications
• Low cardiac output states
• Certain surgical patients
Disadvantages
• Tachycardia and arrythmias
• Myocardial ischaemia
• Nausea and vomiting
• Hypotension
• Angina
• Hypokalaemia and hypoglycaemia
All these drugs are short-acting and their effects on the
circulation are seen immediately (however, a CVP line has a
1 ml dead space capacity so there is a delay before onset of
action unless the drug is bolused along the line first). They
should be increased at frequent intervals (for example, every
15 minutes) until either the desired effect has occurred or an
optimum dose has been reached. A summary of inotrope
actions on different receptors is shown in Table 6.3.
Invasive monitoring in circulatory failure
The central venous pressure (CVP) catheter
Central venous cannulation is used for:
• delivering irritant or vasoactive drugs
• CVP measurement
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Table 6.3 Summary of inotrope actions
Inotropes α β1 β2 DA
Dobutamine +++ ++
Adrenaline + to +++ +++ + +
Dopamine 
0–3 micrograms kg−1 per minute +++
2·5–10 micrograms kg−1 per minute ++ + ++
> 10 micrograms kg−1 per minute ++ ++ + +
Dopexamine + +++ ++
Noradrenaline +++ +
Box 6.6 Norepinephrine (noradrenaline) indications and
disadvantages
Indications
• Septic shock with low SVR
• Treatment of hypotension caused by vasodilation, e.g. regional
anaesthesia
Disadvantages
• Excessive vasoconstriction
• Myocardial ischaemia
• Bradyarrhythmias and tachyarrhythmias
• as a conduit for example, pacing wires
• venous access.
The CVP is expressed in mmHg when transduced (in which
case a mean value is taken) or cm H2O if measured by a
manometer (in which case the value at end-expiration is
used); 10 mmHg is equivalent to 13 cm H2O. Errors in
measurement are commonplace in areas where staff are not
familiar with the equipment.
The CVP is diminished by reduced venous return, which is
caused by hypovolaemia or vasodilatation. Both of these
require volume replacement. However, several factors cause
the CVP to rise:
• raised intrathoracic pressure, for example IPPV
• right heart failure
• lung diseases with pulmonary hypertension, for example
COPD
• compensatory vasoconstriction in healthy people, for
example bleeding
• tension pneumothorax, constrictive pericarditis, or
tamponade.
The most important concept is that the CVP is a pressure
not a volume. Many things affect the pressure in the right
heart that have nothing to do with volume:
• valve disease
• lung disease (afterload)
• vasoconstriction or dilation (preload)
• muscle compliance
• atrial size.
So, although the CVP is being used as an estimate of left
ventricular filling pressure, it has several limitations. Single
readings cannot influence management. It is the response of
the CVP to fluid challenges that can help to assess volume
status – it is possible to have a high CVP and to be volume
depleted.
As mentioned in the previous chapter, the “rule of threes” is
useful guide to fluid therapy. Generally, if the CVP remains
unchanged or rises but then falls back to the original value
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after 5 minutes, a further fluid challenge should be
administered. If the CVP rises and remains elevated, no
further fluid is indicated.
The pulmonary artery (PA) catheter
The PA catheter is an attempt to measure left heart function
more directly than the CVP – but there are still many
variables. It was introduced into clinical practice in the 1970s
by Swan and Ganz. The balloon-tipped catheter is 70 cm long,
with markings every 10 cm. The catheter has several channels
including some for infusions, inflating the balloon, and
connections to a thermistor. PA catheters enable therapy to be
flow-based by measuring the following:
• right atrial, ventricular, and pulmonary artery occlusion
pressures
• cardiac output/index
• derived data for systemic vascular resistance
• mixed venous O2 saturation used to assess oxygen delivery
and uptake.
Complications of the PA catheter (in addition to those of
the CVP) include:
• arrhythmias (50%; sustained or clinically important
arrhythmias are uncommon)
• catheter knotting
• damage to valves or myocardium (for example, mural
thrombus 30–60%)
• pulmonary infarction (0·1–7%)
• pulmonary artery rupture (< 0·1%)
• the reliance on numbers rather than clinical assessment.
An introducer is inserted into the right internal jugular or
left subclavian vein. After the catheter has been prepared, it is
connected to a pressure transducer. The catheter is inserted to
20 cm, beyond the length of the introducer and in the large
veins. The balloon is then inflated and the catheter inserted
further. The balloon helps the catheter tip move with blood
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flow to the right place (Figure 6.2) – hence the expression
“floating a PA catheter”.
When the catheter tip is wedged, it directly communicates
with the left atrium via the pulmonary vessels (Figure 6.3).
The pulmonary artery occlusion pressure (PAOP) is
approximately the same as left atrial pressure. At end-diastole,
left atrial pressure approximates to left ventricular pressure,
which in turn is assumed to reflect left ventricular end-diastolic
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Pressures*
1
2
3
1 = PA > Pa > PV
2 = Pa > PA > PV
3 = Pa > PV > PA
Figure 6.2 PA catheter appearance on a chest x ray film. The PA
catheter is still indirect. The catheter curls in the right ventricle and the
tip sits in the pulmonary artery (lungs) but is trying to measure
pressure changes in the left ventricle – via the whole of the lungs, left
atrium, and mitral valve. The PA catheter tip must sit in a West zone 3
of the lung. West described physiological lung zones; zone 3 is where
pulmonary venous pressure is greater than alveolar pressure. If the tip
is in a non-zone 3, the wedge pressure may reflect alveolar rather than
left atrial pressure. Luckily, balloon catheters tend to enter zone 3
because it is the area with highest blood flow. Although West zones are
anatomical in normal lungs, they are actually physiological zones which
can be altered by disease. Absence of a normal waveform, a wedge
pressure that fluctuates widely with respiration or a rise in wedge
pressure greater than half of any PEEP increase are clues to a
non-zone 3 placement
*Pressure in the pulmonary arteries (Pa), alveolus (PA) and veins (PV).
volume. Readings are taken at end-expiration when
intrathoracic pressure is nearest to zero. Lung and mitral valve
disease are two major factors affecting the assumption that
PAOP is equivalent to left ventricular end-diastolic volume.
Pulmonary vascular resistance is increased in mitral stenosis,
hypoxaemia, acidosis, pulmonary embolism, and acute
respiratory distress syndrome (ARDS). A stiff left ventricle
alters the relationship between pressure and volume.
Furthermore, many values from the PA catheter are calculated
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Figure 6.3 PA catheter trace patterns. (a) Waving the catheter tip in
mid-air before insertion produces a trace like this. Air bubbles damp the
trace as on the right hand side and should be flushed out. (b) First a
characteristic central venous pressure (CVP) trace is seen, followed by a
right ventricular (RV) trace as soon as the catheter tip enters the right
ventricle (note the higher pressures). When the catheter tip enters the
pulmonary artery (PA), the diastolic pressure increases and the trace
changes to have a dichotic notch. When the balloon wedges, a damped
trace is seen. The catheter must not be left wedged as pulmonary
infarction may occur – this is for measurements only. In a healthy
unventilated patient CVP = PAOP. PAOP, pulmonary artery occlusion
pressure; RA, right atrium
from other measurements rather than measured directly, so
entering the incorrect weight and height of the patient can
also introduce error.
Again, trends are more important than a single reading and
should be used in conjunction with a thorough clinical
assessment. Clinical assessment still remains far more
important than numbers alone. PA catheter values are shown
in Table 6.4.
Cardiac output is measured by the thermodilution method.
Cold fluid is injected rapidly via the proximal PA catheter
lumen into the right atrium at end-expiration. The thermistor
measures the temperature change downstream and a
computer calculates CO using the indicator dilution equation.
PA catheters are indicated when there is an operator
experienced in their use and the risk:benefit ratio to the
patient is acceptable. Although practice varies, examples of PA
catheter use are:
• to monitor the effects of therapy, for example in septic
shock where more than one vasoactive drug may be
required;
• in right-sided myocardial infarctions where right and left
ventricular pressures are very different;
• to distinguish cardiogenic from non-cardiogenic pulmonary
oedema in severe sepsis.
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Table 6.4 Normal PA catheter values and intracardiac pressures
Value Normal range 
CVP 0–8 mmHg (aim for > 10 if starts low) 
Right ventricle 0–8 mmHg diastolic, 15–30 mmHg systolic
PAOP 5–15 mmHg
Left atrium 4–12 mmHg
Left ventricle 4–12 mmHg diastolic, 90–140 mmHg systolic 
Stroke volume 55–100 ml
CO 4–8 litres per minute
CI 1·5–4 litres per minute m−2
SVR 770–1500 dyn.s cm−5
CI, cardiac index; CO, cardiac output; CVP, central venous pressure;
PAOP, pulmonary artery occlusion pressure; SVR, systemic vascular
resistance.
Mini-tutorial: controversy around the use of the PA catheter
There has been little evidence to show that the use of PA catheters
improves outcome. Recently, a small number of papers were
published which suggested that PA catheters actually caused harm.
The paper by Connors et al. is one example. They looked at nearly
6000 patients going through an ICU in the USA. Just over 2000 had
PA catheters. They adjusted for severity of illness and paired PA
catheter patients with similar non-PA catheter patients. The PA
catheter patients had worse outcomes and longer ICU stays (thus
increasing costs). Possible explanations include:
• Clinicians tend to put PA catheters in patients who are sicker and
not responding to conventional therapy.
• Clinicians may not be using the PA catheter appropriately – that is,
relying on numbers rather than clinical assessment.
• Studies in the USA may not apply to European intensive care
practice.
Several randomised controlled trials are now in progress to answer
these questions and early results suggest that PA catheters do not
increase mortality. Rhodes et al. looked at 200 patients in intensive
care. In this study the PA catheter did not affect outcome either way.
Clinicians were allowed to use clinical discretion when manipulating
haemodynamic values rather than work to a protocol, and this fact
may be significant. Larger trials are awaited that will help to answer
the question of PA catheter use more definitively. In the meantime,
use of PA catheters varies between different intensive care units.
Other ways to measure cardiac output
Because of the invasiveness of the PA catheter, people have
looked to develop other ways of measuring cardiac output in
the clinical setting. Whilst the PA catheter is considered the
“gold standard”, advances in computer technology, sensor
design and refined interpretation of data have allowed
the development of useful methods of measuring cardiac
output without invasive vascular access. Transoesophageal
echocardiography probes can estimate stroke volume. Doppler
imaging can measure the velocity of blood in the ascending
aorta. The length of a column of blood passing through the
aorta in unit time can be measured. This is multiplied by the
cross-sectional area of the aorta to give stroke volume.
However, this is not feasible for continuous monitoring in
awake patients. Thermodilution and pulse wave analysis
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techniques are also used. These more invasive techniques
include the PiCCO (transpulmonary thermodilution and
arterial pulse contour analysis), LIDCO (lithium dilution and
arterial waveform analysis) and the Transonic (ultrasound
indicator saline dilution) systems.
The PiCCO system requires a central venous cannula and a
thermistor-tipped femoral arterial line. The femoral arterial
line allows pulse contour analysis and from this cardiac output
is derived. A known volume of ice cold saline is rapidly
injected into the central venous cannula. The injectate
disperses into the lungs and all four cardiac chambers. A
temperature difference reaches the femoral thermistor and a
dissipation curve is generated. The global end-diastolic
volume can be estimated from this and this reflects changes in
volume status.
The NiCO system uses the indirect Fick principle using
carbon dioxide rebreathing but requires intubation rather
than vascular access.
Many of the advances in non-invasive cardiac output
monitoring include the ability to monitor parameters
continuously and to follow trends in therapy and interventions.
The most impressive advance in non-invasive cardiac output
monitoring has been the development of reliable techniques
using advanced forms of thoracic bio-impedance measurements.
The EIC (electrical impedance cardiography) and CBII (chest
baseline impedance independent) systems are able to provide
continuous trend monitoring of heart rate and stroke volume
giving derived cardiac output and index parameters using stroke
waveform morphology analysis.
The real advantage of these truly non-invasive techniques is
the opportunity to begin monitoring these parameters in the
Emergency Department, ward, or Coronary Care Unit before
admission to the ICU becomes necessary or possible.
Pump failure
Cardiogenic shock can be split into two main categories:
shock due to pump failure or shock due to mechanical
complications of infarction (for example, acute valve failure,
tamponade, or acute ventricular septal defects) which will not
be discussed further. Over the last 20 years there have been
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major advances in the treatment of myocardial infarction and
in outcome. Despite this the incidence and outcome from
cardiogenic shock has remained roughly the same. It is a
major cause of death among patients with acute coronary
syndromes. The incidence of cardiogenic shock is around
7–10%. The majority occurs after ST elevation myocardial
infarction, but 3% occurs in patients with unstable angina and
2% in patients with non-ST elevation MI. Hospital mortality
is 45–80%.
Randomised trials have tended to define cardiogenic shock
as a systolic blood pressure of < 90 mmHg for at least 1 hour
that is not responsive to fluid administration alone, that is
secondary to cardiac dysfunction, or that is associated with
signs of hypoperfusion (or cardiac index < 2·2 litre per minute
m−2 and pulmonary capillary wedge pressure more than
18 mmHg). In essence, the mainstay of diagnosis is a sustained
systolic blood pressure of < 90 mmHg with evidence of organ
hypoperfusion.
Principles in the management of
cardiogenic shock
Cardiogenic shock has a high mortality. If hypoperfusion is
present (see previous chapter), early intervention is required.
A summary of the interventions in cardiogenic shock is given
in Box 6.7.
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Box 6.7 Interventions in cardiogenic shock
• Reversible causes of pump failure – correct mechanical problems,
heart rate, hypoxaemia, drug effects and hypocalcaemia 
• Reversible ischaemia – thrombolysis is a priority if indicated. Anti
platelet agents should be given. Other interventions may be
indicated as directed by a cardiologist
• Suboptimal preload – assess volume status using fluid
challenges and achieve effective circulating volume
• Haemodynamic data required – CVP line, urinary catheter, arterial
line, (cardiac output measurements)
• Low cardiac output despite optimum heart rate and filling
pressures – start dobutamine. If hypoperfusion still present at
optimum doses, add a drug with α effects. Intra-aortic balloon
pumping may also be used
Identify and treat patients in the preshock state early and
effectively instead of waiting to take action once shock is
established. When acidosis from hypoperfusion occurs,
myocardial function is further depressed, vasoactive drugs are
less likely to work, and it may be difficult to break the
physiological downward spiral. Patients treated early but who
fail to respond to optimum therapy are unlikely to have any
significant cardiac reserve and have a poor prognosis.
Clinical assessment of a patient with
circulatory failure
A and B are still important in a patient with circulatory
failure. This is because the reason the circulation exists is to
get oxygen to the cells. Airway and breathing play a vital role
in this function. After that, circulation can be optimised. The
use of inotropes nearly always follows the use of fluid and
there is a constant cycle of re-assessment (Figure 6.4).
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Fluid challenge – is the patient adequately filled?
Which is the appropriate vasoactive drug?
Inotrope challenge followed by re-assessment
Figure 6.4 Cycle of re-assessment in circulatory failure
The best inotrope or inotrope combination will vary not
only between patients with the same condition but also in the
same patient over the course of their illness. If there is no
satisfactory response to an optimum dose of one inotrope, a
different drug should be considered. Remember the things
which affect cardiac output or flow:
CO = HR × SV (contractility/inotropy, preload, afterload)
and the things which affect blood pressure:
BP = CO × SVR
All of these variables should be considered and manipulated
to get the best organ perfusion possible.
Self-assessment – case histories
1. A 50-year-old man is admitted with an anterior myocardial
infarction and develops hypotension 12 hours later with a poor
urine output. His vital signs are: pulse 90 per minute, blood
pressure 80/50 mmHg, respiratory rate 20 per minute, SaO2
95% on air, temperature 37°C and he is alert. What is your
management?
2. A 60-year-old man is admitted to the HDU for “pre-optimisation”
12 hours before a laparotomy. He is treated normally for
hypertensive heart failure and this is controlled. He has
developed sepsis. He has warm, dry peripheries and his vital
signs are: pulse 98 per minute, blood pressure 110/70 mmHg,
respiratory rate 26 per minute, SaO2 96% on air, temperature
37·5°C and he is alert. He says he is thirsty. His PA catheter
readings are as follows:
• CVP = 14 mmHg
• PAOP = 10 (8–12 mmHg)
• CO = 5·5 (4–8 litres per minute), CI = 3 (1·5–4 litres
per minute m−2) 
• SVR = 1100 (770–1500 dyn.s cm−5)
How would you optimise this patient?
3. A 40-year-old man is admitted with a severe gastrointestinal
bleed. His vital signs are: pulse 100 per minute, blood pressure
150/70 mmHg, respiratory rate 20 per minute, SaO2 98% on air;
he is alert and has cold hands and feet. A CVP line is inserted.
The first reading is 16 mmHg. The doctor decides not to give
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fur ther fluid and observe the patient. What would your
management plan be?
4. You are called to see a postoperative patient who has developed
a poor urine output (< 0·5 mg kg−1 per hour for 2 consecutive
hours). His vital signs are: pulse 90 per minute, blood pressure
120/70 mmHg, respiratory rate 20 per minute, SaO2 95% on
2 litres per minute oxygen via nasal cannulae. His chest is clear.
His arterial blood gases show: pH 7·34, PaCO2 4·0 kPa (30·7
mmHg), PaO2 10·0 kPa (77 mmHg) and bicarbonate 13 mmol/l,
BE − 8. His CVP reading is 12 mmHg. He has mild peripheral
oedema. What would your management plan be?
5. A patient is admitted with an inferior myocardial infarction. His
pulse is 40 per minute (sinus bradycardia) and blood pressure
95/60 mmHg. His urine output is satisfactory. His hands are
warm, his respiratory rate is 16 per minute, temperature 36·5°C
and SaO2 96% on air. What is your management?
6. You are asked to see an 80-year-old lady because she has a low
blood pressure. On examination her vital signs are: pulse 70 per
minute, blood pressure 90/60 mmHg, respiratory rate 14 per
minute, SaO2 95% on air. She has warm hands and feet and is
mobile on the ward. What other parameters would you assess
and what is your management?
7. A patient has developed low blood pressure on the coronary care
unit. One examination the vital signs are: pulse 180 per minute,
blood pressure 80/50 mmHg, respiratory rate 18 per minute,
SaO2 80% on air. He has cold hands. What is the cause of the
low oxygen saturations and what is your management?
8. A 40-year-old man is admitted to ICU with hypotension causing
hypoperfusion that has not responded to fluid challenges. He
has a PA catheter inserted and the initial readings show:
• CVP = 3 mmHg
• PAOP = 5 (8–12 mmHg)
• CO = 10 (4–8 litres per minute), CI = 4·5 (1·5–4 litres per
minute m−2)
• SVR = 300 (770–1500 dyn.s cm−5)
What diagnosis are these readings consistent with? What would
your management be?
Self-assessment – discussion
1. Immediate management includes the following: airway and
breathing should be assessed and treated before circulation. The
hypotension is causing renal hypoperfusion and should be
treated without delay. When any mechanical causes for cardiac
failure has been excluded, the response to a fluid challenge
should be assessed. When preload has been optimised, it
would be appropriate to start an inotrope and assess the
CIRCULATORY FAILURE AND THE USE OF INOTROPES
123
response to this. Intra-aortic balloon pumping should be
considered. Further fluid challenges and other vasoactive drugs
may be required.
2. Airway and breathing should be assessed and treated first.
Ignore the PA catheter readings and assess the patient clinically.
What is his normal blood pressure? Are there signs of
hypoperfusion (What is the urine output and base excess)? He
has warm, dry skin, is tachycardic, and says he is thirsty. He has
a history consistent with volume depletion – sepsis and perhaps
chronic diuretic use. A fluid challenge is indicated. In a patient
with sepsis, one would expect to find a raised cardiac output and
a low SVR. This patient’s response has been altered by heart
failure, so although these readings appear “normal”, they do not
indicate normal physiology.
3. After A and B, circulation is assessed by looking at the vital
signs and for signs of hypoper fusion (for example, skin
temperature). This patient has cold peripheries and is
tachycardic. A 40-year-old man with a severe GI bleed may
compensate by vasoconstriction and this raises the CVP. Single
CVP readings are rarely useful. His volume status should be
assessed with fluid challenges and the response of his vital
signs and CVP readings to these.
4. A and B should be assessed and treated first. In terms of
circulation, he has a “normal” blood pressure, but there are
signs of hypoperfusion – poor urine output and a metabolic
acidosis. The response of the urine output, base deficit, and CVP
to fluid challenges should be assessed.
5. This patient is hypotensive but not hypoperfused. He is exhibiting
the Bezold–Jarisch reflex – a response of coronary artery
chemoreceptors to ischaemia causing hypotension and
bradycardia. This is designed to increased coronary blood flow.
Any poor urine output that occurs normally responds to a fluid
challenge.
6. This patient is hypotensive but not hypoperfused. What is
her normal blood pressure? No emergency intervention is
indicated.
7. Airway and breathing should be assessed and treated. If the
patient is alert and talking, the airway is secure. A high
concentration of oxygen should be given (for example, 15 litres
per minute via a simple face mask or reservoir bag mask).
Assessment of the circulation reveals a low blood pressure
causing hypoperfusion. His heart rate is 180 per minute and this
should be treated first (Figure 6.5). In a compromised patient, DC
cardioversion is indicated. A return to sinus rhythm will probably
restore perfusion. His low oxygen saturations are probably
caused by a weak signal from hypoperfusion and tachycardia
rather than hypoxaemia – arterial blood gas analysis will
confirm this.
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8. These readings show low filling pressures (low CVP and PAOP),
high cardiac output, and low systemic vascular resistance. This
is consistent with a diagnosis of severe sepsis. Fluid challenges
should be given to optimise filling pressures. A persistently low
SVR despite this is treated with vasopressors.
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Figure 6.5 The Treppe effect of heart rate on cardiac output
(CO) (treppe means staircase)
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7: Sepsis
By the end of this chapter you will be able to:
• be aware of the terminology used
• understand the underlying pathophysiology of sepsis
• understand the principles of circulatory resuscitation in sepsis
• understand the role of intensive care in supporting patients
• appreciate the effects of sepsis on the lung
• be aware of recent advances in therapy
• know about microbiological considerations
• apply this to your clinical practice
The incidence of sepsis is increasing and is a major cause of
morbidity and mortality in hospital. It is the leading cause of
death in UK ICUs. The increasing use of immunosuppressant
agents, broad-spectrum antibiotics, and invasive technology is
contributing to the rising incidence. Around one-third of UK
ICU admissions are now due to severe sepsis. In the USA the
annual incidence of sepsis is in the order of 400 000 per year
with 200 000 cases of septic shock and an estimated 100 000
deaths. In Holland it has been recorded that severe sepsis
occurs in 13·6 per 1000 and septic shock in 4·6 per 100 hospital
admissions. Early recognition and treatment is vital – once
organ failure is established, mortality is over 50% (Table 7.1).
Terminology
In 1991 a consensus conference produced definitions of
sepsis and its adverse sequelae. The term systemic inflammatory
Table 7.1 Mortality rates in the sepsis continuum (mortality also
increases with age)
Diagnosis Mortality (%)
Bacteraemia 10–20
Bacteraemia + sepsis 20–30
Severe sepsis 40–60
Sepsis + multiple organ failure over 80
response syndrome (SIRS) defines the clinical manifestations of
the widespread inflammation that results from a variety of
insults including infection, pancreatitis, burns, and trauma
including surgery (Figure 7.1). Sepsis is defined as the systemic
inflammatory response to a documented infection. Severe sepsis
is associated with organ dysfunction and hypoperfusion. Septic
shock refers to those patients who remain hypotensive despite
adequate fluid resuscitation. Box 7.1 shows the definitions in
the sepsis continuum.
The term multiple organ dysfunction syndrome (MODS) is a
clinical syndrome in which the development of progressive
and potentially reversible physiological dysfunction in two or
more organ systems occurs. It is induced by a variety of acute
insults and its occurrence in sepsis is characteristic. MODS is a
continuum – varying from a mild degree of dysfunction to
frank organ failure.
Pathophysiology of sepsis
The features seen in sepsis are the result of an inflammatory
response to a invading organism. This involves the production
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Figure 7.1 Systemic inflammatory response syndrome and sepsis
of cytokines, nitric oxide, thromboxanes, leukotrienes, platelet
activating factor, prostaglandins, and complement. There is
also activation of coagulation and platelet aggregation. All this
leads to:
• increased capillary permeability
• hypovolaemia, hypoperfusion, and a disturbed
microcirculation
• development of a metabolic acidosis with increasing blood
lactate
• impaired oxygen utilisation
• reduced myocardial contractility caused by circulating
myocardial depressants, acidosis, and hypoxaemia
• a reduced systemic vascular resistance (SVR)
• increased pulmonary vascular resistance
• increased oxygen extraction owing to a hypermetabolic
state
• coagulopathy with microvascular thrombosis.
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Box 7.1 Definitions in the sepsis continuum
• Infection – invasion of micro-organisms into a normally sterile
site, often associated with an inflammatory host response
• Bacteraemia – viable bacteria in the blood stream
• Septicaemia – no uniform definition, often interpreted as
bacteraemia plus severe illness 
• Sepsis – clinical evidence of infection plus a systemic response
indicated by two or more of the following:
• hyper (> 38°C) or hypothermia (< 36°C)
• tachycardia (heart rate > 90/minute)
• tachypnoea (respiratory rate > 20/minute)
• white blood cells > 12 × 109 or < 4 × 109 or “left shift”
• Severe sepsis – sepsis associated with organ dysfunction:
• hypotension
• poor urine output
• hypoxaemia
• confusion
• metabolic acidosis
• disseminated intravascular coagulation
• Septic shock – severe sepsis with hypotension unresponsive to
intravascular volume replacement
• Refractory shock – hypotension not responding to vasoactive
drugs
The “typical” patient with severe sepsis has a fever and
tachycardia, and is vasodilated with an increased cardiac
output and low blood pressure. However, poor myocardial
function is also part of severe sepsis and may contribute to
hypotension. Patients can appear vasoconstricted with cold
peripheries especially if there is coexisting hypovolaemia. It is
important to recognise that sepsis is a dynamic process with
rapid evolution of physical signs covering a wide continuum
of physiological responses.
The host response to infection is protective – but in severe
sepsis it seems to be stimulated excessively leading to organ
dysfunction, multiple organ failure, and death. In simplified
terms, severe sepsis can be thought of as dysfunction between
the opposing mechanisms that normally maintain
homeostasis. The main systems that become dysfunctional in
severe sepsis are inflammation, coagulation/fibrinolysis, and
the endothelium. Other factors such as mitochondrial
dysfunction also play a role.
Inflammation
The body’s initial response to a pro-inflammatory insult is
to release mediators like tumour necrosis factor (TNF),
interleukin 1, interleukin 6, and platelet-activating factor
(PAF). These mediators have multiple overlapping effects
designed to repair existing damage and limit new damage. To
ensure that the effects of the pro-inflammatory mediators
do not become destructive, the body then launches
compensatory anti-inflammatory mediators like interleukin 4
and interleukin 10, which downregulate the initial pro-
inflammatory response. In severe sepsis, regulation of the
early response to a pro-inflammatory insult is lost and a
massive systemic reaction occurs with excessive or inappropriate
inflammatory reactions, resulting in the development of
diffuse capillary injury.
Coagulation
As well as inflammation, there are abnormalities of both
coagulation (clot formation) and fibrinolysis (break down of
clot) as illustrated in Figure 7.2.
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The many inflammatory mediators that are released
promote coagulation. In addition, infectious agents can cause
endothelial damage themselves, which also promotes
coagulation. At each step in the cycle auto-amplification
occurs, accelerating the coagulation abnormalities. Pro-
inflammatory cytokines, such as interleukin 1A, interleukin
1B, and TNF, induce the expression of tissue factor (TF) on
endothelial cells and monocytes initiating coagulation. TF is a
key mediator between the immune system and coagulation
and is the principle activator of coagulation causing large
amounts of thrombin to be generated.
Fibrinolysis
The end result of the clotting pathway is the production of
thrombin, which converts soluble fibrinogen to insoluble
fibrin. The fibrin aggregates and forms a clot together with
platelets, blocking the damaged blood vessel and preventing
further bleeding. The fibrinolytic system (Figure 7.3) is directly
influenced by the septic process and, in most patients with
sepsis, it is suppressed while coagulation proceeds. Two key
inhibitors of fibrinolysis that are produced by sepsis are
plasminogen activator inhibitor 1 and thrombin activeatable
fibrinolysis inhibitor.
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Increased coagulation driven
by pro-inflammatory
mediators, endothelial cell
injury, tissue factor
expression, and thrombin
production
Suppressed fibrinolysis via
increased plasminogen activator
inhibitor 1, thrombin activatable
fibrinolysis inhibitor and reduced
protein C
Figure 7.2 Abnormalities of coagulation and fibrinolysis
Bleeding
Coagulation and fibrinolysis are usually finely balanced.
Inappropriate activation of the coagulation cascade results in
widespread fibrin deposition (clot formation), and coagulation
factors and platelets are consumed faster than they can be
replaced. Hence the paradox of both microvascular thrombosis
and bleeding. The fibrin strands fragment passing red blood
cells and the resulting microangiopathic haemolysis may be
seen on the blood film.
The following laboratory changes are therefore seen in
severe sepsis:
• reduced platelets
• prolonged APTT, PT, and TT
• reduced fibrinogen
• elevated d-dimer
• microangiopathic haemolysis leading to anaemia and
reticulocytosis.
This picture is described as disseminated intravascular
coagulation (DIC).
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Figure 7.3 Fibrinolysis (clot breakdown). Venous occlusion or thrombin
stimulates tissue plasminogen activator release. Sepsis produces
PAI −1. Activated protein C inactivates PAI −1. Fibrin degradation
products (FDPs) are used clinically to measure the activity of the
fibrinolytic system, but d-dimers are more specific – produced by the
digestion of cross-linked fibrin
The endothelium
The normal role of the endothelium includes interaction with
leucocytes, the release of cytokines and inflammatory mediators,
the release of mediators of vasodilatation and vasoconstriction,
and a part in the coagulation system. In severe sepsis there is
physical as well as chemical dysfunction of the endothelium.
Holes appear, which lead to persistent capillary leak.
The circulation in severe sepsis
There is a common failure to understand that the
hypovolaemia in patients with severe sepsis requires successive
fluid challenges rather than a simple fluid infusion. Large fluid
deficits can result from diarrhoea or third space losses in
peritonitis, but vasodilatation and capillary leak also lead to
dramatic intravascular volume depletion. Fluid challenges
should be titrated to the clinical endpoints of blood pressure,
heart rate, urine output, and other markers of perfusion. In
persistent hypotension with hypoperfusion, it is essential that
the attending doctor stays with the patient until acceptable
parameters have been reached or the patient is transferred to the
ICU for further monitoring and treatment with vasoactive drugs.
Invasive or more sophisticated monitoring than simple pulse,
blood pressure, and urine output should be instituted early in
severe sepsis. Early goal-directed therapy has been shown to
improve outcome. Severe sepsis is a complex ICU disease. Close
attention must be paid during the administration of fluids as
signs of pulmonary oedema and bilateral infiltrates on the chest
x ray film can appear without obvious fluid overload if ARDS is
present (see later). PA catheters are often used in severe sepsis
precisely because it can be difficult to evaluate the degree of
hypovolaemia, the presence of cardiac dysfunction, and thus
the aetiology of any pulmonary oedema.
Unlike other causes of shock, the cardiac output is often
maintained or even increased in severe sepsis. Septic shock
results from alterations in the distribution of blood flow. There
is loss of control of the microvasculature with the abnormal
distribution of cardiac output. Reduced oxygen and nutrient
delivery to the tissues causes organ dysfunction. The goal of
therapy is therefore to restore tissue perfusion through the use
of fluids and vasoactive drugs.
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Systemic vascular resistance (SVR) can be measured by
invasive and non-invasive means and is of great value in
titrating vasoactive drugs in severe sepsis, when the SVR is
usually low. SVR may be thought of as the resistance against
which the heart pumps. It is calculated using a PA catheter as
follows:
The normal range is 1000–1500 dyn.s cm−5. SVR is mainly
determined by the diameter of arterioles, which is affected by
intrinsic autoregulation, locally produced substances that
vasodilate (for example, nitric oxide), hypoxaemia, neural
factors, and circulating toxins. SVR increases with normal
ageing in Western populations. SVR × body surface area in kg
m−2 gives the systemic vascular resistance index (SVRI), which
is often used in clinical practice.
Ideally, blood pressure is measured invasively with an
arterial line, as measurement of blood pressure with a cuff is
often unreliable and inaccurate at low blood pressures. The
level of mean arterial pressure (MAP) to aim for is not clear but
most studies have shown that a MAP of < 60 mmHg is
associated with compromised autoregulation in the coronary,
renal, and brain circulations. MAP is not commonly used on
general wards – a practical guide is that you should aim for a
blood pressure that adequately perfuses the tissues and this is
usually – but not always – > 90 mmHg systolic. To a certain
extent adequate perfusion depends on the patient’s usual
blood pressure, which should be identified if possible. Some
patients require higher pressures for adequate perfusion.
Mini-tutorial: dopamine or norepinephrine (noradrenaline) in
septic shock?
Dopamine
Clinicians vary in the use of high dose dopamine or norepinephrine in
septic shock. There are several theoretical reasons why
norepinephrine is better and this is supported by some studies.
Much of our knowledge of the effects of dopamine comes from
healthy humans. Dopamine is a naturally occurring catecholamine.
You may recall that dopaminergic receptor stimulation predominates
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SVR in dyn.s cm−5 =
CO in litres per minute
MAP − CVP in mmHg × 80 (correction factor)
at low doses, causing an increase in renal and mesenteric flow. β1
stimulation occurs at moderate doses causing increased myocardial
contractility, heart rate, and cardiac output; α stimulation occurs at
higher doses, increasing systemic vascular resistance and reducing
renal blood flow. In the critically ill, there is wide interpatient variation
in plasma clearance of dopamine. In healthy humans, dopamine
infusions have theoretical beneficial effects on renal and splanchnic
circulations but this has not translated into improved outcomes in
studies. In fact, there is some evidence to suggest that dopamine
may have detrimental effects on the splanchnic circulation in
patients with sepsis.
Norepinephrine (noradrenaline)
Septic shock is characterised by a high cardiac output, low systemic
vascular resistance, and a normal or low pulmonary arterial occlusion
pressure. Norepinephrine is a potent α receptor agonist, that is, it
vasoconstricts. It also stimulates β1 receptors at higher doses,
increasing cardiac output, but has no effect on β2 receptors. If
norepinephrine is used in patients with uncorrected hypovolaemia, or
in haemorrhagic shock, it has severe detrimental effects on tissue
perfusion, particularly in the kidneys. Norepinephrine reduces renal,
hepatic, and muscle blood flow but, when used in patients with septic
shock who have been adequately fluid resuscitated, norepinephrine
improves both urine production and renal function. This is because it
improves renal perfusion pressure by raising blood pressure.
One prospective, double-blind, randomised trial compared
norepinephrine and dopamine in the treatment of septic shock.
Patients with similar characteristics were assigned to receive either
norepinephrine 0·5–5 micrograms kg−1 per minute or dopamine 2·5–25
micrograms kg−1 per minute. If the haemodynamic and metabolic
abnormalities were not corrected with the maximum dose of one
drug then the other was added. The aim of therapy was to achieve
for at least 6 hours an SVRI of > 1100 dyn.s cm−5 and/or a MAP of
> 80 mmHg, a target cardiac index of > 4 litres per minute m−2 and
normalisation of oxygen delivery and uptake. Only 31% patients were
successfully treated with dopamine compared with 93% with
norepinephrine. Ten of the 11 patients who did not respond to
dopamine and remained hypotensive and oliguric were successfully
treated with norepinephrine. The authors conclude that norepinephrine
was more effective and reliable than dopamine in reversing the
abnormalities in septic shock (defined by hypotension despite
adequate fluid therapy with a low SVR, high cardiac output, oliguria,
and lactic acidosis). A decrease in lactate levels was also seen with
norepinephrine. The effects of norepinephrine on oxygen transport
remain unclear from available data; however, most studies have found
clinical parameters of peripheral perfusion to be significantly improved.
Increased splanchnic blood flow has been demonstrated in patients
with septic shock treated with norepinephrine.
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Other inotropes used in septic shock
Dobutamine
Dobutamine is considered by many to be the pharmacological
agent of choice to increase cardiac output when this is depressed
in septic shock. It has a predominantly β1 effect that increases
heart rate and contractility, hence cardiac output. It has no
specific effects on renal blood flow but the increase in cardiac
output can improve glomerular filtration rate.
Epinephrine (adrenaline)
In patients who have failed to respond to fluid administration
or vasopressors, epinephrine can increase arterial pressure by
increasing cardiac output and systemic vascular resistance.
Refractory shock
The role of steroids
The evidence for the use of steroids in the treatment of severe
sepsis has gone full circle in the last 20 years, with recent
interest focusing on low doses. In patients with severe sepsis
there are complex effects on the hypothalamic–pituitary–
adrenal axis. On the one hand there is stimulation of the axis
and loss of negative feedback control, which usually leads to
high adrenocorticotrope hormone (ACTH) and cortisol levels.
On the other hand various mediators cause adrenal suppression
and glucocorticoid resistance. With time ACTH levels may fall
due to inhibition or pituitary depletion – this leads to relative
adrenal suppression. Recent studies have shown that patients
with sepsis who are dependent on vasoactive drugs may benefit
from stress doses of hydrocortisone (50–100 mg intravenously
4 times a day for 7 days). A proportion of these have relative
adrenal insufficiency as defined by the short synacthen test and
these patients have the greatest benefit in terms of mortality.
Whilst a proportion of patients may benefit, steroids are not a
routine treatment in sepsis.
Plasmapheresis
Plasmapheresis is a non-selective method of removing toxic
mediators from the circulation. Several reports have been
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published on the use of plasmapheresis in severe sepsis but
these have been inconclusive. Plasma is removed from the
circulation and replaced with donor fresh frozen plasma
during plasmapheresis. The first prospective randomised
controlled trial of plasmapheresis in septic shock has come
from a Russian–Norwegian collaboration. They looked at 106
consecutive patients with severe sepsis or septic shock and
randomised them to receive either standard therapy or add-on
treatment with plasmapheresis. The patients had equivalent
APACHE III scores at entry. The main endpoint was 28-day
mortality: 33·3% (18/54) patients in the plasmapheresis group
died compared with 53·8% (28/52) in the control group. This
represented an absolute risk reduction of 20·5% with
plasmapheresis. The number needed to treat was 4·9 patients
with severe sepsis to prevent one death. Plasmapheresis
appeared to be a safe procedure. However, the study population
was heterogeneous with respect to the cause of sepsis. The
authors concluded that a large multicentre prospective
randomised controlled trial is needed to confirm these positive
results.
Plasmapheresis lowers circulating endotoxins and cytokines,
but replacement of donor plasma may also replenish
deficiencies in immunoglobulins and clotting factors. There
are immunological similarities between severe sepsis and
thrombotic thrombocytopenic purpura (TTP) in which
endothelial injury results in the release of multiple mediators
and the presence of a large von Willebrand factor fragment.
Plasmapheresis has lowered mortality in this condition from
90 to 10%. Patient selection may be important when using
plasmapheresis in severe sepsis – but data on this are awaited.
At the moment plasmapheresis is sometimes considered in
patients with septic shock who are not responding to
conventional therapy on the ICU.
Vasopressin
Endogenous vasopressin levels appear to be inappropriately
low in severe sepsis compared with the raised levels seen in
other shock states (for example, hypovolaemic and
cardiogenic). Continuous infusion of vasopressin has been
shown to have an effective pressor action in many patients
with refractory shock, which is unresponsive to fluid
resuscitation and noradrenaline. However, rebound hypotension
often occurs on discontinuation of the drug.
Methylene blue
Methylene blue can be useful in elevating blood pressure in
refractory shock with a bolus dose of 2 mg kg−1 over 15
minutes. It acts by inhibiting guanylate cyclase. Nitric oxide is
formed from L-arginine by nitric oxide synthases. Nitric oxide
stimulates guanylate cyclase to produce vasodilatation and
reduced responsiveness to catecholamines. Methylene blue
thus increases vascular tone.
Other supportive therapies
As sepsis is associated with multiple system organ failure,
there are other supportive therapies used to treat these patients,
which do not directly relate to the sepsis itself. Deep vein
thrombosis (DVT) prophylaxis, nutritional support, and stress
peptic ulcer prophylaxis are important adjuvant therapies.
Nutritional support, especially enteral (via nasogastric tube) is
important in supporting the hypercatabolic critically ill patient,
preventing stress ulcers, and maintaining gut mucosal integrity.
Tight glucose has also been shown to improve outcome.
Principles of resuscitation in severe sepsis
Hypoperfusion rapidly leads to organ dysfunction in severe
sepsis. This systemic response to inflammation is an
emergency. Immediate resuscitation should not be delayed by
investigations as resuscitation can prevent further organ
damage. A, B, C is more urgent than an exact diagnosis in the
first instance. Diagnosis and the hunt for a source of infection
can safely follow later. From the pathophysiology discussed so
far, a methodical approach to resuscitation in severe sepsis is
outlined in Box 7.2.
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The role of intensive care in supporting
patients with severe sepsis
The use of vasoactive drugs in severe sepsis should only follow
adequate fluid resuscitation and this usually requires more
extensive monitoring than can be done in an ordinary ward. In
the ICU, therapeutic strategies are aimed at normalising as far as
possible the global, regional, and microcirculatory defects in
oxygen transport that occur in severe sepsis. These strategies are
guided by the more explicit measurements of cardiac output and
SVR. The effects of different vasoactive drugs on the
microcirculation are also considered. Intubation and ventilation
is an important part of the strategy to improve oxygen delivery
(DO2) and reduce uptake (V
·
O2). Early referral to ICU should be
considered in all patients with severe sepsis.
The lung in sepsis
The development of respiratory dysfunction in patients
with sepsis lies on a continuum from subclinical disease to
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Box 7.2 Methodical approach to resuscitation in severe
sepsis
A
• Reduced conscious level may compromise airway
• Oxygen therapy is needed
B
• Hypoperfusion and hypoxaemia increase the respiratory rate
• ARDS may be present 
• Pneumonia can be the cause of severe sepsis
C
• Hypovolaemia requires successive fluid challenges
• Vasopressors may be needed because of an abnormally low SVR
• Reduced myocardial contractility may also require treatment
• Clotting abnormalities need correcting
D and E
• Arterial blood gases to assess A, B, and C
• Full examination is required to locate the source of inflammation,
including microbiological screening and imaging
overwhelming organ dysfunction. At the worst end is the
acute respiratory distress syndrome (ARDS), a severe form of
acute lung injury (ALI). The definition of ARDS is adapted
from the American European Consensus Conference held in
1994:
• acute in timing
• PaO2 in mmHg/FIO2 (for example, 0·6 for 60% oxygen) of
≤ 200
• bilateral infiltrates on the chest x ray film
• a pulmonary arterial occlusion pressure of < 18 mmHg.
These criteria show an incidence varying from 5 to 71 per
100 000 people in the USA and accounting for nearly 5 billion
dollars’ worth of financial support. Morbidity and mortality
associated with ALI and ARDS is in excess of 40%. Mortality is
often due to unresolved sepsis or multiple organ failure as
opposed to progressive respiratory failure. The hallmark of
ARDS is alveolar epithelial inflammation, air space flooding
with plasma proteins and cellular debris, surfactant depletion
and inactivation, and loss of normal endothelial reactivity.
Hypoxaemia in sepsis is caused by extensive right-to-left
intrapulmonary shunting of blood, which may account for
more than 25% of the total cardiac output (see Figure 4.2).
Usually compensation occurs through hypoxaemic
vasoconstriction, limiting the amount of shunt by reducing
perfusion to poorly ventilated lung units. However, in states of
lung injury, hypoxaemic vasoconstriction may be ineffective
or even absent. The shunting of blood through non-ventilated
lung units accounts for the relative refractory nature of
hypoxaemia in ARDS. The hypoxaemia is often out of
proportion to initial x ray film findings. Lung compliance is
the change in volume for a given change in pressure and is
reduced in ARDS because of small airway and alveolar
collapse. In early ARDS the volume of functional lung is also
reduced by alveolar oedema and surfactant abnormalities.
There is also an increase in airway resistance caused by
airway secretions, oedema, and mediators that provoke
bronchospasm.
As a result of changes in lung compliance in ARDS, greater
airway pressures are needed to achieve a given tidal volume.
This increases the work of breathing, which is exacerbated by
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the increased respiratory rate seen in severe sepsis.
Hypoxaemia in sepsis therefore results from the following:
• ventilation–perfusion mismatch
• respiratory muscle dysfunction
• decreased thoracic compliance
• increased airway resistance due to bronchoconstriction.
Oxygen delivery is also affected by upper airway obstruction
where there is a reduced conscious level, circulatory collapse,
metabolic acidosis, and reduced haemoglobin levels.
The pathological changes in ARDS are divided into three
phases:
1. the early exudative phase (days 1–5), characterised by
oedema and haemorrhage;
2. the fibroproliferative phase (days 6–10), characterised by
organisation and repair;
3. the fibrotic phase (after 10 days) characterised by fibrosis.
These times are approximate and characteristic features in
each phase often overlap. When the initial signs and
symptoms of sepsis first appear, between 28–33% of patients
meet the criteria for ARDS.
Since ARDS was first reported, mortality has remained
relatively constant at 60–70%. More recent reports suggest
that mortality has declined to around 40%. The explanation
for this apparent improvement in patient outcome is not clear
but could be due to differences in patient populations,
changes in ventilation strategies, greater attention to fluid
management, improved haemodynamic and nutritional
support, improved antibiotics for hospital-acquired infections,
or corticosteroid use (small randomised trials have suggested
benefit with intravenous corticosteroid therapy in patients
with a prolonged fibroproliferative phase of ARDS). No one
therapeutic intervention has been proved to be effective in
reducing the incidence of respiratory failure in sepsis nor its
mortality.
Intubation and mechanical ventilation is considered early
in severe sepsis, especially if ARDS is present. The indications
for intubation include:
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• patient cannot protect own airway;
• correction of refractory hypoxaemia – PaO2 < 8·0 kPA
(60 mmHg) – despite maximum oxygen therapy;
• respiratory rate > 35 per minute and vital capacity < 15 ml
kg−1 – invasive ventilation alleviates the increased work of
breathing allowing blood to be redirected to other vital
organs.
Non-invasive ventilation has not been shown to be effective
in ARDS, although limited data exist.
Much has been written on the different ventilatory
strategies in ARDS, which is beyond the scope of this book.
Pressure-controlled inverse ratio ventilation is often used as a
means of recruiting non-ventilated lung units. Smaller tidal
volumes limit barotrauma and volutrauma. Permissive
hypercapnia means that the CO2 is allowed to rise to allow
these ventilation strategies. Prone positioning of the patient
can improve oxygenation but has not been shown to improve
outcome. Finally, fluid balance can be difficult in ARDS
because overhydration can be a disadvantage when the lung
has leaky capillaries – but cardiac function and organ
perfusion also have to be optimised.
Recent advances in severe sepsis
In recent years many new therapies for sepsis have been
tested in randomised trials. All have attempted to counteract
the effects of sepsis mediators with the use of specific
antibodies, inhibitors, or antagonists. These trials have tended
not to have an effect on mortality. The most promising of new
treatments is Drotrecogin Alfa (activated), a recombinant form
of activated protein C.
Activated protein C
Drotrecogin Alfa (activated) is the first therapeutic
intervention shown to reduce all-cause mortality in severe
sepsis. At 28 days 24·7% of Drotrecogin Alfa (activated)
patients died versus 30·8% of patients treated with placebo.
There was a 19·4% reduction in the relative risk of death
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(numbers needed to treat = 16). Significant decreases in levels
of protein C have been well documented in severe sepsis. The
benefit of giving activated protein C is explained by the fact
that it inhibits the generation of thrombin via inactivation of
factor Va and VIIIa. D-dimer levels are seen to decrease in the
first week of infusion and rise when the infusion is stopped.
Activated protein C (APC) also reduces inflammation –
interleukin 6 levels are reduced in studies. It is postulated
that APC inhibits neutrophil activation, cytokine release,
and adhesion of cells to the vascular endothelium, and has
antithrombotic activity. Reductions in risk of death were seen
whether or not patients had baseline low levels of activated
protein C. Bleeding was the most common adverse event –
one serious bleed occurred for every 66 patients treated. This
was more likely in patients with gastrointestinal ulceration,
trauma to a blood vessel, injury of a vascular organ, or highly
abnormal coagulation (low platelets, raised PT, and APTT), for
example in liver disease.
The role of bacterial gut translocation
in multiple organ failure
All the inotropes described above have been studied with
regard to their effect on the splanchnic circulation. Gastric
mucosal pH can be measured using nasogastric probes and is
thought to be a marker of perfusion in this particular vascular
bed. A fall in gastric mucosal pH indicates vasoconstriction
and reduced perfusion. Compromised perfusion allows
breakdown of the mucosal barrier, and gut bacteria pass into
the portal circulation. Bacteria and endotoxin come into
direct contact with Kupffer cells in the liver, stimulating
cytokine production and release. These mediators spill over
into the systemic circulation and lead to organ dysfunction.
This theory has been demonstrated in animal studies, but the
role of bacterial gut translocation in the development of
multiple organ failure in humans is still an area of research.
There is a great interest in nutrition, immunonutrition, and
the effects of various vasoactive drugs on the splanchnic
circulation for this reason.
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Microbiological considerations
Once resuscitation is underway, an attempt should be made
to isolate the cause of severe sepsis. In many cases, this involves
the hunt for an infective organism using serial blood cultures
and imaging. This is an important aspect of management as
intervention, such as the drainage of an abscess, can improve
the course of illness more effectively than antibiotics alone.
Serial C-reactive protein or procalcitonin measurements are
useful markers in severe sepsis. Procalcitonin is thought to be
more specific in differentiating bacterial from non-bacterial
inflammation and may be of value in the initiation of empirical
antibiotic therapy. Bacterial infections are the commonest
aetiological agents of both community-acquired and hospital-
related sepsis (Figure 7.4), but a causative organism is confirmed
in only 60% cases. Disease progression is similar regardless of
organism. However, there has been a rise in multiply resistant
bacteria such as Acinobacter species, Enterococci and methicillin-
resistant Staphylococcus aureus (MRSA).
Retrospective studies have shown that early administration
of appropriate antibiotics reduces the mortality of patients
with Gram negative bacteraemia and it is likely that
appropriate antibiotic therapy also reduces the morbidity and
mortality in Gram positive sepsis. The choice of antibiotic
should take into account history, examination, and
microbiological investigations. “Blind” antibiotic therapy is
often started in severely ill patients based on history and
examination alone (Table 7.2).
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Unconfirmed
45%
Gram neg
20%
Gram pos
19%
Fungal
3%
Mixed bacteria
10%
Mixed other
3%
Figure 7.4 Pathogens in sepsis
ESSENTIAL GUIDE TO ACUTE CARE
144
Table 7.2 UK “blind” antibiotic therapy in severe sepsis (policies vary
between institutions)
Symptoms and signs Likely organisms Intravenous therapy
Severe community-
acquired pneumonia
Hospital-acquired
pneumonia
Intra-abdominal
sepsis (e.g.
postoperative or
peritonitis)
Pyelonephritis
Meningitis
Meningitis in patients
aged over 50
Neutropenic patients
(e.g. from
chemotherapy)
Line infections
Bone – osteomyelitis
or septic arthritis
Acute endocarditis
Pneumococcus,
Mycoplasma,
Legionella
Staphylococcus
aureus, mixed
anaerobes, Gram
negative rods
Gram negative
bacteria, anaerobes
Escherichia, coli,
Enterobacter
Pneumococcus,
Meningococcus
Pneumococcus,
Meningococcus,
Listeria, Gram
negative rods
Staphylococcus
aureus, Pseudomonas,
Klebsiella,
Escherichia coli
Staphylococcus
aureus, Gram negative
bacteria
Staphylococcus
aureus
Staphylococcus
aureus, Gram negative
bacteria,
Streptococcus
viridans
Cefuroxime +
erythromycin (high
dose erythromycin +/−
rifampicin for
Legionella)
Cefotaxime (take into
account antibiotic/ICU
history and sputum
cultures)
Cefuroxime and
metronidazole +/−
gentamicin
Cefotaxime or
ciprofloxacin
Cefotaxime
Cefotaxime + ampicillin
Piperacillin-tazobactam +
gentamicin
Replace line if
possible. Flucloxacillin +
gentamicin or
vancomycin
Flucloxacillin +/−
fucidic acid
Benzylpenicillin +
gentamicin
Returning traveller Seek advice from consultant microbiologist
because of resistant strains
Note: If there is serious penicillin or cephalosporin allergy, consult
urgently with microbiologist.
The most common radiological investigations include chest
x ray film and abdominal CT scanning (Box 7.3). Laparotomy
does not improve outcome in a critically ill patient in whom
radiological examination has failed to show a surgically
correctable problem.
Self-assessment – case histories
1. A 52-year-old man underwent an elective colonoscopy for
investigation of constipation. Two hours later he developed severe
abdominal pain and vomiting. The duty doctor diagnosed colonic
perforation, which was confirmed by x ray film. The surgical team
was informed and part of his large bowel was resected at
laparotomy. Later, the patient’s observations are as follows:
temperature 38°C, pulse 110 per minute, RR 30 per minute, BP
90/50 mmHg and poor urine output. He is mildly confused.
Investigations show: Hb 10·5 g dl−1, WBC 20 × 109 litre−1,
platelets 70 × 109 litre−1, Na 135 mmol litre−1, K 4·7 mmol litre−1,
urea 15 mmol litre−1 (BUN 41·6 mg dl−1), and creatinine 150 µmol
litre−1 (1·8 mg dl−1). Arterial blood gases on 5 litres per minute via
a simple face mask showed: pH 7·26, PO2 8·2 kPa (63 mmHg),
PCO2 5·3 kPa (40·7 mmHg), bicarbonate 17·5 mmol/l, BE − 8. A
CVP line has been inserted after 1500 ml colloid. The initial
reading is 12 mmHg. What is your further management?
2. A 50-year-old lady was seen in the Emergency Department and
treated for a urinary tract infection on the basis of symptoms and
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Box 7.3 Microbiological investigations in severe sepsis
Initial tests
• Blood count, urea and electrolytes, liver tests, clotting screen,
glucose, and CRP
• Repeated blood cultures, urine culture, chest x ray
• Serology and PCR tests (take advice)
Chest signs
• Sputum culture or bronchoscopy + lavage
CNS signs
• Brain CT +/− lumbar puncture
Abdominal signs, postabdominal surgery or no obvious cause of
sepsis
• Abdominal ultrasound + CT 
Heart murmur
• Echocardiogram
a positive urine dipstick. The next day she returned having
collapsed. On arrival her observations were as follows: alert,
pulse 120 per minute, temperature 38°C, BP 80/50 mmHg, RR
20 per minute, SaO2 95% on air, urine output normal. What is your
management and what other immediate tests do you perform?
3. A 19-year-old intravenous drug user was admitted with a severe
hand infection secondary to injecting with dirty needles. His hand
and arm were becoming increasingly swollen. He is alert but his
other observations are: BP 70/40 mmHg, pyrexial, RR 20 per
minute, SaO2 95% on air, pulse 130 per minute. He has no
peripheral venous access possible. Describe your management.
4. A 45-year-old lady with severe rheumatoid arthritis is admitted
with a painful right hip. She is on monthly infusions of
immunosuppressant therapy for her rheumatoid disease as well
as daily steroids. Her admission blood tests show a raised
C-reactive protein and neutrophil count. Her vital signs on
admission are: BP 130/60 mmHg, temperature 36·7°C, RR 16
per minute, SaO2 98% on air, and pulse 80 per minute. She is
alert. However, 24 hours later she develops hypotension (BP
75/40 mmHg) and a tachycardia (110 per minute). A blood
culture report is phoned through as “Staphylococcus aureus in
both bottles”. She is alert, apyrexial, with a respiratory rate of
24 per minute and SaO2 of 87% on air. What is your management?
5. A 50-year-old man is admitted with pneumonia. He is seen by a
junior doctor and prescribed intravenous antibiotics and fluids.
When you review him, his vital signs are as follows: BP 90/50
mmHg, pulse 100 per minute, RR 30 per minute, SaO2 85% on
5 litres per minute via a simple face mask, temperature 39°C,
and he is alert. What do you do next?
6. A 40-year-old man is admitted with abdominal pain, which is
diagnosed as acute pancreatitis (amylase of 2000 units litre−1).
He is given a high concentration of oxygen, intravenous fluids,
and analgesia. Six hours later he develops a poor urine output.
His vital signs are: BP 95/60 mmHg, pulse 120 per minute, RR
25 per minute, SaO2 90% on 10 litres per minute via a reservoir
bag mask, temperature 38°C, and he is alert. Blood lactate is
2·8 mmol litre−1 (normal 0·7–1·2 mmol litre−1). What is your
management?
7. A 60-year-old lady develops a poor urine output following an
emergency endoscopic retrograde cholesytopancreatogram
(ERCP) for common bile duct stones and ascending cholangitis.
Her vital signs are: BP 100/75 mmHg, pulse 80 per minute, RR
20 per minute, SaO2 97% on air, temperature 37·5°C, and she is
alert. What is your management?
8. A 30-year-old man is admitted with a severe gastrointestinal bleed
and receives 14 units of packed red blood cells plus other colloids
during 4 hours of stabilisation followed by upper gastrointestinal
endoscopy. He is then transferred to theatre for surgical repair of
a large bleeding duodenal ulcer. Twenty four hours after surgery
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he is still ventilated and has increasing oxygen requirements.
A chest x ray film shows bilateral patchy infiltrates. His vital signs
are: BP 110/70 mmHg, pulse 110 per minute, RR 14 per minute
(ventilated), SaO2 95% on 60% oxygen, temperature 37°C. What
is the diagnosis and what is your management?
9. A 29-year-old lady arrives in the resuscitation room drowsy with the
following vital signs: BP 80/50 mmHg, pulse 130 per minute, RR
28 per minute, SaO2 95% on 10 litres per minute via a reservoir
bag mask, temperature 38·5°C. Her arterial blood gases show:
pH 7·3, PaO2 35·5 kPa (273 mmHg), PaCO2 3·5 (26·9 mmHg),
bicarbonate 12·7 mmol/l, BE − 10. She has a petechial rash on her
trunk. She responds to voice. Her bedside glucose measurement
is 6·2 mmol litre−1 (103 mg dl−1) and there is no neck stiffness.
What is your management?
Self-assessment – discussion
1. Bacterial peritonitis has caused severe sepsis. Mortality associated
with perforation varies according to site – < 5% for small bowel and
appendix, 10% for the gastroduodenal tract, 20–30% for the colon,
and 50% for postoperative anastomotic leaks. This man has signs
of organ dysfunction, hypoperfusion (low BP, urine output, and
metabolic acidosis), and possibly DIC. The PaCO2 is normal, though
a compensatory respiratory alkalosis is expected. This is because
he is unable to maintain a high minute volume indefinitely and is
tiring. The immediate management includes ensuring a patent
airway and administering a high concentration of oxygen.
Assessment of breathing includes looking for signs of ARDS (note
his PaO2 of 8·2 – a chest x ray film is indicated). For circulation,
intravenous access followed by repeated fluid challenges is
required. Intravenous analgesia should not be forgotten. Since the
cause of the sepsis is known, appropriate antibiotics can be given.
The initial CVP reading is 12 mmHg, but fluid should still be given
because it is the response to a fluid challenge, not a single reading,
that allows interpretation of the CVP and volume status. If the
patient is adequately filled but still hypotensive and oliguric, a
vasopressor should be administered to increase renal perfusion
pressure. Early referral to the ICU team is imperative.
2. Immediate management in this case includes assessment of the
airway and giving a high concentration of oxygen (for example, 15
litres per minute via a reservoir bag mask), examining the chest,
and an assessment of the circulation (pulse, blood pressure,
skin temperature, etc.). She is alert. Immediate tests in acutely
ill patients always consist of arterial blood gases and a bedside
glucose measurement. As intravenous access is required, blood
cultures, haematology, and biochemistry can be taken at the
same time. The likeliest source of sepsis in this case is the urine
and this should be cultured. Successive fluid challenges are
required to restore organ perfusion and the attending doctor
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should stay with the patient until satisfied that this is the case
but, if this fails, the patient should be referred to the ICU for
treatment with vasoactive drugs.
3. Again this patient needs assessment and treatment of A, B, C –
high concentration oxygen and several fluid challenges in this
case. A CVP line is indicated immediately because of his lack of
peripheral venous access. The swelling could be cellulitis, but
search also for soft tissue crepitus. The presence of a rapidly
progressing site of infection with severe systemic symptoms and
signs is suggestive of necrotising fasciitis, which requires urgent
surgical debridement as well as intravenous antibiotics. Check
the creatinine kinase levels as the patient may also be
developing compartment syndrome with rhabdomyolysis.
4. Check A, B, and C. The airway is secure. Examination of
breathing reveals a respiratory rate of 24 per minute and low
oxygen saturations (87% on air). Oxygen therapy is required, for
example 15 litres per minute via a reservoir bag mask. In the
circulation, fluid challenges are required in order to treat
hypoperfusion. However, capillary leak and other changes in the
lung mean that pulmonary oedema can develop with normal left
ventricular function. If fluid loading does not improve blood
pressure and perfusion, invasive monitoring and vasopressors
are required. In this case the source of sepsis is known
(staphylococcal septic arthritis) and high dose intravenous
antibiotics should be given. Advice should be taken on surgical
drainage of the affected hip. If she is on a significant dose of
long-term steroids, these will need to be increased. The low
oxygen saturations and high respiratory rate could indicate the
development of ARDS. Taken together, these signs indicate
severe sepsis and consideration should be given to the
aggressive prevention of full blown multiple organ dysfunction
syndrome. This patient requires early admission to ICU. Mortality
increases with increasing organ failure (Table 7.3).
5. Assess the airway by asking the patient a question. If he is alert
and talking, the airway is secure. Administer a higher
concentration of oxygen (for example, 15 litres per minute via a
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Table 7.3 Mortality and number of failing organ systems
Number of failing organs ICU patients (%) Mortality (%)
0 35 3
1 25 10·5
2 17 25·5
3 12 51·5
4 6·5 61
5 3·0 67
6 1·5 91
reservoir bag mask). Next, assess breathing. His respiratory rate
is raised and examination of the chest will be consistent with
pneumonia. Then assess circulation. Is there hypovolaemia or
hypoperfusion? Fever and increased respiratory rate caused by
pneumonia cause dehydration. Arterial blood gas analysis may
indicate hypoperfusion. His hypotension may respond simply to a
fluid challenge. If severe sepsis is present, the hypotension may
not respond to fluid challenges alone. In that case, invasive
monitoring is required to be sure the patient is adequately filled,
followed by the use of vasoactive drugs. The patient should be
referred to the ICU.
6. The management in this case is the same – A, B, C. In this
patient, attention to detail may prevent the multiple systemic
complications of severe acute pancreatitis, especially respiratory
failure, renal failure, and infection. The classic presentation in
severe cases is SIRS (systemic inflammatory response
syndrome) and MODS (multiple organ dysfunction syndrome).
Mortality is as high as 20–30%. This patient requires oxygen and
fluid challenges immediately. Make your goals known to the
nursing staff. Aim for:
• systolic BP > 100 mmHg
• CVP > 10 mmHg
• urine output > 0·5 ml kg−1 per hour
• reduction in lactate or base deficit.
Look for developing ARDS and the need for early ventilation. This
patient requires ICU care. If the hypoperfusion does not respond to
fluid challenges, invasive monitoring and vasoactive drugs are
required in order to:
• restore an effective circulating volume
• restore adequate perfusion
• maintain an adequate cardiac output and oxygen delivery.
7. Again, this lady requires assessment of airway, high
concentration oxygen therapy, assessment of breathing and
circulation followed by fluid challenges. Note that a blood
pressure of 100/75 mmHg is causing hypoperfusion here – in
some patients this is a normal blood pressure. Antibiotics are
required. She needs referral to the ICU if fluid challenges fail to
correct the hypoperfusion. How many fluid challenges would one
give in this situation? At first, clinical endpoints of blood
pressure, pulse, peripheral skin temperature, and respiratory
rate may be used to assess volume status. However, after
several fluid challenges, there is potential for fluid overload
without improvement in perfusion, especially in the context of
capillary leak. Invasive monitoring is then helpful in assessing
volume status and in the administration of vasoactive drugs.
8. This patient has received a massive blood transfusion, which can
cause ARDS. Arterial blood gases would show a large A–a
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gradient from intrapulmonary shunting. The ventilator may
calculate lung compliance which would be low and typical of
developing acute lung injury. The management in this case is to
continue invasive ventilation on the ICU. The various ventilation
strategies employed are discussed in the chapter.
9. This patient has severe sepsis according to the definition at the
beginning of the chapter. The arterial blood gases show a
metabolic acidosis indicating hypoperfusion. Ensure a patent and
protected airway, give a high concentration of oxygen (for
example, 15 litres per minute via a reservoir bag mask), assess
and treat any breathing problems, assess and treat any circulation
problems, and assess conscious level. A full examination and
appropriate investigations (including blood and other cultures)
should follow. In this case, fluid challenges are required. The
petechial rash is a clue to the possible cause of sepsis and
intravenous antibiotics should be given to cover meningococcal
and staphylococcal infections.
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8: Acute renal failure
By the end of this chapter you will be able to:
• appreciate that prevention is better than cure
• understand the important physiological factors in renal perfusion
• know the evidence – or lack of it – behind various treatments for
acute renal failure
• understand the principles of renal replacement therapy
• apply this to your clinical practice
Preventing renal failure
Acute renal failure is defined as acute oliguria (< 400 ml per
day) or a rapid (hours to weeks) decline in glomerular
filtration rate manifested by a rise in urea and creatinine. The
rise in creatinine is often slow. In fact, if all renal function is
lost, the serum creatinine rises by only 80–160 µmol litre−1
(1–2 mg dl−1) per day. Oliguria is defined as the production of
100–400 ml urine per day. Anuria is defined as the production
of < 100 ml per day, whilst absolute anuria is no urine output.
Absolute anuria reflects urinary tract obstruction until proven
otherwise. It is generally believed that a urine output of
< 0·5 ml kg−1 per hour for greater than two hours is an important
marker of renal hypoperfusion and should trigger remedial
action. However, 50–60% of acute renal failure is non-oliguric.
Hypotension, dehydration, and sepsis are the commonest
causes of acute tubular necrosis. Prerenal causes of acute renal
failure are the most common in both hospital and the
community (Box 8.1). Overall mortality from unselected cases
of acute renal failure has remained at around 50% (70% on
ICU). Mortality increases with serum creatinine: 5–20% < 165
µmol litre−1 (2 mg dl−1) and 64% over 250 µmol litre−1 (3 mg
dl−1). Mortality has not changed significantly in over 20 years,
making prevention of acute renal failure a high priority. Even
with the advent of renal replacement therapy, the change in
case mix, increasing age of patients, and severity of underlying
conditions may help to explain the static mortality rate.
Overall it is estimated that 5% hospital admissions and 30%
intensive care admissions have acute renal failure and 2–5%
hospitalised patients develop it; 30% patients with acute renal
failure will need renal replacement therapy.
The kidney is especially vulnerable to injury resulting from
hypoperfusion and/or critical illness. A study by Hou et al. in
1993 looked at all patients admitted to medicine and surgery in
their hospital over a 6-month period (excluding those with
renal failure). Patients were screened during their stay for
worsening of renal function: 5% of these patients developed
renal insufficiency – 42% because of hypoperfusion (of these
hypotension 41%, major cardiac dysfunction 30%, and sepsis
19%). Major surgery accounted for 18%, contrast media 12%,
aminoglycoside administration 7%, and miscellaneous causes
21% (for example, obstruction). The severity of renal
insufficiency as judged by serum creatinine was the most
important indicator of a poor prognosis. The overall mortality
rate was 25% – but this rose to 64% in those patients with an
increase in creatinine of 265 µmol litre−1 (3·18 mg dl−1) or more.
Mortality is especially high in acute renal failure in those
patients who have had a myocardial infarction or stroke, have
oliguria, sepsis, are male, elderly, or are mechanically ventilated.
Patients at risk of acute renal failure can be identified, and
hypoperfusion and obstruction can be treated early, so it is
likely that a proportion of mortality from acute renal failure is
preventable. The reality is that much hypoperfusion is left
untreated for several hours and incorrect treatment leads to
further deterioration, causing irreversible renal failure.
It is imperative that early effective action is taken to prevent
permanent renal failure as soon as renal function becomes
compromised.
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Box 8.1 Causes of acute renal failure
• Acute tubular necrosis – 45%
• Prerenal causes – 21%
• New onset chronic renal failure – 13%
• Obstruction – 10%
• Glomerulonephritis 3%
• Acute tubulo-interstitial nephritis 2%
• Vasculitis 1·5%
• Other 3·5%
Renal blood flow
Renal blood flow is normally 1200 ml per minute, just over
20% cardiac output. It is affected by various factors (Box 8.2).
There is autoregulation of renal blood flow between a MAP of
70–170 in normal subjects (autoregulation in hypertensive
patients is shifted to the right, Figure 8.1). Resistance of the
renal vascular bed plays a large part in autoregulation – the
smooth muscle walls of the afferent and efferent arterioles in
the cortex constrict and dilate according to changes in pressure.
Renal artery perfusion depends on a critical perfusion pressure.
that is, renal blood flow is maintained, within the limits of
autoregulation, by changing the pressure gradient and
resistance of the vascular bed.
The kidney is one of the most highly perfused organs in the
body. In other organs, as blood flow falls, oxygen extraction
increases but, in the kidney, oxygen consumption falls in
parallel with blood flow. Initially the afferent (input) vessels
dilate and the efferent (output) vessels constrict, to try and
maintain an effective perfusion pressure to produce a
glomerular filtrate. Total renal oxygen consumption is low
except in the outer medulla where active sodium reabsorption
occurs. Frusemide blocks the active sodium–potassium–
chloride cotransport system in the thick ascending limb of the
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Box 8.2 Factors affecting renal blood flow
Renal vasoconstrictors
• Volume depletion
• Low mean arterial pressure
• Sympathetic stimulation
• Increased angiotensin ll levels
• Endothelin
Renal vasodilators
• Atrial natriuretic peptide
• Nitric oxide
• Prostaglandins*
* Increase cortical flow and reduce medullary flow.
Renal blood flow =
resistance of renal vascular bed
input pressure − output pressure
loop of Henle (Figure 8.2). This area is normally relatively
hypoxic because of high tubular reabsorptive activity. In rats,
frusemide abolishes the physiological outer medullary
hypoxia despite a fall in blood flow but this has failed to
translate into a benefit in clinical practice.
Estimating renal function
Neither urine output nor creatinine are good estimates of
renal function. Creatinine clearance is more helpful and can
be estimated by the equation:
Normal is around 100 ml per minute but this formula was
derived for use in the steady state and, if the creatinine is
rising, true clearance will be lower. In oedematous patients,
the GFR can be overestimated as total body weight is greater
than lean body mass. However, it is useful and can provide
guidance for drug adjustments. Particularly in the elderly, with
less muscle mass, “normal” creatinines can be deceptive. If an
80-year-old man of 60 kg has a creatinine of 100 µmol litre−1
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Figure 8.1 Renal blood flow. The renal blood flow autoregulation curve
is shifted to the right in chronic hypertension
Clearance = (× 1·2 for men)
creatinine in µmol litre−1
(140 − age) × weight in kg
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Figure 8.2 The nephron (the functional unit of the kidney). A, afferent
arteriole where ACE inhibitors act (angiotensin ll plays a role in
autoregulation of renal blood flow by constricting the afferent blood
vessels when there are low pressures); CD, collecting duct; DCT, distal
convoluted tubule; E, efferent arteriole where NSAIDs act
(prostaglandins play a role in regulation of renal blood flow and increase
cortical flow; in a person on ACE inhibitors and NSAIDs who is admitted
with vomiting and diarrhoea – or hypovolaemia of any cause – both
these drugs should be temporarily stopped; the combination of
hypovolaemia, lack of constriction in the afferent vessels, and lack of
vasodilatation in the efferent vessels reduces GFR; in cirrhosis and
congestive cardiac failure where prostaglandins are recruited to
increase renal blood flow, NSAIDs are more potent); F, thick ascending
limb of the loop of Henle where frusemide blocks active sodium–
potassium–chloride cotransport (despite documented protective effects
in experiments, frusemide has failed to prevent postoperative renal
failure in high risk patients or ameliorate established acute renal failure
in clinical practice); LH, thick and thin descending and ascending Loop
of Henle; PCT, proximal convoluted tubule.
(1·2 mg dl−1), although this is within the “normal” range, his
actual creatinine clearance is 43 ml per minute.
Pathophysiology of acute renal failure
The pathophysiology behind acute renal failure (ARF) is
complex and only partly understood. Many data come from
animal models where acute tubular necrosis is induced by
transiently clamping a renal artery. Real patients are more
complex, where renal failure is often part of a developing
multisystem illness. The outer medulla is relatively hypoxic
and prone to injury. When there is an ischaemic or septic
insult, inflammatory mediators damage the endothelium. It is
not as simple as damaged tubular cells sloughing and blocking
the collecting ducts; there is a complex response Involving
programmed cell death (apoptosis) and damage to the actin
cytoskeleton, which facilitates cell-to-cell adhesion and forms
the barrier between blood and filtrate. Genetic factors also play
a role. “Knockout” mice without the gene for a cell adhesion
molecule ICAM−1 (which helps leukocytes bind to the
endothelium) do not develop ARF after an ischaemic insult.
Ischaemic or nephrotoxic acute tubular necrosis (ATN)
accounts for 80–90% perioperative renal failure. A prospective
multicentre study in Madrid in 1998 showed that out of 253
cases of acute renal failure in ICU, 76% were due to ATN, 18%
due to a prerenal cause, and only two cases due to obstruction.
In the critically ill, glomerulonephritis as a cause of acute renal
failure is uncommon.
In animal models, interruption of blood flow for less than
25 minutes results in oliguria but no anatomical changes and
renal function returns to normal; 60–120 minutes of
interrupted blood flow causes tubular cell damage. These are
the metabolically active cells. Renal recovery can occur if
further insults are avoided. Interruption of blood blow for over
120 minutes causes renal infarction and irreversible acute
renal failure. High risk surgical procedures for the development
of acute renal failure are cardiac surgery, vascular surgery,
biliary and hepatic surgery (because bile salts bind endotoxins,
which cause renal vasoconstriction, and this action ceases in
cholestasis), urological surgery, and procedures associated with
intra-abdominal hypertension.
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Regardless of the cause of acute renal failure, the reduction
in renal blood flow represents a common pathological
pathway leading to reduced glomerular filtration. Causes of
acute renal failure are traditionally divided into three groups
(Box 8.3).
During the period of reduced renal blood flow, the kidneys
are particularly vulnerable to further insults. At risk patients are
those with diabetes, vascular disease, known renal impairment,
with a recent major upset such as myocardial infarction, major
surgery or GI bleed, and on nephrotoxic medication (in particular
the combination of angiotensin converting enzyme [ACE]
inhibitors and non-steroidal anti-inflammatory drugs [NSAIDs])
and also drugs such as aminoglycosides, allopurinol, and
digoxin. Up to 25% hospital patients receiving therapeutic
aminoglycosides sustain some degree of renal impairment.
Recovery from acute renal failure does not just depend only
on restoration of renal blood flow, although early restoration
leads to improved outcome. In intrinsic renal failure, once
renal blood flow is restored, the remaining functional
nephrons increase their filtration and hypertrophy. Recovery
is dependent on the number of remaining functional
nephrons. If this is below a critical value, continued
hyperfiltration results in progressive glomerular sclerosis,
which eventually leads to nephron loss. Continued nephron
loss causes more hyperfiltration until renal failure results. This
has been termed the hyperfiltration theory of renal failure,
and it explains why progressive renal failure is sometimes
observed after apparent recovery from acute renal failure.
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Box 8.3 Causes of acute renal failure
Prerenal causes 
• Reduced cardiac output (dysfunction or hypovolaema)
• Redistribution of blood flow (sepsis, liver failure)
Renal causes
• Acute tubular necrosis (ATN) – from any prolonged prerenal cause
• ATN from toxins (drugs, contrast media)
• Vasculitis, myeloma, emboli, glomerulonephritis
Post-renal causes
• Obstruction (stones, prostate, tumours, ureteric damage during
surgery)
There are various urine tests that can help point towards
renal or prerenal causes (Table 8.1). This is based on the fact
that in prerenal failure the kidney avidly reabsorbs salt and
water, but in renal failure where tubular function is disrupted,
the kidney loses sodium in the urine. In practice these are not
much help in patients already in hospital where there is often
a clear precipitating cause. Diuretics also increase the urinary
excretion of sodium and this makes urinary sodium values
difficult to interpret.
Treatment of acute renal failure
Early action saves kidneys. The principles of treatment are as
follows:
• Treat any life-threatening hyperkalaemia first.
• Correct hypovolaemia and establish an effective circulating
volume.
• Treat hypoperfusion.
• Exclude obstruction as soon as possible.
• Treat the underlying cause.
In acute renal failure, early restoration of volume may be all
that is required. Sometimes, volume replacement fails to
restore blood pressure (for example, in severe sepsis or acute
cardiac failure) in which case vasoactive drugs are required to
improve renal perfusion. Bicarbonate should not be given to
treat a metabolic acidosis that is due to hypoperfusion. After
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Table 8.1 Measurements which may point towards the cause of
acute renal failure
Parameters Prerenal Renal
Urine osmolality (mmol litre–1) > 500 < 350
Fractional excretion of Na (%)* < 1 > 4
Urine Na (mmol litre–1) < 20 > 40
Urine:plasma creatinine ratio > 40 < 10
*Urine Na/serum Na
× 100
Urine creatinine/serum creatinine
volume restoration, fluid may be restricted to measurable plus
insensible losses to avoid volume overload in oliguric patients.
Frusemide is often used at his point. If the patient fails to
respond to restoration of volume and perfusion, renal
replacement therapy (RRT) is the next step. Patients require
RRT for an average of 13 days and around 36% patients with
acute renal failure require this. Only 3% require RRT long
term. Liaison with a renal specialist is important.
Non-obstructive urinary tract infection is an important
cause of acute renal failure, sometimes overlooked, and should
be aggressively treated (Figure 8.3).
Many treatments improve urine output but have no effect
on outcome in established ARF:
• high dose loop diuretics (bolus or infusion)
• mannitol
• dopamine.
Frusemide is said to cause a reduction in renal oxygen
demand and mannitol is thought to scavenge free radicals –
theoretical benefits that are not borne out in clinical practice.
However, loop diuretics can help convert oliguric renal failure
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UTI plus obstructive
uropathy
Septicaemia Antibacterial drug
therapy
Bacterial tubulo-interstitial
nephritis (pyelonephritis)
Figure 8.3 Acute renal failure caused by urinary tract infection (UTI).
There is evidence to suggest a direct effect on the kidney by
endotoxins. Dehydration owing to vomiting and NSAID use also
contribute. Pre-existing renal impairment or diabetes increases risk.
Reprinted with permission of Oxford University Press (Advanced Renal
Medicine, by AEG Raine, 1992)
to non-oliguric renal failure and thus avoid problems with
volume overload.
There are many potential treatments that have been tried in
the prevention of ARF and have been found to be ineffective:
• frusemide
• mannitol
• dopamine and dopexamine
• other experimental treatments (for example, theophylline
and acetylcysteine).
Mini-tutorial: low dose dopamine in acute renal failure
Using low dose dopamine at 0·2–2·5 micrograms kg−1 per minute
(“renal dose”) for both the prevention and treatment of acute renal
failure is common. Yet randomised trials have shown it is of no
benefit either as prevention in high risk postoperative patients or as
treatment in established acute renal failure. The effects of a
dopamine infusion are complicated because it acts on a number of
different receptors that have opposing actions. The action of
dopamine is not constant throughout its dose range (see a fuller
description in Chapter 6). Stimulation of α receptors causes systemic
vasoconstriction and the blood pressure rises; β1 receptors increase
contractility of the heart, β2 receptors reduce afterload, and
dopamine (DA) receptors cause renal and splanchnic vasodilatation.
Dopamine acts on all these receptors. In addition, there are two
major subgroups of DA receptor: DA1 receptors are in the renal and
mesenteric circulation; DA2 receptors are in the autonomic ganglia
and sympathetic nerve endings and inhibit noradrenaline release.
Dopamine and its synthetic sister dopexamine have been used
extensively to theoretically improve renal blood flow and therefore
function. Dopexamine is also used to improve splanchnic blood flow
in certain postoperative situations.
Dopamine causes a diuresis and natriuresis independent of any
effect on renal blood flow by inhibiting proximal tubule Na–K–ATPase
(via DA1 and DA2 stimulation). So the effect we see with low dose
dopamine is a diuresis – not a change in creatinine clearance. In one
randomised prospective double-blind trial, 23 patients at risk for
renal dysfunction were given either dopamine at 200 micrograms per
minute, dobutamine at 175 micrograms per minute, or 5% dextrose.
Dopamine increased urine output without a change in creatinine
clearance and dobutamine caused a significant increase in creatinine
clearance by increasing cardiac output without an increase in urine
output. This illustrates the difficulty of using urine output as a
surrogate marker for renal function.
Critically ill patients have reduced dopamine clearance and may
consequently have higher plasma levels than anticipated, so it is not
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correct to assume that low dose dopamine is acting only on the renal
circulation. In one study, there was a 27-fold variability in the range
of plasma dopamine levels. In some individuals, infusion of “renal
dose” dopamine results in plasma levels in the α-receptor range.
This leads to side effects such as tachyarrhythmias and increased
afterload. In summary, there is no evidence to justify the use of
dopamine to prevent or treat acute renal failure.
Renal replacement therapy – haemodialysis
and haemofiltration
Indications for RRT in acute renal failure are as follows:
• hyperkalaemia especially if ECG changes
• volume overload
• worsening severe metabolic acidosis
• uraemic complications, for example encephalopathy,
pericarditis, and seizures.
Haemodialysis removes solutes from blood by their passage
across a semipermeable membrane. Heparinised blood flows
in one direction and dialysis fluid flows in another at a faster
rate. Dialysis fluid contains physiological levels of electrolytes
except potassium, which is low, and molecules cross the
membrane by simple diffusion along a concentration
gradient. Smaller molecules move faster than larger ones. Urea
and creatinine concentrations are zero in the dialysis fluid
because they are to be removed as much as possible. A 3–4-hour
treatment can reduce urea by 70%. Water can be removed
by applying a pressure gradient across the membrane if
needed.
Haemofiltration involves blood under pressure moving
down one side of a semipermeable membrane. This has a
similar effect to glomerular filtration, and small and large
molecules are cleared at the same rates. Instead of selective
reabsorption, which occurs in the kidney, the whole filtrate is
discarded and the patient is infused with a replacement
physiological solution instead (Box 8.4). Less fluid may be
replaced than is removed in cases of fluid overload. In original
haemofiltration, the femoral artery and vein were cannulated
(continuous arteriovenous haemofiltration or CAVH). Blood
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passed through the filter under arterial pressure alone – but
circuit disconnection could lead to rapid blood loss and
patients with low blood pressures often had slow moving
circuits with the associated risk of blood clotting. In more
common use today is continuous venovenous haemofiltration
or CVVH. A large vein is cannulated using a double lumen
catheter and a pump controls blood flow. The extracorporeal
circuit is anticoagulated in both CAVH and CVVH. Automated
systems have a replacement fluid pump that can either
balance input and output or allow a programmed rate of
fluid loss.
Haemofiltration removes virtually all ions from plasma
including calcium and bicarbonate. Replacing these is
difficult, since solutions containing enough of these two ions
can precipitate. Lactate is commonly used instead of
bicarbonate but, although in normal people lactate is
converted to bicarbonate, this is not true of patients with
lactic acidosis. In these situations bicarbonate infusions must
be given separately. Haemofiltration has advantages over
haemodialysis in the critical care setting because such patients
cannot be fluid restricted and often have a compromised
circulation. CVVH avoids the hypotension often seen in
dialysis, is continuous so it can remove large volumes of water
in patients receiving parenteral nutrition and other infusions,
offers better clearance of urea and solutes, may better preserve
cerebral perfusion pressure, and also has a role in clearing
inflammatory mediators.
The differences between haemodialysis and haemofiltration
are shown in Figure 8.4.
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Box 8.4 Typical composition of haemofiltration replacement
fluid (mmol litre−1)
• Sodium – 140
• Potassium – Variable and added just before use 
• Calcium – 1·6
• Magnesium – 0·75
• Chloride – 101
• Lactate – 45
• Glucose – 11
Rhabdomyloysis
Certain situations warrant the use of diuretics early in acute
renal failure after restoration of intravascular volume. These
are rhabdomyolysis and poisoning (for example, lithium,
theophylline and salicylates). Rhabdomyolysis is an important
cause of acute renal failure. It occurs when there is massive
breakdown of muscle. Myoglobin is released into the circulation
along with other toxins, which leads to kidney dysfunction and
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Figure 8.4 The difference between haemodialysis and haemofiltration.
creat, creatinine; K, potassium; Na, sodium; phos, phosphorus
general metabolic upset. Unlike many other causes of acute
renal failure, prognosis is good in rhabdomyolysis and the
kidneys usually recover. This makes it an important condition
not to miss. Causes include:
• crush injury/reperfusion after compartment syndrome
• prolonged immobility following a fall or overdose
especially with hypothermia
• drug overdose, for example Ecstasy and carbon monoxide
poisoning
• extreme exertion
• myositis (caused by illnesses like influenza, severe
hypokalaemia or drugs like statins)
• malignant hyperthermia (triggered by some anaesthetic
agents)
• neuroleptic malignant syndrome
• heat-stroke.
Myoglobin and urate from muscle breakdown are said to
obstruct the tubules. Yet tubular obstruction is probably not
what causes acute renal failure in rhabdomyolysis, because
studies show that intratubular pressures are normal. More
likely is free radical mediated injury. Renal vasoconstriction
also occurs, partly because of the underlying cause and partly
because myoglobin itself causes vasoconstriction.
Fluid resuscitation remains the most important aspect
of management in rhabdomyolysis. Early and aggressive
intravenous fluid has dramatic benefits on outcome when
compared with historical controls. Guidelines go as far as
12 litres of fluid a day to “flush” the kidneys and achieve a
urine output of 200–300 ml h−1. Alkalinisation of the urine
significantly improves renal function, probably by inhibiting
free radical mediated damage. The urine is dipsticked every
hour and sodium bicarbonate is given intravenously to raise
the urine pH to 7·0. Mannitol is the first-line diuretic in
rhabdomyolysis, but it has not been shown to be better
than volume diuresis alone. Frusemide acidifies the urine
but is sometimes administered after a trial of mannitol.
Plasmapheresis is not an established therapy in rhabdomyolysis,
although myoglobin can be removed from the circulation
this way.
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Self-assessment – case histories
1. A 30-year-old man was admitted after being found lying on the
floor of his apartment. He had taken intravenous heroin the night
before. His admission blood results showed a normal full
blood count, sodium 130 mmol litre−1, potassium 6 mmol litre−1,
urea 64 mmol litre−1 (blood urea nitrogen [BUN] 177 mg dl−1)
and creatinine 500 µmol litre−1 (6 mg dl−1). His vital signs were:
drowsiness, blood pressure 90/60 mmHg, pulse 100 per
minute, respiratory rate 8 per minute and oxygen saturations
95% on air. What is your management?
2. A 60-year-old man was admitted with a general deterioration in
health. He is treated for heart failure and is taking the following
medication: ramipril 10 mg, frusemide 80 mg, and allopurinol
300 mg at night. He had been treated for a chest infection and
pleurisy the week before admission with antibiotics (amoxycillin)
and a NSAID. On examination he was drowsy and appeared
dehydrated. His blood pressure was 70/40 mmHg, pulse 90 per
minute, and regular, respiratory rate 25 per minute. His blood
results showed: sodium 133 mmol litre−1, potassium 5·0 mmol
litre−1, urea 50 mmol litre−1 (BUN 138 mg dl−1), creatinine 600
µmol litre−1 (7·2 mg dl−1). His last blood tests in hospital were a
year ago, which showed a urea of 7 mmol litre−1 (BUN 19·4 mg
dl−1), and creatinine 100 µmol litre−1 (1·2 mg dl−1). Discuss your
management.
3. A 34-year-old lady was admitted with breathlessness, which had
started one week ago. The chest x ray film showed bilateral patchy
shadowing and she reported coughing up blood the day before
admission. Her blood results showed a normal full blood count,
sodium 135 mmol litre−1, potassium 4·2 mmol litre−1, urea
40 mmol litre−1 (BUN 111 mg dl−1), and creatinine 450 µmol litre−1
(5·4 mg dl−1). Her vital signs were: alert, blood pressure 180/85
mmHg, pulse 80 per minute, respiratory rate 20 per minute, and
oxygen saturations 95% on air. What is your management?
4. You are asked to see a 55-year-old man on the ward. He is being
treated for ascending cholangitis and had a failed endoscopic
retrograde cholangiopancreatogram (ERCP) that day for treatment
of a stone in the common bile duct. His vital signs are: alert,
blood pressure 80/60 mmHg, pulse 80 per minute, respiratory
rate 30 per minute, temperature 38°C, and oxygen saturations
96% on air. He has warm hands and feet. His medication chart
shows a β blocker, calcium channel blocker, and a nitrate for
angina. He has been given gentamicin intravenously for his
infection. He also has a left nephrectomy scar from 15 years ago.
The nurse alerts you to his urine output, which has been 10 ml h−1
for the last 2 hours. What is your management?
5. A 60-year-old lady is admitted with diarrhoea and vomiting, which
she has had for 4 days. She has been taking a NSAID for aches
and pains during the course of this illness. Her usual medication
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includes bendrofluazide for hypertension. On admission her vital
signs are: alert, blood pressure 90/60 mmHg, pulse 100 per
minute, respiratory rate 28 per minute, and oxygen saturations
98% on air. She reports that she is passing less urine. Her blood
results show: sodium 145 mmol litre−1, potassium 4·0 mmol litre−1,
urea 25 mmol litre−1 (BUN 69 mg dl−1) and creatinine 300 µmol
litre−1 (3·6 mg dl−1). From her records, her urea and creatinine
were normal one month ago. Discuss your management.
6. An 80-year-old lady is admitted after a fractured neck of femur.
She receives non-steroidal anti-inflammatory analgesia in the
perioperative period. On admission her urea is 6 mmol litre−1
(BUN 16·6 mg dl−1), and creatinine 55 µmol litre−1 (0·66 mg dl−1).
Two days postoperatively her blood results are as follows:
sodium 130 mmol litre−1, potassium 3·8 mmol litre−1, urea 20
mmol litre−1 (BUN 55·5 mg dl−1), and creatinine 250 µmol litre−1
(3 mg dl−1). Her vital signs are: alert, blood pressure 180/80
mmHg, pulse 75 per minute, respiratory rate 14 per minute, and
oxygen saturations 95% on air. Can you explain the cause of her
acute renal failure and discuss your management?
7. A 50-year-old man with mild diabetic nephropathy is admitted to the
coronary care with a myocardial infarction. He suffers a ventricular
fibrillation arrest and has no pulse for 5 minutes. He has a 2-hour
episode of hypotension following this, which is treated with fluid
and vasoactive drugs. Although his cardiac condition recovers, his
renal function worsens. On admission his urea was 12 mmol litre−1
(33·3 mg dl−1), and creatinine 150 µmol litre−1 (1·8 mg dl−1). Now
his urea is 22 mmol litre−1 (61 mg dl−1) and creatinine 300 µmol
litre−1 (3·6 mg dl−1). What are the reasons for his deteriorating renal
function and what is your management?
8. A 55-year-old lady undergoes an elective abdominal aortic
aneurysm repair. The aneurysm was located above the renal
arteries and the aorta was cross-clamped for 10 minutes. She
returns to the ICU from theatre still intubated. Her vital signs are:
pulse 100 per minute, blood pressure 120/60 mmHg, CVP
8 mmHg, temperature 34°C. Her arterial blood gases on 40%
oxygen show: pH 7·2, PaCO2 4·0 (30·7 mmHg), bicarbonate 11·5
mmol/l, BE − 12 PaO2 25·0 kPa (192 mmHg). Her urine output has
been 20 ml h−1 for the last 2 hours. Discuss your management.
Self-assessment – discussion
1. Any airway and breathing problems should be assessed and
treated first. It may be that this patient requires naloxone to
improve his conscious level and respiratory rate. Emergency
treatment of hyperkalaemia is always indicated above 6·5 mmol
litre−1 or if there are changes on the 12-lead ECG. The blood
pressure of 90/60 and tachycardia could indicate volume
depletion so fluid should be given to restore intravascular
volume. Treatment with vasoactive drugs may be needed if
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perfusion is inadequate despite volume replacement. The patient
should be catheterised to allow hourly measurements of urine.
An urgent renal tract ultrasound should be arranged. Finally, one
should look for a treatable underlying cause. In this case,
creatinine kinase should be measured as the combination of a
drug overdose and prolonged immobilisation is a classical cause
of rhabdomyolysis.
2. The combination of dehydration from a chest infection and
medication (ACE inhibitor and NSAIDs) has triggered acute renal
failure. Hypotension is causing hypoperfusion of the kidneys and
making the renal impairment worse. Oxygen should be given,
followed by fluid challenges to expand intravascular volume. In a
patient normally treated for heart failure, invasive monitoring may
be considered earlier than in people with normal cardiac function.
Once intravascular volume is adequately replaced, vasopressors
may be necessary to treat ongoing hypotension. He should be
catheterised and a renal tract ultrasound scan arranged.
Nephrotoxic medication should be stopped. If renal function fails
to improve with these measures, renal replacement therapy
should be considered. As with all cases of acute renal failure,
urine should be sent for microscopy and culture. More
specialised tests may be recommended by a renal specialist to
look for other possible causes.
3. Treatment starts with an assessment of airway and breathing
followed by circulation. Intravenous fluid should be given to correct
any volume depletion. There is unlikely to be hypoperfusion in this
case as the blood pressure is 180/85 mmHg, but other signs of
this should be assessed. She should be catheterised to allow
accurate measurement of urine output and an urgent renal tract
ultrasound arranged. The underlying cause should be
investigated. Dipstick testing, microscopy, and culture of the urine
should be requested. This gives clues in conditions such as
glomerulonephritis (microscopic haematuria and proteinuria) and
acute tubulo-interstitial nephritis (eosinophiluria), and diagnoses
urinary tract infection, which is an important cause of acute renal
failure, especially in the elderly. Although the combination of
breathlessness with bilateral patchy shadowing and acute renal
failure may be due to chest infection and dehydration/medication
as in case 2, one should consider a pulmonary-renal syndrome,
for example Goodpasture’s (anti-GBM disease). A renal specialist
should be contacted.
4. After assessing A and B, blood cultures may be taken at the
same time as gaining intravenous access. Assuming there is no
life-threatening hyperkalaemia, fluid challenges should be given
to treat volume depletion. Invasive monitoring may be needed if
there is any uncertainty as to when the patient is adequately
filled in the presence of persisting hypotension/hypoperfusion.
Any anti-hypertensive medication should be temporarily stopped
(apart from β blockers, which can be reduced). This patient is at
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high risk of acute renal failure because of oliguria, cholestasis
(which causes renal vasoconstriction), gentamicin therapy, and a
previous nephrectomy – early action is essential to prevent
irreversible damage to his remaining kidney. Persisting
hypoperfusion despite adequate volume replacement requires
vasoactive drug therapy in a high dependency area. He should be
catheterised and an urgent renal ultrasound arranged. The cause
of acute renal failure here is most likely to be acute tubular
necrosis from hypoperfusion and sepsis.
5. The history and examination in this case point to volume depletion,
which should be corrected with fluid challenges. If hypotension/
hypoperfusion persists despite this, invasive monitoring and
vasoactive drug therapy may be required. Note she is normally
hypertensive – her normal blood pressure should be ascertained
to guide therapy. She should be catheterised to allow accurate
measurements of urine output. The underlying cause in this case
is likely to be dehydration exacerbated by NSAID use. Frusemide is
often used to improve urine output after adequate filling and
perfusion has been achieved. Frusemide does not affect outcome
nor alter GFR but is useful when there is persisting oliguria and the
patient still requires intravenous medications. Renal replacement
therapy would be the next step if there is no improvement.
6. Surgery can be associated with episodes of hypoperfusion
(because of volume depletion and hypotension due to anaesthesia).
Perioperative NSAID use in addition, especially in the elderly, has
caused acute renal failure in this case. There is no life-threatening
hyperkalaemia. Volume depletion should be treated with
intravenous fluid, a urinary catheter should be inserted and a
renal tract ultrasound arranged. Urinary tract infection should be
excluded and nephrotoxic drugs stopped.
7. This man is at risk of developing acute renal failure because he
has pre-existing diabetic renal disease and has had a major
cardiovascular upset. A period of hypoperfusion has caused
acute renal failure. Management is the same as in the other cases:
treat any life-threatening hyperkalaemia, then hypovolaemia, then
any hypoperfusion, catheterise, exclude higher obstruction
with an ultrasound scan, and treat the underlying cause. If renal
function continues to deteriorate, renal replacement therapy
should be considered.
8. The cause of acute renal failure in this case is the transient
interruption of blood flow to the renal arteries. The patient is
hypoperfused as indicated by the history, low temperature, and
metabolic acidosis. She should be “warmed up and filled up”.
Dopexamine is often used in post-aneurysm repair patients
because a few small studies have suggested a beneficial effect
on creatinine clearance following major surgery – probably owing
to increased cardiac output and systemic vasodilatation. However,
the vast majority of clinical studies of dopamine and dopexamine
following major surgery have not demonstrated a benefit.
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9: Brain failure
By the end of this chapter you will be able to:
• manage the unconscious patient with confidence
• understand primary and secondary brain injury
• understand the principles of brain protection
• understand the neurological prognosis following cardiac arrest
• apply this to your clinical practice.
The unconscious patient
A reduced conscious level is common in acute illness and can
be associated with potentially life-threatening complications
requiring urgent intervention. Coma (or unconsciousness) is
when the Glasgow Coma Scale is 8 or less (Box 9.1).
Box 9.1 Glasgow Coma Scale
Score
Eye opening
• spontaneous – 4
• to speech – 3
• to pain – 2
• nil – 1
Best motor response
• obeys commands – 6
• localises pain – 5
• withdraws to pain – 4
• abnormal flexion to pain – 3
• extensor response to pain – 2
• nil – 1
Best verbal response
• orientated – 5
• confused conversation – 4
• inappropriate words – 3
• incomprehensible sounds – 2
• nil – 1
Any patient with a GCS of 8 or less will have reduced airway
reflexes and a high risk of aspiration. These patients, and those
in whom the GCS falls by more than 2 points, should be
referred to the ICU, if appropriate, as they will almost
certainly require intubation.
In non-trauma patients who have been unconscious for
6 hours:
• 40% will have taken some form of sedative
• and of the remaining 60%
• 40% have hypoxic brain injury (for example, following
cardiac arrest)
• 30% have a cerebrovascular cause (infarct or
haemorrhage)
• 25% have a metabolic coma.
Because hypoxic brain injury and stroke are by far the most
common causes of non-traumatic coma, it is not surprising
that 23% of these patients die within 1 hour, 64% within 1
week, 76% within 1 month, and 88% within 1 year.
Traumatic brain injury (TBI) is common and is the leading
killer and cause of disability in children and young adults.
Most research on brain injury and brain protection has been
done in TBI but the principles are the same for all brain injury,
whether caused by trauma or not.
There are many different causes of an unconscious patient and
there is sometimes no history. A systematic approach is therefore
required. Unconscious patients should always be considered an
emergency. A, B, C, D, E is the system used to assess them:
• A – ensure patent, safe airway and treat if needed
• B – ensure adequate breathing and treat if needed
• C – assess circulation and treat if needed
• D – assess disability. The simple AVPU scale can be used
at first, but the Glasgow Coma score should also be
recorded so that any later changes can be documented
precisely
• E – expose and examine the patient fully once A, B, and C
is stable. Certain clusters of signs may point to a particular
diagnosis
• While all this is going on, request a bedside glucose
measurement.
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Patients with focal neurological signs but no meningism are
likely to have a stroke or tumour. Patients with meningism are
likely to have meningitis or subarachnoid haemorrhage.
Patients with neither focal signs nor meningism are likely to
have hypoxic brain injury, intoxication, metabolic problems,
severe sepsis, hypothermia, or epilepsy (non-convulsive status
epilepticus is unusual, but one-fifth of patients with status
may not appear to be convulsing).
The diagnosis and deliberation must not delay the need to
actively treat A, B, C. In meningococcal meningitis securing
the airway, and administering oxygen and intravenous fluid
could save the patient’s life more quickly than antibiotics
(although in practice these are given together).
Indications for intubation in brain injury, if appropriate, are:
• coma (GCS 8 or less)
• loss of protective laryngeal reflexes from any cause
• ventilatory insufficiency (hypoxaemia or hypercapnia)
• spontaneous hyperventilation causing a low CO2
• respiratory arrhythmia
• in certain situations where patients may need intubation
prior to transfer (significantly deteriorating conscious level,
bilateral fractured mandible, bleeding into the airway, or
seizures).
Brain injury
Primary brain injury has limited treatment (it has already
happened), so efforts have concentrated on preventing
secondary brain injury. Secondary injury has a profound
influence on outcome. It occurs as a result of the complications
of primary brain injury – raised intracranial pressure, ischaemia,
oedema and infection. It is important to realise that these
complications are usually delayed and are therefore amenable
to intervention. In TBI, the main precipitants of secondary
injury are hypotension and hypoxaemia. Hypoxaemia, as
defined by oxygen saturations < 90%, and hypotension, as
defined by a systolic blood pressure of < 90 mmHg, are associated
with a statistically significant worse outcome and are common
at the scene of injury. Patients with severe TBI who are intubated
in the prehospital setting have a better outcome.
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Following brain injury, specific cells are rendered
dysfunctional although not mechanically destroyed. If the
subsequent environment is favourable, many of these cells
can recover. Hypoxia or ischaemia can facilitate irreversible
damage.
Cerebral blood flow
Cerebral blood flow (CBF) is around 15% cardiac output and
is affected by various factors (Figure 9.1).
• A high PaCO2 increases CBF by vasodilatation of blood
vessels. Conversely, a low PaCO2 causes vasoconstriction –
reducing the PaCO2 from 5 to 4 kPA (38·5–30·7 mmHg)
reduces CBF by almost 30%.
• Hypoxaemia < 7·5 kPA (51·5 mmHg) has the effect of
increasing CBF.
• Certain drugs affect CBF.
CBF is controlled by alterations in cerebral perfusion
pressure (CPP) and cerebral vascular resistance (R). CBF =
CPP/R. Cerebral perfusion pressure is the pressure gradient in
the brain or the difference between the incoming arteries and
the outgoing veins.
CPP = MAP − venous pressure
Venous pressure is equal to intracranial pressure (ICP), so
CPP is usually expressed as:
CPP = MAP − ICP
Like the kidneys, the brain autoregulates blood flow so that
it is constant between a MAP of 50 and 150 mmHg there is
autoregulation (see Figure 9.1). CBF is regulated by changes in
resistance of cerebral arteries. Unlike the rest of the body, the
larger arteries play a main role in this. Local chemicals,
endothelial mediators, and neurogenic factors are thought to
be responsible. However, blood vessels in injured areas of the
brain do not respond to normal regulation. Hypercapnia
causes vasodilatation in normal tissue but diverts blood away
from injured areas (the steal phenomenon). Hypocapnia may
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increase blood flow through damaged vessels leading to
oedema (inverse steal).
The brain is uniquely vulnerable to secondary insults and
less capable of maintaining an adequate blood flow and
metabolic balance. A decrease in CBF in an injured brain may
induce ischaemia; an increase in CBF may induce oedema.
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Figure 9.1 Cerebral blood flow (CBF), arterial blood gases and mean
arterial pressure (MAP). (a) Between 3·5 and 10·6 kPa CO2 there is an
almost linear increase in CBF. There is little change in CBF until below
7·5 kPa O2. (b) Autoregulation of cerebral perfusion occurs between a
MAP of 60 and 150. Beyond these limits, CBF is dramatically affected
Raised intracranial pressure
Normal supine intracranial pressure is 7–17 mmHg and is
frequently measured on neurointensive care units. Cerebral
perfusion pressure can then be calculated and manipulated. A
reasonable estimate of ICP can be made in patients with brain
injury who are not sedated:
• drowsy and confused with GCS 13–15: ICP 20 mmHg
• GCS < 8: ICP 30 mmHg
Clinical features of raised ICP are nausea and vomiting,
confusion and a reduced conscious level. Raised ICP can occur in
cerebral haemorrhage, infarction with surrounding oedema,
tumours, encephalitis, global ischaemia, or after TBI. As the skull
is a rigid box, its contents are incompressible so ICP depends on
the volume of intracranial contents (normally 5% blood, 5–10%
CSF, and 85% brain). The Monro–Kellie doctrine is named after
two Scottish anatomists (Figure 9.2). It states that, as the cranial
cavity is a closed box, any change in intracranial blood volume
is accompanied by an opposite change in CSF volume, if
intracranial pressure is to be maintained.
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Figure 9.2 The Monro–Kellie doctrine. The CT scan shows a large
extradural haematoma. Brainstem herniation eventually occurs
When ICP is raised the following occurs:
• CSF moves into the spinal canal and there is increased
reabsorption into the venous circulation;
• compensatory mechanisms are eventually overwhelmed,
so further small changes in volume lead to large changes in
pressure (Figure 9.3);
• as ICP rises further, CPP and CBF decrease;
• eventually brainstem herniation (coning) occurs.
The principles of brain protection
Preventing raised ICP and saving the penumbra (the area
around the primary injury with potential to recover) with its
compromised microcirculation is important. An uncontrolled
increase in ICP and brainstem herniation is the major cause of
death after TBI or primary brain haemorrhage. Because raised
ICP can be caused by an increase in the volume of blood, CSF,
or brain tissue, treatment is aimed at reducing the volume of
these three components and is summarised in Table 9.1.
The cerebral metabolic rate for oxygen is the volume of
oxygen utilised by the brain. It is around 50 ml per minute
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Figure 9.3 Effect of increasing intracranial volume on intracranial
pressure (ICP)
and is reduced in hypothermia by 5% for each degree celsius
drop. Hypothermia has been used in the past for cerebral
protection during complex cardiac and neurosurgery. Interest
in its potential as a treatment for brain injury has resurfaced.
Animal models demonstrate its benefits but actively cooling
normothermic humans with brain injury has not been shown
to improve outcome. However, the converse applies. Pyrexia is
associated with an adverse outcome in brain injury, including
stroke, and should be treated. Active rewarming of patients
who arrive with mild hypothermia in the early period after
head injury is discouraged.
Hypertonic saline has been studied extensively in traumatic
brain injury. The theory is that the hypertonic solution will
draw intracellular water into the intravascular space, reducing
cerebral oedema and expanding intravascular volume at the
same time. The results of clinical trials have been mixed. In
patients with other injuries, such as burns, there is an
increased incidence of renal failure and death with the use of
hypertonic saline, so its use is not recommended in the
routine resuscitation of trauma victims.
Treatment protocols for traumatic brain injury that use the
physiological principles outlined above improve outcome
(Box 9.2). This is also true of non-traumatic conditions such as
bacterial meningitis with raised intracranial pressure.
Therefore the priority in managing all patients with brain
injury, whether subarachnoid haemorrhage, TBI, meningitis
with raised ICP, or stroke, is to prevent secondary brain injury.
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Table 9.1 Methods to reduce intracranial pressure (ICP)
Blood CSF Brain tissue
Avoid high PaCO2 Surgical drainage Mannitol for 
generalised oedema
Nurse head up Steroids for 
150 if possible tumour-related
oedema
Avoid coughing Frusemide also 
and straining* sometimes used
Keep head in 
midline*
*To encourage venous drainage. CSF, cerebrospinal fluid.
Subarachnoid haemorrhage
Subarachnoid haemorrhage (SAH) is included here as an
example of brain injury because misdiagnosis is common. It
occurs in 6–12 per 100 000 per year and has a peak incidence
around the age of 50 years. Headache is common, but studies
have found that, if patients with the worst headache of their
lives and a normal neurological examination only were
considered, 12% had SAH. Neurological examination is often
normal and in these cases, a third of patients are misdiagnosed
in studies. These studies also show that misdiagnosis leads to
worse outcome – 65% misdiagnosed patients rebled and
rebleeding carries a 40–50% mortality.
SAH commonly presents with a thunderclap headache – a
distinct, sudden, severe headache. It need not be in any
location; neck pain or vomiting may predominate. The first
episode of severe headache cannot be classified as migraine or
tension headache (International Headache Society). The
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Box 9.2 Summary of basic management to prevent
secondary brain injury
A
• Secure airway
• Avoid and treat hypoxaemia
B
• Maintain normal PaCO2
C
• Avoid and treat hypotension (colloids give less interstitial volume
increases)
• Maintain MAP at around 90 mmHg
D
• Treat pyrexia 
• Ensure adequate sedation and analgesia in intubated patients
• Avoid placing patient head down
• Mannitol/steroids for oedema or surgery for evacuation of
haematomas
• CSF shunt if indicated
E
• Full examination once the above secured
sudden release of catecholamines can cause cardiac
arrhythmias. Non-contrast CT scans are sensitive, but the
pick-up rate decreases each day (92% on the same day, 76%
2 days later, and 58% 5 days later). MRI may be more sensitive
in detecting SAH more than 4 days later. A negative CT scan
does not exclude SAH. Lumbar puncture (LP) should then be
performed (spectrophotometry to look for xanthochromia is
most accurate. This is present within 4 hours, maximum at
1 week and persists for 3 weeks). The sample should be
protected from light in transit and spun down immediately.
SAH is suggested by ≥ 1000 red cells mm−3 but traumatic taps
are common (20%). The method of counting red cells in tube
1 and 3 to distinguish a pathological from a traumatic tap can
be unreliable. Since up to 6% people have incidental
aneurysms, this is highly relevant. CSF pressure measurements
should always be performed in diagnostic LPs.
Ultra-early rebleeding in SAH is not uncommon and this
should justify immediate CT scanning followed by LP and
transfer to the nearest neurosurgical centre. In one study, 17%
patients had ultra-early rebleeding (admitted within 24 hours
of bleed but rebled before surgery, which was scheduled for
the next day). Ultra-early rebleeding was more likely to occur
if it had happened once already, if systolic blood pressure
was > 200 mmHg, and if the GCS was lower.
Most patients with SAH will be transferred to a
neurosurgical centre for further treatment. Some of these
patients will require intubation with anaesthesia and invasive
monitoring prior to departure. Any fall in MAP during
anaesthesia could reduce CPP to a critical level with a
significant risk of adversely affecting outcome. Prognosis in
SAH for those that reach hospital is that one-third will be in a
coma, one-third will develop neurological deterioration, and
one-third will make a good recovery.
Sedatives as a cause of coma – tricyclic poisoning
The most common sedative with potential for serious
complications in the UK is tricyclic poisoning. This accounts for
up to half of all adult admissions with poisoning to ICUs. It is
the leading cause of death from drug overdose in patients who
arrive in the Emergency Department alive. The typical cluster of
signs includes coma within 1–2 hours of ingestion, respiratory
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depression, dilated pupils, divergent strabismus, myoclonic
jerks, and bilateral upgoing plantars. A neutrophilia is
commonly seen. Potentially lethal cardiovascular complications
occur (arrhythmias and hypotension). The 12-lead ECG on
admission can predict toxicity in that the majority of patients
at risk for arrhythmias or convulsions will have a QRS width
> 160 ms. Cardiotoxicity is due to slowing of the first phase
of depolarisation through the His–Purkinje system and
myocardium with a resulting prolongation of the QRS complex.
The development of arrhythmias is made worse by a rapid heart
rate, hypoxaemia from upper airway obstruction, acidosis,
hypotension, and the anticholinergic effects of tricyclics.
Although sinus tachycardia is more common (leading to
problems differentiating this from ventricular tachycardia
because of the wide QRS), bradyarrhythmias also occur owing to
impaired cardiac automaticity. These are treated with temporary
pacing, chronotropic drugs, or high dose intravenous glucagon.
ECG changes are mainly due to sodium channel blockade and
it is thought that sodium loading is one reason why sodium
bicarbonate acts as an “antidote” to tricyclic poisoning. In the
only human study reported, 91 patients with severe tricyclic
poisoning were given sodium bicarbonate. Hypotension was
corrected in 96% of patients, QRS prolongation in 80%, and
conscious level in 47%. Current recommendations are that
50–100 ml boluses of 8·4% sodium bicarbonate are given
when the QRS duration is > 120 ms, and there are malignant
arrhythmias or hypotension (after securing the airway, giving
oxygen, and administering fluid). Sodium bicarbonate is
given even if there is no metabolic acidosis until the arterial
pH is 7·4–7·5.
Imaging in coma
Recent advances in neuroimaging have increased our
diagnostic ability. Computed tomography (CT) and magnetic
resonance imaging (MRI) are the two techniques used in
acutely ill adults. CT is the investigation of choice in trauma,
subarachnoid haemorrhage, or stroke. It is readily available,
quick and virtually all patients can be scanned. MRI provides
images in several planes and provides superior grey/white
matter contrast with a high sensitivity for most pathological
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processes compared with CT. MRI would be the investigation
of choice in suspected posterior fossa lesions, epilepsy, and
inflammatory processes. MRI is also more sensitive for thin
extradural haematomas and diffuse axonal injury in trauma
but requires special consideration for anaesthetised patients
because of the interference from the electromagnetic field to
anaesthetic and monitoring equipment.
Brain imaging is usually undertaken as soon as A, B, C are
stable and a full evaluation has led to a differential diagnosis.
When imaging is undertaken, it should lead to a diagnosis or
have the potential to change management.
Brain injury following cardiac arrest
Cerebral ischaemia can be global (complete in cardiac arrest
or incomplete in hypotension) or focal (as in cerebrovascular
disease). In complete global ischaemia, waste products
accumulate and the integrity of cell membranes breaks down,
leaking potassium out of cells and allowing calcium into cells.
Neurotransmitters accumulate and the chance of brain
recovery is thought to be small after 4–5 minutes.
The widespread use of CPR often brings unrealistic
expectations of recovery following cardiac arrest. Prognosis
after cardiac arrest has been extensively investigated. A
summary is as follows:
• In a Dutch study, survival to discharge of 8% for witnessed
arrests at home and 18% outside the home was observed.
• In a German study, survival to discharge of 5·3–16·6% after
out-of-hospital resuscitation was observed.
• A review of 26 000 in-hospital arrests showed 15·2%
survival to discharge.
• Another study showed 8% survival to discharge after
in-hospital cardiac arrest.
• 20–50% survivors have neurological or neuropsychological
deficits.
These studies include all types of cardiorespiratory arrest,
ranging from ventricular fibrillation on a Coronary Care Unit
to cardiorespiratory arrest in multiple organ failure on the
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ICU. The British Medical Association and UK Royal College of
Nursing guidelines on “decisions related to cardiopulmonary
resuscitation” make the following points and discuss in detail
the principles surrounding communication, advance decision-
making, and legal issues (see Further Reading below):
• Cardiorespiratory function ceases as part of dying, thus
CPR can theoretically be attempted on every individual
prior to death. So it is essential to identify patients in
whom cardiorespiratory arrest is a terminal event in their
illness and in whom CPR would be inappropriate
• It should be made clear that a “Do not attempt CPR” refers
to CPR only. All other treatments will still be given unless
specified to the contrary.
• In the UK, it is good practice to discuss with patients their
wishes regarding CPR, if appropriate, but it is not
mandatory.
• In cases of incapacity, the role of the next of kin in England
and Wales is to communicate what the patient would
have wanted in the circumstances. They have no legal
jurisdiction and clinical decisions remain the responsibility
of the specialist in charge of the patient’s care.
• Good communication is the essential ingredient in
decision-making on CPR.
Mini-tutorial: decision-making after cardiac arrest
Clinicians know that CPR has a poor outcome in most cases;
communication around this point can be difficult. Therefore various
investigators have attempted to predict outcome based on
physiological observations post-arrest. One paper looked at
predictors of death and neurological outcome in 130 out-of-hospital
witnessed cardiac arrest survivors presenting to the Emergency
Department. The investigators used time to return of spontaneous
circulation, systolic blood pressure at the time of presentation, and
a simple neurological examination to score patients (Table 9.2):
• return of spontaneous circulation < 25 minutes (score 0) or > 25
minutes (score 1)
• systolic BP at time of presentation > 90 mmHg (score 0) or < 90
mmHg (score 1)
• initial neurological examination: alert and orientated/rousable/
moves extremities (score 0) or unresponsive with only simple
reflexes (score 1).
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The authors suggested that a simple scoring system could be used
to triage patients and select those who would benefit from early
aggressive measures such as urgent cardiac revascularisation. Note
that pupil reflexes were not included in neurological examination –
this is because the drugs used during CPR affect pupils, and
pupillary reflexes should never be used as a prognostic sign
immediately following cardiac arrest.
Although the above may be evidence to support decision-making,
this is an incredibly difficult area as there is plenty of anecdotal
evidence to show that some people survive to discharge against all
the odds.
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Table 9.2 Score after cardiac arrest and prognosis
Score Mortality (%) Neurological outcome (%)
0 19 85
1 45 58
2 63 29
3 94 0
Self-assessment – case histories
1. A 20-year-old man is admitted unresponsive with a suspected
heroin overdose. He received 400 micrograms intravenous
naloxone in the Emergency Department and was sent up to the
ward with a GCS of 15. You find him unresponsive, lying supine,
and snoring loudly. He has an oxygen mask on and the pulse
oximeter shows his oxygen saturations are 99%. His other vital
signs are: blood pressure 110/60 mmHg, pulse 70 per minute,
respiratory rate 5 per minute, temperature 37°C. How do you
assess and manage him?
2. A 40-year-old man is found collapsed in his room with a bottle of
tablets nearby. No history is available. On examination his airway
is clear, breathing is normal, blood pressure is 80/40 mmHg,
pulse is 130 per minute, sinus tachycardia with a broad QRS
complex. He is unresponsive, has globally reduced tone,
although he appears to have jerking movements every so often
and has bilateral upgoing plantars with dilated pupils. What is
your management?
3. A 25-year-old builder was hit on the head by machinery and is
brought in unresponsive to the Emergency Department. There is a
haematoma to the left side of his head. Airway is clear, breathing
is normal, and he is cardiovascularly stable (blood pressure
140/70 mmHg and pulse 90 per minute). His Glasgow Coma
Score is calculated as 7 out of 15. What is your management?
4. A 70-year-old man is brought in with a dense left hemiplegia. His
blood pressure is 220/100 and pulse is 75, sinus rhythm. A
colleague calls you to ask whether this blood pressure should be
treated acutely and whether the patient has “malignant
hypertension”. Discuss your management.
5. A 30-year-old lady describes a sudden severe headache followed
by vomiting. She has become drowsy on the way to hospital. You
assess her GCS as 12. Outline your management priorities.
6. A 19-year-old man arrives having been found unresponsive by his
girlfriend in the morning. He went to bed the evening before
complaining of ’flu-like symptoms and a headache. On
examination he has a GCS of 8, respiratory rate 30 per minute,
pulse 130 per minute, BP 70/40 mmHg, SaO2 98% on 10 litres
per minute oxygen. There is some neck stiffness and a faint
purpuric rash on his trunk. What is your management?
7. A 70-year-old lady is admitted having fallen off a step-ladder and
injured her head. She has been lying on the floor for 4 hours. Her
vital signs on admission are: GCS 4, respiratory rate 10 per
minute, pulse 30 per minute, BP 60/30 mmHg, and temperature
29°C. Her arterial blood gases show: pH 7·20, PaCO2 6·0 kPA (46
mmHg), PaO2 11·0 kPA (84·6 mmHg), bicarbonate 17·2 mmol/l,
BE − 12. What is your management? What are your thoughts on
the reasons for her abnormal vital signs?
8. A 23-year-old man arrives in the Emergency Department
unconscious. He was the passenger in a car involved in a high-
speed accident and was found by the paramedics, having been
ejected from the car. He has extensive contusions on his head
with a fixed and dilated right pupil. He groans and withdraws his
limbs from painful stimuli on the right, but does not move his left
side. He will not open his eyes. What is his GCS? What is his
prognosis? Outline your management plan.
9. A 62-year-old man is resuscitated from a cardiac arrest. He had
a pancreatoduodenectomy 3 days before for cancer. Twenty-four
hours after the arrest he has a heart rate of 100 per minute, BP
118/75 mmHg, and a good urine output. Neurological
examination reveals no pupillary light reflexes, no spontaneous
or roving eye movements and absent motor reflexes. Discuss the
neurological prognosis for this patient.
Self-assessment – discussion
1. In this case, the partially obstructed airway (snoring) should be
relieved. The respiratory rate in this patient is 5 per minute.
Oxygen saturation measurements do not assess ventilation.
Arterial blood gas analysis will reveal a respiratory acidosis.
Naloxone has a short half-life. This patient is unresponsive and
requires either a naloxone infusion or intubation because of the
risk of aspiration.
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2. This case describes the characteristic cluster of signs seen in
tricyclic poisoning and the label on the bottle of tablets found
nearby will confirm this. The management starts with A
(intubation), B, C (fluid), and D – including bedside glucose
measurement and arterial blood gases as first line tests. Sinus
tachycardia with a broad QRS complex and hypotension is
common in serious tricyclic poisoning and can be difficult to
distinguish from ventricular tachycardia. A 12-lead ECG may help
to distinguish the two; 50 ml boluses of 8·4% sodium
bicarbonate is given, even with a normal arterial pH, when the
QRS duration is greater than 120 ms, if there are malignant
arrhythmias or persistent hypotension (after securing the airway,
and giving a high concentration of oxygen and intravenous fluid).
CT scanning of the brain is not necessarily indicated when there
is a clear history and signs consistent with poisoning.
3. The builder with a head injury should be managed by a team
experienced in major trauma and ATLS (Advanced Trauma and
Life Support) – this will ensure that other injuries are not missed.
A (with cervical spine control), B, and C are still the immediate
management in this case. Tracheal intubation is indicated and
the anaesthetist will pay attention to preventing secondary brain
injury by the following means:
• Even though the patient is unconscious, he will be given a
general anaesthetic and paralysed before intubation to avoid
any rise in intracranial pressure (tracheal intubation is
extremely stimulating causing a rise in blood pressure and
tachycardia in people not fully sedated).
• PaCO2 will be kept within normal range and constantly
monitored; hypoxaemia will be avoided.
• MAP will be maintained at around 90 mmHg (blood pressure
not too high and not too low).
• The patient will be catheterised to avoid the stimulation of a
full bladder, which may lead to a rise in ICP as well as
increasing anaesthetic requirements.
• He will need an urgent CT scan of the head and neck, which
may indicate the need for urgent neurosurgical intervention.
4. Hypertension following stroke is a common response to brain
ischaemia. Blood pressure should not be lowered as blood
supply to the potentially viable ischaemic penumbra could be
compromised. Many stroke patients are normally hypertensive
so a “normal” blood pressure may in fact be too low. The use of
sublingual nifedipine gives an unpredictable response and may
end up extending the stroke. If the stroke is caused by
haemorrhage (in 15% cases), some neurologists would consider
lowering an excessively high blood pressure in a controlled way,
but not to “normal” levels – seek expert advice. In this patient,
attention must be paid to the following: airway, oxygen
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saturations, hydration, treatment of fever, lowering of high
glucose levels, and good nursing care. “Malignant” hypertension
is rare and the term “hypertensive crisis” is better. It occurs
either on a background of hypertensive disease or as part of
other conditions – eclampsia, phaeochromocytoma, and
postoperatively (cardiac surgery). There is progressive severe
hypertension with encephalopathy (confusion, headache, visual
disturbances, fitting, reduced conscious level) and other end-
organ damage: renal impairment and heart failure. If this occurs
on a background of hypertensive disease, oral therapy is
preferred as sudden dramatic falls in blood pressure may cause
organ damage through hypoperfusion.
5. The history is consistent with subarachnoid haemorrhage.
Management priorities here are to ensure a patent, protected
airway and to administer oxygen. Assess and treat any breathing
or circulation problems. This patient is drowsy. A formal GCS and
neurological examination should be performed. This will provide
an objective assessment of subarachnoid haemorrhage
according to the World Federation of Neurological Surgeons scale
(Table 9.3). A bedside glucose measurement is required. If A, B,
C, and D are stable, there is time for a full history and
examination. Arterial blood gas analysis would be helpful in
assessing oxygenation, ventilation, and perfusion, all important
in the prevention of secondary brain injury. The patient should be
transferred for an urgent CT scan and neurosurgical opinion as
soon as possible.
6. The most important diagnosis is meningococcal sepsis.
However, immediate management priorities are A, B, C. The low
GCS score indicates the need for urgent intubation. The patient
requires fluid loading whilst preparations for intubation are made.
A bedside glucose measurement and arterial blood gas is
required. A full history and formal examination can be done once
A, B, and C are stable. Blood cultures should be taken and
intravenous antibiotics given whilst arrangements are made for
an urgent CT of the head. Lumbar puncture is not necessary in
cases of obvious meningococcal meningitis. Clotting
abnormalities are a contraindication to LP. The bacteria can be
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Table 9.3 World Federation of Neurological Surgeons SAH grading
WFNS grade GCS Major focal neurological deficit
1 15 Absent
2 13–14 Absent
3 13–14 Present
4 7–12 Present or absent
5 3–6 Present or absent
isolated from blood cultures and swabs of the throat and skin
lesions. This patient requires further management on the ICU.
7. This lady has a head injury and an unstable cervical spine until
proven otherwise. Intubation is indicated, with careful
immobilisation of the C-spine. Intravenous atropine and warmed
fluids are required to treat the circulation abnormalities. The
arterial blood gases show a metabolic acidosis from
hypoperfusion. Persistent hypotension may require invasive
monitoring and vasoactive drugs. Active rewarming is indicated in
severe hypothermia. A bedside glucose measurement and arterial
blood gas are required. Differential diagnosis is straightforward
hypothermia from lying on the floor or spinal shock. Spinal shock
results from spinal cord concussion and gives rise to 24–72 hours
of initial paralysis, hypotonicity, and areflexia. Return of activity
below the level of the injury, such as the bulbocavernous reflex
(anal sphincter contraction in response to tugging on the urinary
catheter), signifies the end of spinal shock. Prolonged absence of
distal motor function or perirectal sensation indicates complete
spinal cord injury. Resuscitation in spinal shock includes raising
the legs to reduce peripheral blood pooling, intravenous atropine to
block vagal effects, vasopressors to support blood pressure, and
high dose intravenous methylprednisolone, which improves
outcome by minimising spinal oedema and by its anti-inflammatory
actions. Once A, B, and C are stable, urgent CT imaging of the head
and neck should be arranged with referral to the neurosurgical
team if required.
8. The patient’s GCS is 7 (E1, M4, V2). He has signs consistent with
an extradural haematoma. These arise from tears in the dural
arteries, usually the middle meningeal artery, and are often
associated with linear skull fractures over the parietal or temporal
areas. Extradural haematomas account for 1% of severe head
injuries. The prognosis is generally good as the primary brain
injury is usually not serious. However, secondary brain injury
occurs rapidly owing to raised intracranial pressure, and is fatal if
the clot is not evacuated. Immediate measures to reduce ICP may
be required whilst surgery is being prepared. Extradural
haematomata classically present as a loss of consciousness
immediately after injury, followed by a lucid interval, and then a
gradually decreasing conscious level associated with the
development of an ipsilateral fixed dilated pupil and contralateral
hemiparesis. However, presentation may be atypical or with coma,
as in this case. Management in the Emergency Department is
directed at stabilising life-threatening problems with A, B, or C,
initiating measures to reduce intracranial pressure and
transferring the patient safely to theatre. The only procedure to
delay craniotomy would be life-threatening haemorrhage. It may be
possible to perform a laparotomy and craniotomy simultaneously.
9. The patient has suffered global cerebral ischaemia following
cardiac arrest. The best neurological recovery is seen in patients
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who have a short duration of coma. Patients who remain in a
coma 7–14 days after global ischaemia are unlikely to ever
become independent. Individual signs suggesting neurological
recovery are related to certain brainstem reflexes at the time of
the initial examination. Absent light reflexes during the initial
examination (allowing for the effects of cardiac arrest drugs to
have worn off) place the patient in a very poor prognostic
category. The presence of pupillary light reflexes with the return
of spontaneous eye opening and conjugate eye movements,
accompanied by motor responses, improves the prognosis and
chance of independence. Based on this patient’s examination at
24 hours, independent function is very unlikely.
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10: Optimising physiology
before surgery
By the end of this chapter you will be able to:
• understand the nature of the medical consultation
• assess perioperative risk in patients with cardiac and respiratory
disease
• understand the principles behind ‘preoptimisation’
• prepare a patient for emergency surgery
• apply this to your clinical practice
The medical consultation
The physician is part of a team (including the surgeon,
anaesthetist, nurse, and physiotherapist) whose role is to plan
perioperative care. This involves postoperative care as well as
preoperative care. The physician’s role is particularly in assessing
the level of risk and recommending measures to reduce that risk,
in consultation with the patient and colleagues. It is not his or
her role to clear the patient for surgery, which implies no risk at
all. Most requests are specifically to help the anaesthetist in the
assessment of perioperative risk with particular attention being
paid to cardiac and respiratory disease.
Physiological reserve is an important concept in patients
facing major or emergency surgery and in critical illness
generally. The cardiovascular system in particular has to
mount a compensatory response to the physiological stress.
Patients who lack the ability to do this because of impaired
organ function have increased mortality as demonstrated by
the American Society of Anaesthesiologists’ classification of
disease severity (Box 10.1).
Key components of the medical consultation are to:
• Find out the severity and stability of the disease in question.
• Specifically recommend measures to treat the disease,
optimise the patient’s function and reduce perioperative risk.
• Plan postoperative care with colleagues.
The assessment of patients with cardiac disease
The largest single cause of perioperative death is cardiac
related. Cardiovascular disease affects 25% of the US
population. Much work has been done to try to assess
cardiovascular risk before surgery as perioperative myocardial
infarction carries a 30–50% mortality. There are five main
types of cardiac disease that present before surgery:
• ischaemic heart disease
• heart failure
• valvular disease 
• cardiac arrhythmias especially atrial fibrillation
• hypertension.
The greater the cardiovascular stress during surgery, the
greater the risk of cardiac complications (Table 10.1).
Ischaemic heart disease
Major clinical predictors of perioperative cardiac
complications are patients with recent (within 6 months)
myocardial infarction, severe or unstable angina, and
significant arrhythmias. However, many patients have
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Box 10.1 ASA classification of disease severity (mortality
increases with class)
ASA 1 Healthy patient
ASA 2 Mild systemic disease that does not limit function
ASA 3 Moderate systemic disease that limits function
ASA 4 Severe systemic disease that is a constant threat to life
ASA 5 Moribund patient who will not survive 24 hours without
surgery
ASA 3E would indicate a patient who is ASA 3 undergoing emergency surgery.
The ASA (American Society of Anesthesiologists) system does not account for
age, smoking, or obesity, factors that also increase risk.
controlled ischaemic heart disease and, although there are a
number of tests available to assess this group, they are not
necessarily helpful. History, examination, and resting ECG can
readily categorise risk (Table 10.2).
Additional scoring systems have been developed (for
example, the Goldman cardiac risk index) that can help
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Table 10.1 Risk of major perioperative cardiac event according to
type of surgery
Low risk (< 1%) Intermediate risk (1–5%) High risk (> 5%)
Endoscopic Carotid endarterectomy Emergency major surgery
procedures
Superficial Head & neck Aortic/major 
procedures vascular surgery
Cataract Intraperitoneal Peripheral vascular
Breast Intrathoracic Prolonged procedure 
with large fluid 
shifts/blood loss
Orthopaedic
Prostate
Table 10.2 Risk of major perioperative cardiac event according to
type of patient
Minor Intermediate Major
Advanced age Mild angina Unstable coronary syndromes
(class 1–2)
• recent MI (< one month)
• unstable/severe angina
Abnormal ECG Previous myocardial Decompensated heart
infarction (history failure
or ECG)
Rhythm other Compensated or Significant arrhythmias
than sinus previous heart
failure
Low functional Diabetes Severe valve disease
capacity
History of stroke 
Uncontrolled 
hypertension
quantify risk and these are based on observational studies.
Probably the most useful measure with regard to ischaemic
heart disease is the patient’s functional ability. Risk is
increased in patients who cannot reach 4 METS (metabolic
equivalents) workload; 1 MET is equivalent to the oxygen
consumption of a resting 40-year-old 70 kg man. Climbing a
flight of stairs, briskly walking on the flat, mowing the lawn,
swimming, or playing a round of golf is at least 4 METS.
Surgery may proceed without further evaluation in patients
with minor risk factors and good function who are undergoing
low or intermediate risk surgery. Patients with intermediate
risk factors and poor functional capacity may need further
evaluation and optimisation before surgery. Exercise ECG
testing is widely available but impractical for many high risk
surgical patients.
Dobutamine stress echocardiography is the best test to
predict perioperative events, according to most studies. It has
a 100% negative predictive value and patients with extensive
ischaemia experience 10 times more perioperative cardiac
events than those with limited ischaemia. Coronary
angiography is indicated in appropriate high risk patients or
intermediate risk patients after screening.
Overall, less than 10% surgery is associated with a
perioperative cardiac event. However, vascular surgery poses
particular risks because many of the risk factors for peripheral
vascular disease are the same for coronary artery disease
(diabetes, smoking, and hyperlipidaemia). In one study, 1000
consecutive patients with peripheral vascular disease but no
clinical evidence of ischaemic heart disease underwent coronary
angiography; 37% had at least one coronary artery stenosis
of > 70%. The incidence is higher in vascular patients with
clinical evidence of ischaemic heart disease – approximately
60%. Cardiac symptoms may be masked in some of these
patients because their mobility is limited. Major vascular
surgery is also associated with fluctuations in intravascular
volume and blood pressure, which stress the heart.
Several randomised trials have looked at medical therapy to
reduce perioperative risk (β blockers, nitrates and calcium
channel blockers). There is evidence to suggest that
perioperative β blockers reduce cardiac complications
(ischaemic episodes, myocardial infarction, and mortality).
One randomised trial used prophylactic atenolol immediately
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before and up to 7 days after non-cardiac surgery. This reduced
the cardiovascular mortality rate at 6, 12, and 24 months. In
both vascular and general surgery, atenolol reduces
perioperative cardiac mortality and ischaemic complications.
In a study on vascular patients, cardiac mortality and
morbidity was reduced by bisoprolol from 34% to 3·4%.
β blockers are therefore recommended for high risk patients
and patients with hypertension, ischaemic heart disease, or
risk factors for ischaemic heart disease. If preoperative
administration is not possible, intravenous β blocker given at
induction of anaesthesia followed by postoperative treatment
is also effective. The intraoperative use of nitroglycerine in
high risk patients does not affect outcome despite reduced
ischaemia on the ECG.
The diagnosis of myocardial infarction in the perioperative
period can be difficult. One half of patients do not have
typical chest pain. They may present with arrhythmias,
pulmonary oedema, hypotension, or confusion. ECG changes
are common postoperatively and do not necessarily indicate
myocardial infarction. Up to 20% postoperative patients have
new ECG abnormalities – usually T wave changes. Creatinine
kinase rises non-specifically with surgery and troponin
measurements are more appropriate.
Heart failure
Lack of cardiopulmonary reserve is a more important
predictor of perioperative death than cardiac ischaemia. It has
long been observed that high risk patients who survive surgery
have greater compensatory increases in cardiovascular and
oxygen transport measurements than patients who die – non-
survivors are unable to compensate for the added metabolic
and cardiorespiratory demands of surgery and die of multiple
organ failure. High risk patients are those who are most
critically ill at the time of surgery or who face major surgery. 
In the preoperative period, high risk patients have an
increased incidence of severe physiological impairment as
measured by a PA catheter. In many patients the baseline
values can be improved by relatively simple measures, for
example giving fluid or inotropes. Previous studies have
shown that careful invasive monitoring of high risk patients
in the perioperative period improves outcome. More recently,
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“preoptimisation” or screening to see which patients could
benefit from giving therapy preoperatively has also been
shown to improve outcome.
In one study, patients underwent preoperative invasive
cardiovascular monitoring with a PA catheter and were
classified as groups 1 (normal) to 4 (severe physiological
impairment). All of group 1 survived surgery. Groups 2 and 3
had moderate physiological impairment, which could be
corrected with simple measures. Their mortality was 8·5%. In
group 4, with uncorrectable physiological impairment, seven
patients had lesser surgery and survived, 19 were cancelled,
and all 8 who went ahead with the planned surgery died. In
another study, patients were divided in to three groups. Group 1
was assessed using a PA catheter and treated with fluid
loading, afterload reduction, and/or inotropes 12 hours
preoperatively. Group 2 was investigated and treated 3 hours
preoperatively, and group 3 was the control (no PA catheter).
The aim was to achieve a PAOP of 8–15 mmHg, cardiac index
> 2·8 litres per minute m−2, and SVR < 1100 dyn.s cm−5 .
Patients with a PA catheter and subsequent intervention had
significantly fewer adverse intraoperative events and less
overall mortality.
Based on studies like this, practice is moving in the direction
of invasive cardiac monitoring in high risk patients before
major surgery in order to correct pre-existing physiological
impairment and to improve compensatory responses. This
illustrates the general importance of adequate resuscitation
before major surgery.
Echocardiography does not appear to be a useful predictor
of perioperative cardiac events, although a reduced ejection
fraction correlates with an increased risk of perioperative
pulmonary oedema.
Valvular heart disease
Severe aortic stenosis (AS) poses the greatest perioperative
risk. This is because, if hypotension occurs during anaesthesia
and surgery, it can be a difficult problem to correct. AS is a fixed
obstruction and limits maximum cardiac output during stress.
Patients cannot respond normally to the peripheral dilation
associated with anaesthesia and blood pressure can fall
dramatically. This causes myocardial ischaemia, as the
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myocardial hypertrophy seen in AS is associated with increased
oxygen demand. AS may be asymptomatic and patients with
severe stenosis do not necessarily exhibit classical features on
examination. According to the Helsinki Ageing Study, 3%
people aged 75–85 have critical aortic stenosis.
It is also important to recognise mitral stenosis because it is
necessary to control the heart rate in order to preserve
diastole. This aids filling of the left atrium and generates
enough pressure to squeeze blood through the stenosed valve.
The presence of any murmur requires a preoperative
echocardiogram, and antibiotic prophylaxis is required for
most patients with valve disease undergoing surgery.
Cardiac arrhythmias especially atrial fibrillation
Arrhythmias following surgery are common, often
exacerbated by the abrupt withdrawal of cardiac drugs due to
fasting. They are also caused by hypotension, metabolic
derangements, and hypoxaemia – all of which are preventable.
It is important that patients with heart disease are maintained
on their usual drugs, via alternative routes if possible, during
the perioperative period. This particularly applies to β blockers,
which should be administered on the day of surgery.
Five per cent patients over the age of 65 have chronic atrial
fibrillation (AF) and it is a common preoperative finding.
Certain procedures are associated with the development of AF,
for example intrathoracic surgery. Patients with chronic lung
or cardiac disease are at greater risk of developing
postoperative AF. The main difference in the preoperative
period is that β- or calcium channel blockers are considered
more effective than digoxin in controlling the ventricular rate
during stress. If the patient is anticoagulated, this also needs
to be addressed in the preoperative period.
Prophylactic cardiac pacing may be required prior to surgery
in patients at risk of developing complete heart block. These
include patients with bi- or trifascicular block on the ECG, and
they should be assessed by a cardiologist.
Hypertension
The risks of preoperative hypertension are unclear, with
some studies showing increased cardiovascular complications
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and others no increased risk. Hypertension alone is therefore
considered a borderline risk factor. However, hypertension is a
risk factor for ischaemic heart disease.
Mini-tutorial: preoptimisation of the high risk surgical patient
High risk surgical patients are those with poor preoperative status or
who are about to undergo a major procedure or one involving heavy
blood loss. In 1979, Shoemaker et al. defined the criteria for high
surgical risk:
• patient history: age > 70 years with major limitations of
physiological function, previous severe cardiopulmonary or
vascular disease, severe nutritional disorders
• critical factors: severe multiple trauma, massive acute blood loss,
shock, severe sepsis, respiratory failure, acute abdominal
catastrophe, acute intestinal or renal failure
• surgical procedure: extensive surgery for cancer or prolonged
surgery.
Shoemaker’s group observed a mortality of 25% in their own high
risk surgical patients. Outcome was dramatically influenced by the
ability of the patient’s cardiopulmonary system to adapt. Values for
CO, DO2, and oxygen uptake were significantly higher in survivors
than in non-survivors. It was postulated that the observed increase
in CO and DO2 were circulatory responses owing to increased
postoperative oxygen demand. However, subsequent trials which
aimed for “supranormal” values in CO and DO2 were associated with
adverse outcomes.
In high risk surgical patients, reduced cardiac output may
compromise perfusion in organs such as the gastrointestinal tract
and kidney, leading to ischaemia and reperfusion injury. The
subsequent release of reactive oxygen species and inflammatory
mediators leads to activation of immune cells and distant organ
injury (for example, lung and liver) leading to MODS. Early detection
of gastrointestinal hypoperfusion could provide advance warning of
this – it is associated with more severe organ dysfunction, longer ICU
stay, and greater mortality in surgical and trauma patients.
Gastrointestinal hypoper fusion as detected by gastric pH
measurements (tonometry) in postoperative cardiac surgery patients
has been shown to be an early indicator of circulatory failure and
increased morbidity.
The role of dopexamine
In one randomised trial, Boyd et al. used dopexamine to increase
perioperative DO2 in high risk surgical patients. The mean dose of
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dopexamine infused was 1·2 µg kg−1 per minute preoperatively and
1·3 µg kg−1 per minute postoperatively. Mortality at 28 days was
5·7% in the dopexamine group and 22·2% in the controls. A few years
later, Wilson et al. randomised high risk patients into three groups.
Controls received routine perioperative care and two groups were
preoptimised. Optimisation consisted of invasive haemodynamic
monitoring, fluid loading to achieve a PAOP of 12 mmHg, blood
transfusion to achieve an Hb of > 11 g dl−1, oxygen therapy to achieve
saturations of > 94%, and either adrenaline or dopexamine to
increase DO2 to > 600 ml O2 per minute. Inotropic support was
continued during surgery and for at least 12 hours afterwards; 70%
of patients had more than two Shoemaker entry criteria. Mortality
was reduced in both the adrenaline and dopexamine groups (2% and
4%) compared with the controls (17%). This was statistically
significant. Dopexamine also significantly reduced postoperative
morbidity when compared with both the adrenaline and the control
groups.
Dopexamine has anti-inflammatory proper ties as well as
improving regional blood flow and renal function in rat models of
sepsis to a greater extent than either dopamine or dobutamine. Its
various anti-inflammatory effects have yet to be proved in clinical
practice.
In most of these outcome studies, PA catheters were used to
monitor cardiac output and calculate oxygen transport. Research
has concentrated on developing and evaluating less invasive
methods for assessing the adequacy of resuscitation. Intramucosal
pH (pHi) has been shown to be of greater value in monitoring trauma
patients than oxygen transport measurements. In elderly patients
with proximal femur fractures, using oesophageal Doppler
monitoring to guide volume replacement, led to more fluid
administration to the treatment group and a significant reduction in
hospital stay. There was no impact on hospital mortality, possibly
because of the small numbers studied. In elective cardiac surgical
patients with ejection fractions > 50%, patients who received
volume expansion to maximum stroke volume had a significantly
reduced morbidity and hospital stay. These studies support the
concept that adequate fluid resuscitation is of vital importance in
high risk surgical patients.
The assessment of patients with lung disease
Preoperative lung function tests and arterial blood gases can
predict the need for postoperative ventilatory support and
quantify the type and degree of respiratory impairment. High
risk patients include those who are breathless at rest, have a
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PaCO2 > 6·0 kPa (46 mmHg), FEV1 > 1 litre, or an FEV1/FVC
ratio of < 50%. Other factors which make pulmonary
complications more likely include:
• upper abdominal or thoracic surgery (closer to the
diaphragm carries higher risk)
• high ASA class
• COPD
• smoking within the previous 8 weeks
• surgery of longer than 3 hours duration
• obesity.
Certain measures may help to reduce perioperative
pulmonary complications. These are: stopping smoking,
preoperative inhaled β-agonists for patients with COPD, or
intravenous steroids if needed, the use of regional anaesthesia
(with or without general anaesthesia), and lung expansion
exercises postoperatively. Morbidly obese patients (> 115 kg or
250 lb) and smokers are twice as likely to develop
postoperative pneumonia.
Assessment of patients with other problems may be
required. Impairment of any organ system leads to an increase
in perioperative complications. Endocrine disorders (for
example, diabetes), renal failure, liver disease, haematological,
and neurological disorders are not discussed here. Other
scoring systems have been developed that assist in the
assessment of risk prior to surgery, for example the
Child–Pugh classification of liver disease.
Preparation of patients prior to emergency surgery
Surgery, especially emergency surgery, is a physiological
insult. In some cases surgery takes precedence over full
resuscitation (for example, in ruptured aortic aneurysm), but
in most cases there is time to resuscitate the patient. General
and spinal anaesthesia sometimes involve a drop in blood
pressure owing to vasodilatation, and this is exaggerated
if the patient is volume-depleted prior to induction.
Hypovolaemia before emergency surgery is common and is
due to:
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• vomiting and diarrhoea
• fasting
• bleeding
• fluid loss in to an obstructed bowel
• sepsis or SIRS.
As stated throughout this book, proper resuscitation makes
a big difference to outcome – not only in terms of
perioperative mortality but also in terms of postoperative
morbidity. In terms of simple physiology (A, B, C) one should
aim to restore the observations as far towards the patient’s
normal as possible before surgery. This is so that they can
mount a successful compensatory response during the
perioperative period.
Preoperative aims are:
• airway secure
• respiratory rate 10–30
• PaO2 > 10 kPa (77 mmHg)
• well perfused with good cardiac output
• urine output > 1 ml kg−1 per hour
• haemoglobin > 8 g dl−1
• normal electrolytes (especially K+ and Mg2
+)
• acceptable BE (> − 5)
Self assessment – case histories
1. A 75-year-old woman has been admitted 24 hours previously with
large bowel obstruction. She is warm and tachycardic and had
been unwell at home for several days before coming to hospital.
Her urine output per hour has slowly decreased throughout the
day and is now < 0·5 mg kg−1 per hour. She is scheduled for
theatre in a few hours. Outline your management.
2. A 70-year-old woman is due for a partial gastrectomy for stomach
cancer but the surgeons have noted that her ECG has changed
in the last 4 weeks. There is new T wave inversion in leads
V1–V4. You are asked to decide whether or not she has had a
myocardial infarction. She says she had an hour of chest
discomfort 2 weeks ago, but did not seek medical attention. She
does not suffer from angina or breathlessness, and is walking
around the hospital with no symptoms. What is her perioperative
risk, what can you do to reduce that risk, and what do you advise
the surgeons?
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3. A 60-year-old man comes to the Outpatient Department, referred
by an orthopaedic surgeon. The patient has a history of
ischaemic heart disease and has had a myocardial infarction
many years ago. He does not have angina nowadays (on
treatment). He arrives using a walking stick because of his
painful knee, which is due to be replaced. The orthopaedic
surgeon has asked whether it is safe to proceed with the planned
surgery in view of his heart disease. What is the question you are
being asked? How do you assess the patient?
4. A 75-year-old lady is admitted following a fall and a fractured left
neck of femur. There is no past medical history. She has been
lying on the floor for 18 hours at home. On examination her skin
feels warm and dry. She has the following vital signs: in pain,
pulse 110/minute, BP 110/60 mmHg, RR 26 per minute,
temperature 38°C, SaO2 94% on air, urine output – has not
passed urine since admission (not catheterised). There are
coarse crackles at the left base of the lungs and a chest x ray
film shows pneumonia. She is scheduled for theatre as soon as
possible. What do you need to do before then?
5. You are asked to see a 60-year-old man who is being booked for
an elective inguinal hernia repair. In the Outpatient Clinic it is
noted that his oxygen saturations are 89% on air and he is
breathless on exertion. You are asked to advise on his chest
condition before surgery. Further history reveals that he is a
lifelong smoker and used to be a miner. He has several years’
history of breathlessness on exertion but has never seen a
doctor about it. On examination he has hyperexpanded lungs and
prolonged expiration with scattered wheeze. His chest x ray film
shows clear lung fields and his arterial blood gases on air show:
pH 7·4, PaCO2 6·0 kPa (46 mmHg), bicarbonate 27 mmol/l,
BE + 1, PaO2 7·5 kPa (57·6 mmHg). What is your advice to the
surgeons?
6. A 65-year-old lady is admitted with small bowel obstruction, which
is being treated with a nasogastric tube and intravenous fluids.
She has a history of stable angina and hypertension. Her usual
medication includes atenolol 50 mg a day. You are asked to see
her urgently because her pulse is 140 per minute (previously 60
per minute). The ECG shows atrial fibrillation. Why has this
happened and what is your management?
7. A 60-year-old man on treatment for angina and heart failure is
admitted with bowel obstruction. He has been unwell with
vomiting for 4 days. On examination he has a pulse of 100 per
minute, BP 100/50 mmHg, RR 24 per minute, temperature
37·5°C and SaO2 95% on air. His blood results show a raised
white cell count and urea of 15 mmol litre−1 (BUN 41 mg dl−1),
creatinine 300 µmol litre−1 (3·6 mg dl−1). His urea and creatinine
were normal 3 months ago. He is scheduled for theatre as soon
as possible. Should he be “preoptimised”?
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Self assessment – discussion
1. Looking back, preoperative aims were summarised as:
• airway secure
• respiratory rate 10–30
• PaO2 > 10 kPa (77 mmHg)
• well perfused with good cardiac output
• urine output > 1 ml kg−1 per hour
• haemoglobin > 8 g dl−1
• normal electrolytes (especially K+ and Mg2
+)
• acceptable BE (> − 5)
Is this case due to simple hypovolaemia or is this patient
developing SIRS? Management consists of A (giving a high
concentration of oxygen), B (treating any breathing problems),
and C (giving fluid). Hypoperfusion should be assessed further
by measuring blood pressure, respirator y rate, skin
temperature, and arterial blood gases. Invasive monitoring may
be helpful. Particular attention should be paid to the possibility
of electrolyte disturbances from nasogastric losses. Surgery
should be postponed for a short time while resuscitation takes
place – ask whether she should be preoptimised in a high
dependency area.
2. Myocardial infarction is diagnosed from history, electrocardiogram
changes, and a cardiac enzyme rise. Two out of three indicates a
probable recent myocardial infarction. This, and the type of
surgery, places the patient at high risk of perioperative cardiac
complications but, as the surgery is for cancer, it would be
impractical to postpone this for 6 months. In terms of function the
patient is quite good with no angina, breathlessness, nor limitation
of mobility. Post-myocardial infarction treatment is indicated
(including a β blocker, which will also reduce perioperative risk). A
discussion of the risks involved should take place between the
surgeon, anaesthetist, and patient. High risk patient and high risk
surgery should lead to consideration of perioperative invasive
cardiac monitoring.
3. The questions being asked are:
• How significant is this patient’s ischaemic heart disease?
• What is his perioperative cardiac risk?
• Can that risk be reduced by any specific measures?
The patient should be asked about cardiac symptoms and
general function. The Goldman score can be used at this point.
General cardiovascular risk factors should be sought and treated
(for example, hypertension, high cholesterol, diabetes, and
smoking). Perioperative β blockers would be indicated. He is an
intermediate risk patient facing intermediate risk surgery with
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good function. However, his mobility may be limited by his painful
knee, masking angina symptoms. Non-invasive cardiac testing
may therefore be indicated to assess this further.
4. With the list of preoperative aims in Question 1 in mind, this
patient needs oxygen therapy, treatment for pneumonia, and fluid
for dehydration. Analgesia is required, but not with NSAIDs
(oliguria). A urinary catheter and arterial blood gases are
indicated. Blood should be sent for full blood count and
electrolytes. In this case creatinine kinase levels should be
measured, as the patient has been lying on the floor for a long
time and has oliguria (possible rhabdomyolysis). Outcome is
better after a fractured neck of femur if surgery is within 24 hours
and regional anaesthesia is used. The dilemma here is that
delaying surgery while waiting for the chest to improve may not
help. Early surgery, good postoperative care, physiotherapy, and
mobilisation may in fact be better for the chest.
5. This man has a new diagnosis of COPD. This can be confirmed
by pulmonary function tests. He needs treatment for this
condition under the supervision of a chest specialist. Once this
is done and the patient is as fit as he can be (which may mean
he is still breathless and hypoxaemic), the following
recommendations should be made:
• the patient should stop smoking
• perioperative inhaled beta agonists should be prescribed.
Intravenous steroids can be considered. Early mobilisation and
chest physiotherapy are indicated after surgery and a discussion
should take place with the anaesthetist and surgeon as to
whether or not a general anaesthetic can be avoided.
6. The abrupt withdrawal of this patient’s β blocker and possible
electrolyte disturbance (from bowel obstruction and intravenous
fluid administration) have caused atrial fibrillation in this lady with
ischaemic heart disease. Treatment still starts with A, B, C.
Correction of any low potassium or magnesium and intravenous
administration of a β blocker is a logical course of action in this
case.
7. Yes! This patient has significant premorbid conditions and is
about to undergo major surgery. He already has symptoms and
signs of organ dysfunction. Volume depletion may be the cause
of his acute renal failure. He requires aggressive but careful fluid
resuscitation in order to maximise his compensatory responses
to surgery. He should be referred to the ICU where fluid therapy
can be titrated using more advanced forms of monitoring. “Goal-
directed therapy” in this patient may stop the slide from SIRS to
MODS. Goals should be set according to the monitoring available
in your hospital (pressure-based or flow-based). Useful tests to
monitor the success or failure of resuscitation are clinical status
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and biochemical markers of hypoperfusion (base deficit, lactate,
and pHi). Inotropes should be commenced if appropriate.
Dopexamine at a rate of 0·5–1·5 µg kg−1 per minute can improve
oxygen delivery and tissue perfusion. Monitoring should be
continued during surgery and the immediate postoperative
period. “Optimisation” after surgery is less effective in improving
outcome.
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post-operative complications
capillary leak syndrome  81
pulmonary  198
renal failure  156
sodium/water retention  
77, 78
preoperative care  189, 198–9
aims  199
preoperative consultation  189
key components  198
preoperative physiology  
189–203
disease severity
classification  190
physiological reserve  198
self-assessment/case studies  
199–203
Swan–Ganz catheter  114
synchronised intermittent
mandatory ventilation
(SIMV)  59
systemic inflammatory response
syndrome (SIRS)  80, 127
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